
<html lang="en"     class="pb-page"  data-request-id="214758ec-be36-45a2-8dcc-e8182bfad648"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b01489;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2017.60.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking" /></meta><meta name="dc.Creator" content="Wenying  Yu" /></meta><meta name="dc.Creator" content="Chenglong  Li" /></meta><meta name="dc.Creator" content="Wenda  Zhang" /></meta><meta name="dc.Creator" content="Yuanzheng  Xia" /></meta><meta name="dc.Creator" content="Shanshan  Li" /></meta><meta name="dc.Creator" content="Jia-yuh  Lin" /></meta><meta name="dc.Creator" content="Keqin  Yu" /></meta><meta name="dc.Creator" content="Mu  Liu" /></meta><meta name="dc.Creator" content="Lei  Yang" /></meta><meta name="dc.Creator" content="Jianguang  Luo" /></meta><meta name="dc.Creator" content="Yijun  Chen" /></meta><meta name="dc.Creator" content="Hongbin  Sun" /></meta><meta name="dc.Creator" content="Lingyi  Kong" /></meta><meta name="dc.Description" content="Targeting signal transducer and activator of transcription 3 (STAT3) is a potential anticancer strategy. However, STAT3 inhibitors with good selectivity and bioavailability are rare. The aim of thi..." /></meta><meta name="Description" content="Targeting signal transducer and activator of transcription 3 (STAT3) is a potential anticancer strategy. However, STAT3 inhibitors with good selectivity and bioavailability are rare. The aim of thi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01489" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01489" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01489" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01489" /></link>
        
    
    

<title>Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01489" /></meta><meta property="og:title" content="Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0020.jpeg" /></meta><meta property="og:description" content="Targeting signal transducer and activator of transcription 3 (STAT3) is a potential anticancer strategy. However, STAT3 inhibitors with good selectivity and bioavailability are rare. The aim of this study was to discover selective direct STAT3 inhibitors with good druglikeness. By the advanced multiple ligand simultaneous docking (AMLSD) method, compound 9 was designed as an orally bioavailable STAT3 inhibitor that presented superior druggability and selectivity compared with other representative STAT3 inhibitors. 9 directly and selectively inhibited the pY705 site of STAT3 with an affinity (Ki) of 440 nM. The IC50 of 9 for MDA-MB-231 breast cancer cells was 184-fold lower than its IC50 for MCF-10A normal breast epithelial cells. 9 in vivo induced significant antitumor responses (better than gefitinib), and its therapeutic index should be over 100, indicating good safety of 9." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Targeting signal transducer and activator of transcription 3 (STAT3) is a potential anticancer strategy. However, STAT3 inhibitors with good selectivity and bioavailability are rare. The aim of this study was to discover selective direct STAT3 inhibitors with good druglikeness. By the advanced multiple ligand simultaneous docking (AMLSD) method, compound 9 was designed as an orally bioavailable STAT3 inhibitor that presented superior druggability and selectivity compared with other representative STAT3 inhibitors. 9 directly and selectively inhibited the pY705 site of STAT3 with an affinity (Ki) of 440 nM. The IC50 of 9 for MDA-MB-231 breast cancer cells was 184-fold lower than its IC50 for MCF-10A normal breast epithelial cells. 9 in vivo induced significant antitumor responses (better than gefitinib), and its therapeutic index should be over 100, indicating good safety of 9." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0020.jpeg" /></meta><meta name="twitter:title" content="Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01489"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01489">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01489&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01489&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01489&amp;href=/doi/10.1021/acs.jmedchem.6b01489" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2718-2731</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01357" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01499" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenying++Yu">Wenying Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chenglong++Li">Chenglong Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenda++Zhang">Wenda Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuanzheng++Xia">Yuanzheng Xia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shanshan++Li">Shanshan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jia-yuh++Lin">Jia-yuh Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keqin++Yu">Keqin Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mu++Liu">Mu Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Yang">Lei Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianguang++Luo">Jianguang Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yijun++Chen">Yijun Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4920-152X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongbin++Sun">Hongbin Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lingyi++Kong">Lingyi Kong</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-9712-2618" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>State Key Laboratory of Natural Medicines, <sup>‡</sup>Department of Natural Medicinal Chemistry, <sup>∥</sup>Laboratory of Chemical Biology, and <sup>∇</sup>Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">#</span> <span class="aff-text">Water Supply and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div><div class="corresp-info"><strong>*</strong>Phone: +86-25-8327-1405. Fax: +86-25-8327-1405. E-mail: <a href="/cdn-cgi/l/email-protection#eb87928084858cab889b9ec58e8f9ec58885"><span class="__cf_email__" data-cfemail="c1adb8aaaeafa681a2b1b4efa4a5b4efa2af">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01489&amp;href=/doi/10.1021%2Facs.jmedchem.6b01489" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2718–2731</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 28, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 October 2016</li><li><span class="item_label"><b>Published</b> online</span>15 March 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 April 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01489" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01489</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2718%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWenying%2BYu%252C%2BChenglong%2BLi%252C%2BWenda%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D7%26contentID%3Dacs.jmedchem.6b01489%26title%3DDiscovery%2Bof%2Ban%2BOrally%2BSelective%2BInhibitor%2Bof%2BSignal%2BTransducer%2Band%2BActivator%2Bof%2BTranscription%2B3%2BUsing%2BAdvanced%2BMultiple%2BLigand%2BSimultaneous%2BDocking%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2731%26publicationDate%3DApril%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01489"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2032</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01489" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wenying&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Chenglong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Wenda&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yuanzheng&quot;,&quot;last_name&quot;:&quot;Xia&quot;},{&quot;first_name&quot;:&quot;Shanshan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jia-yuh&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Keqin&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Mu&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Jianguang&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Yijun&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Hongbin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Lingyi&quot;,&quot;last_name&quot;:&quot;Kong&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;2718-2731&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01489&quot;},&quot;abstract&quot;:&quot;Targeting signal transducer and activator of transcription 3 (STAT3) is a potential anticancer strategy. However, STAT3 inhibitors with good selectivity and bioavailability are rare. The aim of this study was to discover selective direct STAT3 inhibitors with good druglikeness. By the advanced multiple ligand simultaneous docking (AMLSD) method, compound 9 was designed as an orally bioavailable STAT3 inhibitor that presented superior druggability and selectivity compared with other representative STAT3 inhibitors. 9 directly and selectively inhibited the pY705 site of STAT3 with an affinity (Ki) of 440 nM. The IC50 of 9 for MDA-MB-231 breast cancer cells was 184-fold lower than its IC50 for MCF-10A normal breast epithelial cells. 9 in vivo induced significant antitumor responses (better than gefitinib), and its therapeutic index should be over 100, indicating good safety of 9.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01489&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01489" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01489&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01489" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01489&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01489" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01489&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01489&amp;href=/doi/10.1021/acs.jmedchem.6b01489" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01489" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01489" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01489%26sid%3Dliteratum%253Aachs%26pmid%3D28245116%26genre%3Darticle%26aulast%3DYu%26date%3D2017%26atitle%3DDiscovery%2Bof%2Ban%2BOrally%2BSelective%2BInhibitor%2Bof%2BSignal%2BTransducer%2Band%2BActivator%2Bof%2BTranscription%2B3%2BUsing%2BAdvanced%2BMultiple%2BLigand%2BSimultaneous%2BDocking%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D7%26spage%3D2718%26epage%3D2731%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292576" title="Fluorescence spectroscopy">Fluorescence spectroscopy</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/7" title="Go to Volume 60, Issue 7"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/jmcmar.2017.60.issue-7/20170413/jmcmar.2017.60.issue-7.largecover.jpg" alt="Go to Volume 60, Issue 7"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Targeting signal transducer and activator of transcription 3 (STAT3) is a potential anticancer strategy. However, STAT3 inhibitors with good selectivity and bioavailability are rare. The aim of this study was to discover selective direct STAT3 inhibitors with good druglikeness. By the advanced multiple ligand simultaneous docking (AMLSD) method, compound <b>9</b> was designed as an orally bioavailable STAT3 inhibitor that presented superior druggability and selectivity compared with other representative STAT3 inhibitors. <b>9</b> directly and selectively inhibited the pY705 site of STAT3 with an affinity (<i>K</i><sub>i</sub>) of 440 nM. The IC<sub>50</sub> of <b>9</b> for MDA-MB-231 breast cancer cells was 184-fold lower than its IC<sub>50</sub> for MCF-10A normal breast epithelial cells. <b>9</b> in vivo induced significant antitumor responses (better than gefitinib), and its therapeutic index should be over 100, indicating good safety of <b>9</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Constitutive activated signal transducer and activator of transcription 3 (STAT3) protein is frequently detected in many malignancies,<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> representing one of the most promising anticancer targets.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Activation of the JAK-STAT signaling pathway can be initiated by the binding of cytokines, hormones, and growth factors to the cell surface receptors. Activated receptors phosphorylate JAK kinases, which then phosphorylate STAT3 protein. Phosphorylated STAT3 (p-STAT3) proteins form dimers, which then translocate into the nucleus and bind to DNA, causing cell replication and cancers.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> p-STAT3 can be dimerized by the formation of salt bridges between the R609 residue in the SH2 domain and the pY705 residue of the native peptide. In the STAT3 SH2 domain, there are two “hot spots”, the pY705 (also named pY+0) site and a nearby pY+X site.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The pY705 site is related to the disruption of STAT3 phosphorylation and dimerization of inhibitors, while the nearby pY+X site is associated with the selectivity of STAT3 inhibitors. Therefore, compounds targeting the pY705 and pY+X sites of STAT3 can selectively inhibit both STAT3 phosphorylation and dimerization. In addition, phosphorylation of Ser727 (pS727) of STAT3 enhances transcriptional activation, and acetylation of Lys685 (Ac-K685) is crucial for methylation of tumor-suppressor gene promoters.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Thus, proximal sites, pS727 and Ac-K685 sites, are also functional in tumor cell proliferation.</div><div class="NLM_p">The STAT family includes seven members, among which STAT3 and STAT5 are oncoproteins, but STAT1 plays an opposite role of STAT3 in carcinomas by triggering an antiproliferative effect in tumorigenesis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> STAT5 plays a critical role in lobuloalveolar proliferation, whereas STAT3 regulates lobuloalveolar apoptosis during pregnancy.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In addition, STAT3 is structurally most similar to STAT1 and STAT5. Hence, designing compounds with highly selective inhibitory activity toward STAT3 over STAT1 and STAT5 is difficult and critical for precision anticancer therapy.</div><div class="NLM_p">Strategies for direct deactivation of STAT3 mainly focus on the disruption of STAT3 dimerization and phosphorylation. Several series of direct STAT3 inhibitors have been discovered via both computational and experimental methods, represented by phosphor-peptide mimics,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> non-peptide small-molecule inhibitors,<a onclick="showRef(event, 'ref7 ref8 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref14 ref15 ref16">(7, 8, 14-16)</a> metal-based inhibitors,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and natural-product-like inhibitors.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Some of them have entered clinical trials.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23">(19-23)</a> However, there are no marketed STAT3 inhibitors because of poor selectivity, undesirable pharmacokinetic/pharmacodynamic (PK/PD) properties, or other reasons. Therefore, the improvement of selectivity and druggability will substantially advance the discovery of STAT3 inhibitors as precision anticancer agents.</div><div class="NLM_p">Computer-aided drug design is widely utilized for the efficient identification and optimization of lead compounds.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a> With the aim of designing druggable STAT3 inhibitors, the multiple ligand simultaneous docking (MLSD) method was advanced in two aspects, i.e., fragment library design and linker design (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Using advanced MLSD (AMLSD), we designed compounds that directly inhibit both phosphorylation and dimerization of STAT3 protein, offering an orally available, potent, and selective STAT3 inhibitor, <b>9</b>, which presented superior druggability or selectivity compared with other representative non-peptide small STAT3 inhibitors (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref7 ref8 ref14 ref15 ref19 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref14 ref15 ref19 ref28 ref29">(7, 8, 14, 15, 19, 28, 29)</a> For example, <b>9</b> has better druggability than <b>14</b>,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> which violates Lipinski’s rules.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy of AMLSD for the STAT3 target: (1) Fragment <b>1</b> is paired with each fragment from the polar fragment libraries to form a new library of fragment combinations (FCs), which are simultaneously docked to the pY705 and pY+X sites of the STAT3 protein (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>) and scored by PSO/LGA functions. (2) The best-scoring FCs are linked according to the analysis of their docking modes and redocked to the STAT3 protein. (3) The top-scoring linked compounds are repositioned to their docking modes of the unlinked FCs. Final hits are selected on the basis of the both their repositioned docking modes and scored energies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative small-molecule STAT3 inhibitors. <b>9</b> was designed in this study, and fragment <b>1</b> is colored in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison among <b>9</b> and Other Known STAT3 Inhibitors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">Lipinski’s rule of five</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">selectivity for STAT3 over</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">STAT3 inhibitor</th><th class="colsep0 rowsep0" align="center">MW < 500</th><th class="colsep0 rowsep0" align="center">cLogP < 5<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">orally available for in vivo study</th><th class="colsep0 rowsep0" align="center">STAT1</th><th class="colsep0 rowsep0" align="center">STAT5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">weak</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="left">550</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">626</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">i.p.</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">i.p.</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">weak</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">O: marked if the title requirement is met; otherwise, the violation is listed in detail. “weak” means “weak selectivity”. N/A: marked if the datum was not reported.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">cLogP was calculated using Chemdraw.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design by the AMLSD Method</h3><div class="NLM_p">The first step was design of the fragment libraries. Drug scaffolds (MW < 300) were categorized into six fragment libraries according to their physical properties, including polarity, aromaticity, bulkiness, charge, and acidity/alkalinity. The second step was screening of fragment combinations (FCs). Naphthalene-5,8-dione-1-sulfonamide (fragment <b>1</b>) was paired with each fragment from the polar fragment libraries, forming 963 FCs, which were simultaneously docked to the crystal structure of STAT3 SH2 domain (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>). In the resultant multifragment virtual screening, the FCs were ranked by their binding energies (Table S1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Supporting Information</a> (SI)). The binding modes of the 25 top-ranked FCs are shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. The third step was linker design. Possible linear linkers for the selected FCs were designed by the measured distances. Since the measured distances between two fragments were in the range of 3–5 Å (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Table S1</a>), the length of the linkers should be within the range of 3–5 Å. All of the proper linear linkers are listed in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. Suitable linkers for the FCs were then designed on the basis of two criteria: the feasibility of the synthesis and the superposition of the docking modes of the linked molecules and the separate FCs. Finally, linker <b>a1</b> could connect two fragments through a C–N coupling reaction while the linked compounds could reposition to their FCs. Thus, we chose <b>a</b><b>1</b> as an ideal linker to connect the FCs. The fourth step involved synergistic hit selection. FCs were linked and docked to the STAT3 protein. Their docking modes were repositioned to those of the prelinked FCs. If the linked compound could reposition to its FCs and, in addition, the original contacts between the FCs and protein could be maintained and even more good contacts could be formed after linkage, then we considered the FCs to be synergistically linked. Finally, 10 out of 25 compounds were chosen with synergistic effects (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Table S2</a>). For example, the docking modes of the linked compound <b>9</b> could be repositioned to the docking modes of its FCs (no. 175) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Moreover, additional intermolecular hydrogen bonds were formed between the linker of <b>9</b> and the Ser636 residue, which enhanced the synergistic effects. Finally, the drug-like parameters of the hits were computed, including the ADME and toxicity properties, to predict all of the compounds with decent drug-like properties.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking modes of the 25 FCs selected by AMLSD, labeled by their screening numbers in the library of FCs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Possible linear linkers connecting C6 or C7 of fragment <b>1</b> to a heavy atom of the other fragment. The lengths of the linkers are in the range of 3–5 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of the linked compounds designed by AMLSD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Linked compound <b>9</b> was repositioned to the docking mode of its FC to compare their overlaps. The shortest distance between the two fragments was 3.671 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In order to investigate the selectivities of the 10 compounds for STAT1/3/5 in silico, the compounds were also docked to the crystal structures of STAT1 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF5">1BF5</a>) and STAT5 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U">1Y1U</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Compound <b>1</b> was eliminated since it was also docked to the STAT1 SH2 domain with a free energy of −7.8 kcal/mol. Compounds <b>3</b>, <b>4</b>, <b>6</b>, and <b>8</b> were excluded since they were weakly bound to the STAT5 SH2 domain. Limited by the availability of the starting materials, compound <b>10</b> was not synthesized. Finally, compounds <b>2</b>, <b>5</b>, <b>7</b>, and <b>9</b> were synthesized for further biological tests.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis of the Designed Compounds</h3><div class="NLM_p">Reactions between fragment <b>1</b> and aromatic amines were catalyzed by Cu(OAc)<sub>2</sub>·H<sub>2</sub>O in an acidic environment. The reaction system was heated to 65 °C, and the reaction was terminated when <b>1</b> was consumed completely. The atom numbering of <b>1</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The temperature of the reaction was a key reason for the formation of the cyclized byproducts since the sulfonamide group can attack the nearby 8-ketone with loss of a water molecule to form the cyclized products. A higher temperature can cause a lower yield of the target compounds. For the synthesis of compound <b>9</b>, to ensure selective reaction with the aromatic amine group of the reactant, the piperazine amine was protected with a Cbz group initially and then deprotected with trifluoroacetic acid (TFA).</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0019.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Designed Inhibitors <b>2</b>, <b>5</b>, <b>7</b>, and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu(OAc)<sub>2</sub>·H<sub>2</sub>O, AcOH/H<sub>2</sub>O (1:10 v/v), 65 °C; (ii) TFA, 50 °C.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Cell Assays</h3><div class="NLM_p">In a preliminary in vitro evaluation of the designed compounds, <b>9</b> exhibited better potency than the other compounds against a human basal-like breast cancer cell line, MDA-MB-231 (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). However, its IC<sub>50</sub> for MCF-10A normal breast epithelial cells was 128.9 μM, which is 184-fold higher than that for MDA-MB-231 (0.7 μM). Thus, <b>9</b> was highly selective in targeting of cancer cells. <b>14</b> was selected as the positive control since it is a representative orally available STAT3 inhibitor. Compound <b>9</b> was more potent than <b>14</b> in killing multiple types of cancer cells, i.e., the UW426, UW288-1, BKPC3, MDA-MB-231, and U2OS cell lines (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. IC<sub>50</sub> values of <b>9</b> and positive control <b>14</b> against multiple cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Compound <b>9</b> is a Direct STAT3 Inhibitor</h3><div class="NLM_p">Compound <b>9</b> was predicted to be a direct STAT3 SH2 domain inhibitor by both docking and molecular dynamics (MD) simulations. The intermolecular interactions between compound <b>9</b> and STAT3 were revealed. Analysis of the simulations showed that the sulfamine group of fragment <b>1</b> formed hydrogen bonds with residues Arg609, Ser611, Ser612, and Ser613 in the pY705 site. In detail, the 8-ketone group of fragment <b>1</b> as a major pharmacophore interacted with residues Arg609 and Lys591. The linker amine group contacted with residues Ser636 and Glu638 in the loop. The piperazinyl fragment formed an ionic bond with residue Glu594 and a hydrogen bond with Gln635 in the pY+X site (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The root-mean-square deviations (RMSDs) of the snapshots during the MD simulations also reconfirmed the stable binding between compound <b>9</b> and STAT3 (Figure S2 in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">SI</a>).</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Interactions between <b>9</b> and key residues of STAT3 protein. (B) Interactions between the native peptide and the pY705 site. (C) Docking mode of <b>9</b> to the same binding site as the native peptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The direct binding between <b>9</b> and STAT3 protein was demonstrated by both the fluorescence polarization (FP)-based competitive binding assay and the microscale thermophoresis (MST) assay. <b>9</b> was proven to preferentially bind to the pY705 site of STAT3, competitively disrupting the binding of the native high-affinity, fluorescence-labeled phosphorylated peptide 5-FAM-SpYLPQTV with a <i>K</i><sub>i</sub> value of 0.44 μM (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). In contrast, there was no direct binding between compound <b>9</b> and STAT1/5 proteins. Thus, <b>9</b> was determined to be a selective STAT3 inhibitor by the FP assay. MST is a recently broadly used technology for the analysis of the interactions of biomolecules, and it was used to confirm that <b>9</b> directly bound to the STAT3 protein with a <i>K</i><sub>i</sub> value of 2.42 ± 0.26 μM. The ligand:protein molar ratio was determined to be 1:1 (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B).</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) <b>9</b> competitively and selectively inhibited the binding of fluorescence-labeled peptide to the pY705 site of STAT3 as determined by FP assays. (B) <b>9</b> directly bound to the STAT3 protein as shown by MST assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Selectivity of Compound <b>9</b></h3><div class="NLM_p">The selectivity of 9 was investigated in several ways. (1) <b>9</b> selectively docked to the pY site of STAT3 protein in silico, distant from the pY sites of STAT1/5 proteins (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). (2) <b>9</b> selectively inhibited p-STAT3 at the pY705 site without altering the S727 and K685 sites. The level of p-STAT3(Y705) was reduced in a dose-dependent manner (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>A), while the levels of acetylated STAT3(K685) and p-STAT3(S727) were not dose-dependently influenced by <b>9</b> and the expression of total STAT3 was not changed. This indicates that <b>9</b> selectively decreased the level of pY705-STAT3 and that the decrease was not due to a constitutional decrease in total STAT3 expression (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>B). (3) In Western blot (WB) assays, <b>9</b> selectively inhibited p-STAT3(Y705) (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>A) and interleukin 6 (IL-6)-induced phosphorylation of STAT3 (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>A), without any inhibition of p-STAT1(Y701) (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>B) and interferon-γ (IFN-γ)-induced phosphorylation of STAT1 (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>B). (4) In the electrophoretic mobility shift assay (EMSA), <b>9</b> preferentially inhibited STAT3 homodimer DNA-binding activity over STAT5–STAT5 DNA-binding activity in vitro in a time-dependent manner, indicating that <b>9</b> is a selective STAT3 inhibitor. <b>9</b> weakly decreased the level of STAT1 dimer DNA-binding activity, but there was no observable inhibition of IFN-γ-induced STAT1–STAT1 DNA binding by compound <b>9</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>C). Quantitative real-time polymerase chain reaction (RT-PCR) showed that compound <b>9</b> decreased the expression of the STAT3-specific oncogene MMP9, while the expression of the STAT1-specific gene CDK2 was not significantly influenced upon treatment with <b>9</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>D). (5) The stimulation of STAT3 upstream targets, such as EGFR, can induce not only the level of p-STAT3 but also the levels of p-AKT and p-ERK1/2 kinases. To investigate whether compound <b>9</b> is selective to the JAK-STAT signaling pathway, we also evaluated the levels of p-AKT and p-ERK1/2 kinases in bypass pathways. The phosphorylation levels of both kinases were not inhibited by <b>9</b> either (<a class="ref internalNav" href="#fig11" aria-label="Figures 11">Figures 11</a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">S8</a>). <b>9</b> showed better selectivity than <b>14</b> toward p-AKT, since the level of p-AKT was decreased by <b>14</b> but was not affected by <b>9</b> in the MDA-MB-231 cancer cell line (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>C). In all, compound <b>9</b> selectively inhibited pY705-STAT3 protein.</div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <b>9</b> was docked to the crystal structures of STAT1 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF5">1BF5</a>), STAT3 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>), and STAT5 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U">1Y1U</a>). Their docking energies are marked in red. In each structure, the region circled in yellow is the pY site of the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A, B) Immunoblots of p-STAT3(Y705), p-STAT3(S727), total STAT3 (T-STAT3), Ac-STAT3, p-STAT1(Y701), T-STAT1, SHP-1, and GAPDH from whole-cell lysates from MDA-MB-231 cells were treated with <b>9</b>. (C) MDA-MB-231 cells were treated with <b>9</b> and <b>14</b>, probing for p-AKT, T-AKT, cleaved caspase 3, and GAPDH. (D) Western blot results from (B) were calculated and are presented as the percent of control. (*, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A, B) MDA-MB-231 cancer cells were treated with IL-6, IFN-γ, and <b>9</b>, probing for p-STAT3(Y705), T-STAT3, p-STAT1(Y701), T-STAT1, and β-actin. (C) MDA-MB-231 cells were treated with <b>9</b> at 5 μM for 0–24 h or IFN-γ and different concentrations of <b>9</b> by EMSA assays. (D) The expression of MMP9 and CDK2 genes treated with <b>9</b> was measured by RT-PCR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>9</b> Induced the Expression of SHP-<b>1</b></h3><div class="NLM_p last">Interestingly, <b>9</b> was found to induce the expression of STAT3 phosphatase (SHP-1). The mechanism is still unknown, but the effect may partially contribute to the low IC<sub>50</sub> values of <b>9</b> (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>B,D).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>9</b> Induced Apoptosis in Malignant Cancers</h3><div class="NLM_p last">The inhibition of STAT3 phosphorylation by <b>9</b> seemed to be consistent with the induction of apoptosis, as evidenced by the increase of cleaved caspase-3 in the MDA-MB-231 cancer cell line (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>C).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>9</b> Inhibited the Nuclear Translocation of p-STAT3 to the Nucleus</h3><div class="NLM_p">The IL-6-induced level of p-STAT3 in the cytoplasm and nucleus treated with <b>9</b> was lower than that upon treatment with <b>14</b> as determined by immunofluorescence staining, suggesting that <b>9</b> blocked STAT3 nuclear translocation with a better effect than <b>14</b> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>).</div><figure id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. MDA-MB-231 cells were stimulated with IL-6. The migration of p-STAT3 to the nucleus was treated with <b>9</b> and <b>14</b> (5 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Study of Compound <b>9</b></h3><div class="NLM_p">To investigate the safety profile of compound <b>9</b>, the acute toxicity of <b>9</b> was tested in ICR mice at doses of 200, 400, 600, 800, and 1000 mg/kg (i.p., <i>n</i> = 10 per group). All of the mice were vital and lively even when treated at the highest dose (1000 mg/kg), and thus, the median lethal dose (LD<sub>50</sub>) could not be obtained. Since 70% tumor weight was shrunk at 10 mg/kg <b>9</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Figure S9</a>), the therapeutic index of <b>9</b> should be over 100 (1000/10 = 100), indicating good safety of <b>9</b>.</div><div class="NLM_p">First, we found that <b>9</b> orally inhibited the growth of cancer xenografts with better therapeutic effects than the first-line anticancer drug gefitinib and with less toxicity than doxorubicin. The nude mice tumor xenografts were injected subcutaneously with human breast cancer MDA-MB-231 cells. <b>9</b> orally shrank 53% tumor weight at 2.5 mg/kg, 60% tumor weight at 5 mg/kg, and 70% tumor weight at 10 mg/kg, whereas for gefitinib, a dosage of 40 mg/kg was needed to achieve similar therapeutic effects as <b>9</b> at 10 mg/kg, indicating that <b>9</b> is more active than gefitinib (<a class="ref internalNav" href="#fig14" aria-label="Figures 14">Figures 14</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">S9</a>). The body weight after treatment with either gefitinib or <b>9</b> increased normally (<a class="ref internalNav" href="#fig14" aria-label="Figures 14">Figures 14</a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">S9D</a>), and no damage to the major organs (heart, liver, spleen, lung and kidney) was detected by hematoxylin and eosin (H&E) staining (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Figure S9B</a>).</div><figure id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (A) Anatomical nude mice’s tumor tissues untreated or treated with <b>9</b>. (B) Inhibition percentage of mice’s tumor weight upon treatment with <b>9</b>. (C) Growth curve of tumor volume upon treatment with <b>9</b>. (D) Growth curve of mice’s body weight upon treatment with <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The IC<sub>50</sub> of <b>9</b> was first evaluated as 0.42 μM in the S180 cancer cell line. In the mouse sarcoma tumor xenografts, 73% tumor weight was significantly (<i>p</i> < 0.001) shrunk by <b>9</b> after a 21 day therapy (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>A,C,E), with <b>9</b> at 5 mg/kg showing much lower side effects than doxorubicin at 1 mg/kg. Dramatic loss of body weight was observed from the 13th day upon treatment with doxorubicin, whereas for <b>9</b> the increase in body weight was normal (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>D,F). Additionally, the sizes of the liver, spleen, and kidney upon treatment with doxorubicin were notably smaller than those upon treatment with <b>9</b> (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>B).</div><figure id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0015.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Anatomical mice’s tumor tissues treated with <b>9</b> and doxorubicin. (B) Anatomical major organs (liver, spleen, and kidney) treated with <b>9</b> and doxorubicin. (C) Growth curves of mice’s tumor volume. (E) Inhibition percentages of mice’s tumor weight. (D, F) Growth curves and inhibition percentages of mice’s body weight.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Second, we observed that <b>9</b> disabled STAT3 activity in vivo. The in vivo inhibitory activity of <b>9</b> against the overexpression level of p-STAT3 was studied by both immunohistochemical (IHC) analysis and WB. From the IHC results, <b>9</b> showed dose-dependent inhibitory effects on p-STAT3 (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>). The results were confirmed by the WB results, which showed that <b>9</b> dose-dependently inhibited the level of p-STAT3 but had little influence on the level of total STAT3 (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>).</div><figure id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0016.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. IHC analysis of p-STAT3 in tumor tissues treated with <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0017.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Immunoblots of p-STAT3(Y705), T-STAT3, and GAPDH from whole-cell lysates from tumor tissues treated with 2.5, 5, or 10 mg/kg compound <b>9</b>. Positions of proteins in the gel are shown with the control lane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Third, the oral bioavailability of compound <b>9</b> was measured as 44.7 ± 11.9%, which is comparable to that of gefitinib (47.4 ± 0.9%), by a PK study. The PK parameters of <b>9</b> were well-comparable to those of gefitinib too (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The changes in plasma concentrations in rats from 2 min to 24 h upon treatment with <b>9</b> (i.v. and p.o.) are shown in <a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>. These results indicate that <b>9</b> is an orally bioavailable candidate. The method was fully validated according to the FDA guidelines for selectivity, linearity, lower limits of quantification (LLOQ), accuracy, precision, recovery, matrix effect, and stability (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Tables S8–S11</a>).</div><figure id="fig18" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0018.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Plasma concentration–time profiles of <b>9</b> in rats following i.v. and p.o. administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Main Pharmacokinetic Parameters of <b>9</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">gefitinib</th><th class="rowsep1 colsep0" colspan="2" align="center"><b>9</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">units</th><th class="colsep0 rowsep0" align="center">i.v. (1 mg/kg)</th><th class="colsep0 rowsep0" align="center">p.o. (10 mg/kg)</th><th class="colsep0 rowsep0" align="center">i.v. (1 mg/kg)</th><th class="colsep0 rowsep0" align="center">p.o. (10 mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">2.39 ± 1.18</td><td class="colsep0 rowsep0" align="left">2.17 ± 0.93</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.34</td><td class="colsep0 rowsep0" align="left">1.98 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">ng/mL</td><td class="colsep0 rowsep0" align="left">621.3 ± 83.5</td><td class="colsep0 rowsep0" align="left">1202.7 ± 140.0</td><td class="colsep0 rowsep0" align="left">359.0 ± 77.5</td><td class="colsep0 rowsep0" align="left">540.3 ± 147.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>0</sub></td><td class="colsep0 rowsep0" align="left">ng/mL</td><td class="colsep0 rowsep0" align="left">714.8 ± 137.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">382.3 ± 73.6</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–<i>t</i></sub></td><td class="colsep0 rowsep0" align="left">h·ng/mL</td><td class="colsep0 rowsep0" align="left">490.6 ± 73.7</td><td class="colsep0 rowsep0" align="left">2356.79 ± 43.5</td><td class="colsep0 rowsep0" align="left">189.0 ± 54.4</td><td class="colsep0 rowsep0" align="left">850.0 ± 252.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub></td><td class="colsep0 rowsep0" align="left">h·ng/mL</td><td class="colsep0 rowsep0" align="left">500.8 ± 72.4</td><td class="colsep0 rowsep0" align="left">2371.1 ± 44.7</td><td class="colsep0 rowsep0" align="left">199.2 ± 56.3</td><td class="colsep0 rowsep0" align="left">889.0 ± 236.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub><i>z</i></sub></td><td class="colsep0 rowsep0" align="left">mL/kg</td><td class="colsep0 rowsep0" align="left">6678.0 ± 2397.4</td><td class="colsep0 rowsep0" align="left">13238.7 ± 5903.4</td><td class="colsep0 rowsep0" align="left">4944.2 ± 925.1</td><td class="colsep0 rowsep0" align="left">32092.5 ± 7550.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">mL·h<sup>–1</sup>·kg<sup>–1</sup></td><td class="colsep0 rowsep0" align="left">2028.3 ± 300.1</td><td class="colsep0 rowsep0" align="left">4218.5 ± 79.2</td><td class="colsep0 rowsep0" align="left">5261.7 ± 1289.7</td><td class="colsep0 rowsep0" align="left">11766.8 ± 2612.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUMC<sub>0–<i>t</i></sub></td><td class="colsep0 rowsep0" align="left">h<sup>2</sup>·ng/mL</td><td class="colsep0 rowsep0" align="left">1098.0 ± 734.0</td><td class="colsep0 rowsep0" align="left">5649.7 ± 677.1</td><td class="colsep0 rowsep0" align="left">109.3 ± 59.4</td><td class="colsep0 rowsep0" align="left">1622.6 ± 718.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUMC<sub>0–∞</sub></td><td class="colsep0 rowsep0" align="left">h<sup>2</sup>·ng/mL</td><td class="colsep0 rowsep0" align="left">1261.5 ± 845.2</td><td class="colsep0 rowsep0" align="left">5903.9 ± 687.9</td><td class="colsep0 rowsep0" align="left">149.0 ± 85.1</td><td class="colsep0 rowsep0" align="left">2002.1 ± 575.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT<sub>0–<i>t</i></sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">2.12 ± 1.17</td><td class="colsep0 rowsep0" align="left">2.40 ± 0.30</td><td class="colsep0 rowsep0" align="left">0.55 ± 0.14</td><td class="colsep0 rowsep0" align="left">1.87 ± 0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT<sub>0–∞</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">2.40 ± 1.32</td><td class="colsep0 rowsep0" align="left">2.49 ± 0.31</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.20</td><td class="colsep0 rowsep0" align="left">2.25 ± 0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="left">%</td><td class="colsep0 rowsep0" colspan="2" align="left">47.4 ± 0.9</td><td class="colsep0 rowsep0" colspan="2" align="left">44.7 ± 11.9</td></tr></tbody></table></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> PAINS Analysis</h3><div class="NLM_p">All of the designed compounds were filtered by the online filter for pan-assay interference compounds (PAINS) (<a href="http://zinc15.docking.org/patterns/home/" class="extLink">http://zinc15.docking.org/patterns/home/</a>). The quinone group was detected, which is a common structure in natural products. It is also a substructure for endogenous molecules, such as vitamin K, and some approved drugs, such as mitomycin, menadione, and idebenone. To test the potential reactivity of the α,β-unsaturated carbonyl group as a Michael acceptor site in the quinone group, compound <b>9</b> and cysteamine were mixed in DMSO or water solutions at 37 °C overnight. No reaction was found, as monitored by TLC (see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">SI</a>), indicating that <b>9</b> is not very reactive.</div><div class="NLM_p last">The experimental results proved the good activity, selectivity, and safety of compound <b>9</b>. The STAT3 siRNA transfection experiment demonstrated that the major antitumor target for compound <b>9</b> is STAT3 and that compound <b>9</b> is selective for STAT3 protein (see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">SI</a>). For the cell-based assays, both the MCF-10A normal breast epithelial cell line and the MDA-MB-231 breast cancer cell line were treated with compound <b>9</b>. The IC<sub>50</sub> for normal cells, 128.9 μM, was 184-fold higher than that for cancer cells, 0.7 μM, indicating that compound <b>9</b> selectively targets the tumor cells with good safety. For the acute toxicity study, mice were vital and lively, even upon oral treatment with 1 g/kg compound <b>9</b>, indicating that its therapeutic index should be over 100. The growth of the body weight of mice was also not affected by compound <b>9</b>, although the body weight of mice was significantly decreased by doxorubicin. No damage of the major organs (heart, liver, spleen, lung, and kidney) upon treatment with <b>9</b> was detected by H&E staining (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>B). The sizes of the liver, spleen, and kidney treated with doxorubicin were notably smaller than those upon treatment with <b>9</b> too (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>B). All of the in vivo results indicated that compound <b>9</b> had better safety than the first-line anticancer drug doxorubicin. In addition, in the protein-based assays, compound <b>9</b> was proved to be a direct inhibitor of STAT3 protein. Therefore, both the in vitro and in vivo results point to compound <b>9</b> as a nonpromiscuous, selective STAT3 inhibitor.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">By the AMLSD method, multiple fragments are simultaneously docked to one target, which can cover the chemical spaces of binding sites better than hopping of one ligand. MLSD was advanced in fragment library design and the evolution process. The fragment library design is crucial for successful drug design. In our study, fragments were derived from the drug scaffolds aiming to design more druggable STAT3 inhibitors. Old drugs might “repurpose” for new uses.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The building blocks of clinical drugs share many interesting properties, and thus, there is a higher chance to find drug candidates by designing compounds derived from drug scaffolds.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In addition, AMLSD determines linkers in a manner reminiscent of the BRIDGE program in LUDI.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> For example, different xylenes were determined by distance measurement in our case. Since the intermolecular interactions between fragments have been considered by AMLSD, there is a higher chance that the linked compounds could be repositioned to their fragment combinations. For previous applications of the MLSD method, the fragment library was designed according to the similarity of fragments to the scaffolds of known inhibitors. Then the selected fragments were grouped as FCs, resulting a very limited number of FCs before docking. The number of final linked compounds is small and determined by the variety of known inhibitors. If drug targets lack known inhibitors, then it would be hard to apply the MLSD method to design compounds. AMLSD can overcome the above problems. The selection of fragments no longer relies on the scaffolds of known inhibitors. Thus, AMLSD is more useful to design candidates for a target that is not so well-studied.</div><div class="NLM_p">Compound <b>9</b> was found to selectively bind to the p-STAT3(Y705) protein rather than STAT1/5 proteins, p-AKT and p-ERK kinases in bypass pathways, and other proximal sites. <b>9</b> also selectively targeted the MDA-MB-231 cancer cells by significantly disabling the p-STAT3 level. The IC<sub>50</sub> of <b>9</b> for normal cells was 184-fold higher than that for breast cancer cells. For the animal study, the growth of the body weight of mice was not affected by compound <b>9</b>, which had much less toxicity than the first-line anticancer drug doxorubicin. The therapeutic index of <b>9</b> should be over 100. In protein, cell, and animal levels, <b>9</b> was proved to exhibit good selectivity and safety.</div><div class="NLM_p last">Compound <b>9</b> was found to be a direct small-molecule inhibitor (MW < 500) of STAT3 with a very low <i>K</i><sub>i</sub> value (440 nM). <b>9</b> also showed very low IC<sub>50</sub> values in different cancer cell lines. <b>9</b> had excellent aqueous solubility. The oral bioavailability of <b>9</b> was 44.7% by PK study, comparable to that of the first-line drug gefitinib (47.4%). Thus, <b>9</b> is an orally bioavailable STAT3 inhibitor. All of its physicochemical properties follow Lipinski’s rule of five. In a comprehensive assessment of <b>9</b> and other representative STAT3 inhibitors, <b>9</b> showed outstanding features among all. Further experiments are needed to evaluate the potential of <b>9</b> to undertake clinical trials.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">AMLSD was used to design new STAT3 inhibitors by screening of FCs built from the library of drug scaffolds. Among these compounds, <b>9</b> was proved to directly and selectively bind to the pY705 site of STAT3 protein, which significantly decreased the level of STAT3 phosphorylation/dimerization as a dual-functional inhibitor. <b>9</b> also significantly shrank the tumor weight of both breast cancer and sarcoma cancer xenographs in vivo with better activity than the first-line drug gefitinib and less toxicity than doxorubicin. The therapeutic index of <b>9</b> should be over 100, indicating good safety of <b>9</b>.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Design</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Software</h4><div class="NLM_p last">The design part was mainly performed in Dr. Chenglong Li’s lab at the Ohio State University. MLSD software was written by Dr. Li’s lab.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The Schrödinger package was purchased from its commercial supplier, and its English version was installed. Autodock4 was downloaded from its official Web site (<a href="http://autodock.scripps.edu/" class="extLink">http://autodock.scripps.edu/</a>) for free and installed in English.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Analysis of Binding Sites</h4><div class="NLM_p last">There are two “hot spots” in the STAT3 SH2 domain, the pY705 and pY+X sites. According to the crystal structure of the pY+X site of STAT3 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>), several key polar residues were embedded inside and formed a polar binding region. On the basis of the structural analysis of the crystallized STAT1, STAT3, and STAT5, the pY705 site is highly conserved but the pY+X site varies within this family of proteins, which plays an important role in the selectivity of STAT inhibitors. We combined fragment <b>1</b> with each fragment of the polar fragment libraries to perform the hopping of FCs in the two adjacent pY705 and pY+X sites, aiming to design selective inhibitors of STAT3.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Preparation of Fragment Libraries</h4><div class="NLM_p last">The fragment libraries in our study were generated from 1554 FDA-approved drugs, 4959 experimental drugs, 84 nutraceutical drugs, and 521 investigational drugs collected by the Drugbank database (<a href="https://www.drugbank.ca/" class="extLink">https://www.drugbank.ca/</a>). The complete database of all drugs was downloaded and prepared by LigPrep of Schrödinger using the default parameters.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Fragments were extracted from the drugs using the scaffold decomposition program in Canvas of Schrödinger with the default parameters.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Fragments were calculated with MW and Polar using physicochemical descriptors by Canvas of Schrödinger.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> All of the scaffolds were exported, and the scaffolds with molecular weight higher than 300 were deleted. The total charge of each fragment was calculated by ligfilter descriptors. Other properties were divided manually. Fragments were reorganized using property filters by Canvas of Schrödinger as six fragment libraries: polar_uncharged_nonaromatic fragment library, polar_uncharged_aromatic fragment library, polar_charged_basic fragment library, polar_charged_acidic fragment library, large and bulk fragment library, and nonpolar fragment library.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Screening of FCs and Evolution of FCs to Final Hits</h4><div class="NLM_p">Two fragments as one fragment combination were grouped to probe the two “hot spots” of the STAT3 SH2 domain, the pY705 and pY+X sites. Fragment <b>1</b>, which was the privileged structure of the two most potent STAT3 SH2 inhibitors, <b>16</b> and <b>17</b>,<a onclick="showRef(event, 'ref8 ref35'); return false;" href="javascript:void(0);" class="ref ref8 ref35">(8, 35)</a> formed two dipole–ionic interactions with residue R609 in the pY705 site, as analyzed by MD simulations (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Figure S3</a>). Thus, fragment <b>1</b> was chosen for the inhibition of the pY705 site while fragments fitting the pY+X site were screened from the newly designed fragment libraries. Since the pY+X site of STAT3 has a key polar binding region, fragments fitting to the pY+X site were screened from the four polar fragment libraries, giving a total of 963 fragments, including 280 polar uncharged nonaromatic fragments, 532 polar uncharged aromatic fragments, 61 polar charged basic fragments, and 90 polar charged acidic fragments. The PDB file of each fragment from the four polar fragment libraries was grouped together with the PDB file of fragment <b>1</b> and finally formatted as one PDB file, resulting in 963 fragment combinations. Each FC included two fragments.</div><div class="NLM_p">The FCs best fit for the pY705 and pY+X sites were docked to the crystal structure of STAT3 SH2 domain, scored by the PSO method,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and then ranked by their docking energies.</div><div class="NLM_p">The evolution of fragments to one compound was guided by the docking modes of the FCs, which were no longer determined by designers’ chemical intuition or experience. The shortest distances between C6 or C7 of fragment <b>1</b> and the heavy atoms of the other fragment were around 3–5 Å (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Table S1</a>), as measured by Maestro of Schrödinger. For example, for compound <b>9</b>, the shortest distance between C6 of fragment <b>1</b> and the other 2-(piperazin-1-yl)aniline fragment was 3.671 Å (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Thus, the length of possible linear linkers should be within the range listed in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. Every linker was tried to link the FCs, and the linker <b>a1</b> was finally chosen on the basis of synthetic feasibility and its repositioning ability. Linked compounds were repositioned to the SH2 domain, scored by the Lamarckian Genetic Algorithm (LGA) of Autodock4, and ranked by binding energy. Final hits were selected on the basis of both the docking energies and their repositioned docking modes. They were then synthesized and tested by all kinds of biological assays.</div><div class="NLM_p last">The docking procedure involved the preparation of the ligand and macromolecule using the Schrödinger software.<a onclick="showRef(event, 'ref33 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref36">(33, 36)</a> AutoDockTools were used to assign Gasteiger charges to the ligands. AutoGrid maps were then calculated for all atom types in the ligand set. The grid box was centered in the SH2 domain of the STAT proteins. After 10 million energy evaluations, all of the resulting conformations of the ligands in the binding pocket of the macromolecule were clustered into groups according to their conformations with a root-mean-square deviation threshold of 1.5 Å. The most significant low-energy clusters were identified, and their binding energies were evaluated.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> ADME Prediction</h4><div class="NLM_p last">The designed compounds were prepared using the LigPrep wizard in the Schrödinger software. The ADME properties of the compounds were calculated using the QikProp wizard in the Schrödinger software, including whether (I) fewer than five maximum possible metabolites would be formed in vivo; (II) the clogP value for octanol/water was in the range of −2 to 2, indicating an excellent aqueous solubility profile; (III) the predicted logIC<sub>50</sub> value for hERG K<sup>+</sup> channel blocking was below −5; (IV) the predicted Caco-2 and MDCK cell permeability values were acceptable; (V) the predicted index of binding to human serum albumin was well within the recommended range of −1.5 to 1.5; and (VI) the predicted human oral absorption percentage was above 50%.</div></div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div id="sec5_1_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Chemicals and Reagents</h4><div class="NLM_p last">The solvents and reagents were purchased from commercial suppliers and used as received. Silica gel was purchased from Sigma-Aldrich Chemical Co. (Milwaukee, WI). All of the synthetic derivatives and compounds purchased were obtained with >96.0% purity as determined by HPLC (UV detection at 254 and 280 nm). Positive control <b>14</b> was purchased from commercial suppliers.</div></div><div id="sec5_1_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Synthesis of Fragment <b>1</b></h4><div class="NLM_p last"><b>1</b> was synthesized as previously described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec5_1_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Synthesis of Designed Compounds</h4><div class="NLM_p">Fragment <b>1</b> was reacted with aromatic amines as previously described<a onclick="showRef(event, 'ref8 ref38'); return false;" href="javascript:void(0);" class="ref ref8 ref38">(8, 38)</a> under catalysis by Cu(OAc)<sub>2</sub>·H<sub>2</sub>O in an acidic environment. The reaction system was heated to 65 °C, and the reaction was terminated when <b>1</b> was consumed completely. Compounds <b>2</b>, <b>5</b>, and <b>11</b> were synthesized as reported previously.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div id="sec5_1_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 5-((1,4-Dioxo-5-sulfamoyl-1,4-dihydronaphthalen-2-yl)amino)nicotinic Acid (<b>7</b>)</h5><div class="NLM_p last">Yield: 71%. <sup>1</sup>H NMR (500 MHz, DMSO): δ 8.31 (s, 1H), 8.04 (d, <i>J</i> = 7.6 Hz, 1H), 7.98 (d, <i>J</i> = 2.5 Hz, 1H), 7.94 (d, <i>J</i> = 7.5 Hz, 1H), 7.78 (t, <i>J</i> = 7.5 Hz, 1H), 7.44 (s, 1H), 7.40 (s, 2H), 5.62 (s, 1H), 5.34 (s, 2H). HRMS (ESI) for C<sub>16</sub>H<sub>11</sub>N<sub>3</sub>O<sub>6</sub>SNa [M + Na]<sup>+</sup>: calcd, 396.0266; found, 396.0270.</div></div><div id="sec5_1_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 5,8-Dioxo-6-((2-(piperazin-1-yl)phenyl)amino)-5,8-dihydronaphthalene-1-sulfonamide (<b>9</b>)</h5><div class="NLM_p last">Compound <b>11</b> (0.15 mM, 80 mg) was dissolved in 5 mL of TFA, and the solution was heated to 50 °C for 8 h. As detected by TLC, after <b>11</b> had completely reacted, all of the volatiles were removed under reduced pressure. The resulting crude product was applied to a column of silica gel. The column was eluted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1 v/v), and then the product was further purified by recrystallization. The solvent was removed under reduced pressure to give product <b>9</b>. Yield: 92%. <sup>1</sup>H NMR (300 MHz, DMSO): δ 9.15 (s, 1H), 8.85 (m, 2H), 8.43 (d, <i>J</i> = 7.1 Hz, 1H), 8.09 (m, 2H), 7.63–7.05 (m, 4H), 5.80 (s, 1H), 3.60 (m, 4H), 3.14 (s, 5H). HRMS (ESI) of C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: calcd, 413.1284; found, 413.1290.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Biological Assays and Biochemical Assays</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Cell Cultures</h4><div class="NLM_p">Human medulloblastoma cell lines (UW426, UW288-1, and DAOY) and human pancreatic cancer cell line (BkPC-3) were used as stored in the Center for Childhood Cancer, the Research Institute at Nationwide Children’s Hospital, in 2014. Human breast cancer cell lines (basal-like subtype MDA-MB-231 and luminal A subtype MCF-7), human osteosarcoma cell line (U2OS), human normal breast epithelial cell line (MCF-10A), and mouse sarcoma cell line (S180) were purchased from ATCC in 2015. All cell lines were tested without mycoplasma contamination.</div><div class="NLM_p last">The human cancer cell lines UW426, UW288-1, DAOY, BkPC-3, MDA-MB-231, and MCF-7 were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% penicillin/streptomycin fetal bovine serum (FBS) and stored in a humidified 37 °C incubator with 5% CO<sub>2</sub>. Human bone osteosarcoma (U2OS), human breast cell line (MCF-10A), and mouse sarcoma cell line (S180) were maintained in RPMI-1640 medium supplemented with 10% FBS and antibiotics (100 units/mL penicillin G and 100 μg/mL streptomycin) and stored in a humidified 37 °C incubator with 5% CO<sub>2</sub>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Chemicals</h4><div class="NLM_p last">Compounds were dissolved in sterile DMSO to make 20 mM stock solutions. Aliquots of the stock solutions were stored at −20 °C.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Cell Viability Assay</h4><div class="NLM_p last">Studies were performed as previously described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The UW426, UW288-1, BkPC3, MDA-MB-231, U2OS, S180, and MCF-10A cell lines were seeded in 96-well plates at a density of 3000 cells/well. The cells were incubated at 37 °C for a period of 24 h. For the preliminary assay, <b>2</b>, <b>5</b>, <b>7</b>, and <b>9</b> (5 μM) were added in triplicate to the plates in the presence of 10% FBS for 24 h. 3-(4,5-Dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) was added to evaluate the cell viability. For the IC<sub>50</sub> measurements, different concentrations of <b>9</b> (0.1–10 μM for cancer cells and 3.125–400 μM for MCF-10A), <b>14</b> (0.1–20 μM), and other compounds were added in triplicate to the plates in the presence of 10% FBS. For the S180 cell line, cells were only treated with compound <b>9</b> (0.1–10 μM). MTT was added to evaluate the cell viability. The absorbance was read at 595 nm. IC<sub>50</sub> values were determined using SigmaPlot 9.0 software (SySTAT Software, Inc., San Jose, CA).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Fluorescence Polarization</h4><div class="NLM_p last">Studies were performed as previously described.<a onclick="showRef(event, 'ref8 ref39'); return false;" href="javascript:void(0);" class="ref ref8 ref39">(8, 39)</a> FP assay was used to analyze the ability of <b>9</b> to inhibit phosphopeptide binding to the STAT SH2 domain. STAT3 protein and peptides were purchased from Genscripts. STAT1/5 proteins were purchased from Abcam, and their peptides were purchased from Taopushengwu, Inc. (Shanghai, China).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Microscale Thermophoresis</h4><div class="NLM_p last">A titration series of up to 16 dilutions of inhibitor <b>9</b> was prepared. Here the concentration of the fluorescently labeled STAT3 protein was kept constant at 10–20 nM and the concentration of the titrant was varied. Therefore, 2–20 μM STAT3 protein was labeled with a fluorescent dye using Monolith NT Protein Labeling Kits. The labeling procedure and the subsequent removal of free dye were performed within 45 min. In the dilution series, the highest concentration was chosen to be 20-fold higher than the expected <i>K</i><sub>i</sub>. A 10 μL aliquot of the serial dilution of the nonlabeled molecule was mixed with 10 μL of the diluted fluorescently labeled molecule. Mixed samples were loaded into glass capillaries, and the MST-analysis was performed using the Monolith NT.115 MST instrument.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Western Blot Analysis</h4><div class="NLM_p last">Studies were performed as previously reported.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> MDA-MB-231 cells were treated with <b>9</b> (2.5–10 μM) or <b>14</b> (2.5–5 μM) or DMSO at 60–80% confluence in the presence of 10% FBS for 12 h. UW426 cells were treated with <b>9</b> (1–2.5 μM) or <b>14</b> (1–2.5 μM) or DMSO at 60–80% confluence in the presence of 10% FBS for 24 h.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> IL-6/IFN-γ Induction of STAT3/1 Phosphorylation</h4><div class="NLM_p last">MDA-MB-231 cancer cells were seeded in 10 cm plates and allowed to adhere overnight. The following day, the cells were serum-starved. The cells were then left untreated or treated with <b>9</b> (2.5–5 μM) or DMSO. After 2 h, the untreated and treated cells were stimulated by IL-6/IFN-γ (50 ng/mL). The cells were harvested after 30 min and analyzed by Western blot.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Quantitative Real-Time PCR</h4><div class="NLM_p last">Levels of mRNA expression were analyzed with the RT-PCR assay in MDA-MB-231 cells. Total RNA was isolated using an EASYspin Plus tissue/cell RNA extraction kit (Aidlab Biotechnologies Co. Ltd.), which was quantified at 260 nm. RNA (1 μg) was reverse-transcribed to cDNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Basel, Switzerland). Thermal cycling conditions included 95 °C initial denaturation for 5 min, followed by 40 cycles of denaturation (10 s at 95 °C), annealing (15 s at 60 °C), and extension (15 s at 72 °C with a single fluorescence measurement), a melt curve program (60–95 °C with a 0.11 °C/s heat increase and continuous fluorescence measurement), and a cooling step to 40 °C. The Δ cycle threshold method was used for the calculation of relative differences in mRNA abundance with a LightCycler 480 (Roche Molecular Biochemicals, Mannheim, Germany). Data were normalized to the expression of GAPDH. The RT-PCR primers that were used in this study are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Table S4</a>.</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Immunofluorescence Staining</h4><div class="NLM_p last">Studies were performed as previously described.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Nuclear Extract Preparation and Gel Shift Assays</h4><div class="NLM_p last">Nuclear extract preparations and EMSA were carried out as previously described.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> MDA-MB-231 cells were pretreated with <b>9</b> at 5 μm at different time spots ranging from 0 to 24 h and then harvested for nuclear extract preparation for EMSA analysis at room temperature prior to incubation with the biotin-labeled probe for 30 min before being subjected to EMSA analysis. Serum-starved MDA-MB-231 cells were preincubated with <b>9</b>, stimulated by IFN-γ (50 ng/mL), and then harvested for nuclear extraction.</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Wound-Healing Assay for Migration</h4><div class="NLM_p last">Assays were performed as previously reported.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> In Vivo Tumor Studies</h4><div class="NLM_p last">The experiments were carried out in accordance with the guidelines issued by the Ethical Committee of China Pharmaceutical University (SYXK 2012-0035).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Mouse Xenograft Tumor Model</h4><div class="NLM_p">MDA-MB-231 human breast cancer cells (5 × 10<sup>6</sup>) were injected subcutaneously into the flank area of 6-week-old female athymic SPF BALB/c nude mice, which were purchased from Canvens (Changzhou, Jiangsu, China). After the tumor volume reached about 100 mm<sup>3</sup>, mice were divided into five treatment groups consisting of eight mice per group (each mouse generated one xenograft tumor): saline vehicle control, oral injection of <b>9</b> (2.5, 5, and 10 mg/kg or 6, 12, and 24 μmol/kg), and gefitinib (40 mg/kg or 90 μmol/kg). The inhibitors were directly dissolved in saline. Gefitinib was formulated with 0.05% Tween80 to enhance the solubility. Tumor growth was monitored by measuring the length (<i>L</i>) and width (<i>W</i>) of the tumor every other day with a caliper. The tumor volume (<i>V</i><sub>tumor</sub>) was calculated according to the formula <i>V</i><sub>tumor</sub> = 0.5236 × <i>L</i> × <i>W</i><sup>2</sup>. The treatment lasted for 32 days. The detailed dosage regimen is listed in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Table S6</a>. For the dose of 5 mg/kg, a repeated study was performed. Mice were divided into two groups consisting of 10 mice per group: saline vehicle control and oral injection of <b>9</b> (5 mg/kg).</div><div class="NLM_p last">S180 mouse sarcoma cancer cells (3 × 10<sup>6</sup>) were injected subcutaneously into the flank area of 4-week-old male mice, which were purchased from Canvens. On the second day, mice were divided into two treatment groups consisting of 10 mice per group (each mouse generated one xenograft tumor): saline vehicle control, oral injection of <b>9</b> (5 mg/kg), and i.p. injection of doxorubicin (1 mg/kg or 1.8 μmol/kg). Both compounds were directly dissolved in saline. Tumor growth was determined by measuring the length (<i>L</i>) and width (<i>W</i>) of the tumor every other day with a caliper, and the tumor volume was calculated as <i>V</i><sub>tumor</sub> = 0.5236 × <i>L</i> × <i>W</i><sup>2</sup>. The treatment lasted for 21 days. The detailed dosage regimen is listed in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">Table S7</a>.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> H&E Staining of Mice Organs</h4><div class="NLM_p last">The five major organs (heart, liver, spleen, lung, and kidney) of all groups were anatomized from the mice, which were then fresh-fixed in 10% neutral-buffered formaldehyde for 48 h, embedded in paraffin, and sliced at 5 μm thickness. The sections were stained with H&E and examined by light microscopy.</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> IHC of Tumor Tissues</h4><div class="NLM_p last">Immunohistochemical staining was carried out as previously described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The fixed tumor sections were incubated with antibodies against p-STAT3. The DAB staining kit (NanJing KeyGEN Biotechnology Co., Ltd., Nanjing, China) was used to visualize positive cells according to the manufacturers’ recommendations.</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Acute Toxicity Test</h4><div class="NLM_p last">Both genders of ICR mice (7 weeks, SLACCAS) were randomized and treated intraperitoneally (i.p.) with a single dose of <b>9</b> at 200, 400, 600, 800, or 1000 mg/kg. Each group contained 10 mice, and the animals were observed for abnormal behavior and mortality up to 2 weeks post treatment.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01489">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01489" class="ext-link">10.1021/acs.jmedchem.6b01489</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Design, biological assays, PAINS assay and methods, and method validation of the pharmacokinetic study (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Atomic coordinates of the STAT3/<b>9</b>/(FC of <b>9</b>) complex (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Atomic coordinates of the STAT5/<b>9</b> complex (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Atomic coordinates of the STAT1/<b>9</b> complex (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_005.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf">jm6b01489_si_001.pdf (1.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_002.csv">jm6b01489_si_002.csv (0.58 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_003.pdb">jm6b01489_si_003.pdb (162.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_004.pdb">jm6b01489_si_004.pdb (702.22 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_005.pdb">jm6b01489_si_005.pdb (701.63 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">STAT3β/DNA complex: Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>. STAT1/DNA complex: Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF1">1BF1</a>. STAT5A: Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U">1Y1U</a>. The authors will release the atomic coordinates of the STAT3/<b>9</b>/(FC of <b>9</b>) complex, STAT1/<b>9</b> complex, and STAT5/<b>9</b> complex and the experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01489" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lingyi Kong</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9712-2618" title="Orcid link">http://orcid.org/0000-0001-9712-2618</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bad6c3d1d5d4ddfad9cacf94dfdecf94d9d4"><span class="__cf_email__" data-cfemail="c2aebba9adaca582a1b2b7eca7a6b7eca1ac">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenying Yu</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chenglong Li</span> - <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenda Zhang</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuanzheng Xia</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shanshan Li</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia-yuh Lin</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keqin Yu</span> - <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mu Liu</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Yang</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianguang Luo</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yijun Chen</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4920-152X" title="Orcid link">http://orcid.org/0000-0002-4920-152X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongbin Sun</span> - <span class="hlFld-Affiliation affiliation">†State
Key Laboratory of Natural Medicines, ‡Department of Natural Medicinal
Chemistry, ∥Laboratory of Chemical Biology, and ∇Center for Drug Discovery, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, Maryland 21201, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Water Supply
and Drainage, Nanchang Hangkong University, 696 Fenghe Avenue South, Nanchang 330046, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d174e2513-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Dr. Inhee Park, Dr. Sihui Long, and Dr. Feng Zhang for paper editing. This work was supported by National Natural Science Foundation of China (Grants 81402791 and 81673298), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant BK20140670), the Program for Changjiang Scholars and Innovative Research Team in University (IRT_15R63), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), College Students Innovation Project for the R&D of Novel Drugs (J1030830), and Jiangsu Shuangchuang Talents for Oversea Ph.D.s.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i51" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i51"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i52" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i52"> Abbreviations Used</h2><tr><td class="NLM_term">SH2 domain</td><td class="NLM_def"><p class="first last">Src Homology 2 domain</p></td></tr><tr><td class="NLM_term">pY705</td><td class="NLM_def"><p class="first last">phosphor-tyrosine 705</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamic</p></td></tr><tr><td class="NLM_term">FAM</td><td class="NLM_def"><p class="first last">carboxyfluorescein</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin 6</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">H&E staining</td><td class="NLM_def"><p class="first last">hematoxylin and eosin staining</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde-3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">Ac-STAT3</td><td class="NLM_def"><p class="first last">acetyl-STAT3</p></td></tr><tr><td class="NLM_term">p-STAT3</td><td class="NLM_def"><p class="first last">phosphor-STAT3</p></td></tr><tr><td class="NLM_term">T-STAT3</td><td class="NLM_def"><p class="first last">total-STAT3</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Liu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. F.</span><span> </span><span class="NLM_article-title">Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1007/s10549-014-3000-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1007%2Fs10549-014-3000-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24903225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFeks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2014&pages=71-84&author=C.+Y.+Liuauthor=J.+C.+Suauthor=M.+H.+Niauthor=L.+M.+Tsengauthor=P.+Y.+Chuauthor=D.+S.+Wangauthor=W.+T.+Taiauthor=Y.+P.+Kaoauthor=M.+H.+Hungauthor=C.+W.+Shiauauthor=K.+F.+Chen&title=Obatoclax+analog+SC-2001+inhibits+STAT3+phosphorylation+through+enhancing+SHP-1+expression+and+induces+apoptosis+in+human+breast+cancer+cells&doi=10.1007%2Fs10549-014-3000-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells</span></div><div class="casAuthors">Liu, Chun-Yu; Su, Jung-Chen; Ni, Mei-Huei; Tseng, Ling-Ming; Chu, Pei-Yi; Wang, Duen-Shian; Tai, Wei-Tien; Kao, Yuan-Ping; Hung, Man-Hsin; Shiau, Chung-Wai; Chen, Kuen-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-84</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Interfering oncogenic STAT3 signaling is a promising anti-cancer strategy.  We examd. the efficacy and drug mechanism of an obatoclax analog SC-2001, a novel STAT3 inhibitor, in human breast cancer cells.  Human breast cancer cell lines were used for in vitro studies.  Apoptosis was examd. by both flow cytometry and western blot.  Signaling pathways were assessed by western blot.  In vivo efficacy of SC-2001 was tested in xenograft nude mice.  SC-2001 inhibited cell growth and induced apoptosis in assocn. with downregulation of p-STAT3 (Tyr 705) in breast cancer cells.  STAT3-regulated proteins, including Mcl-1, survivin, and cyclin D1, were repressed by SC-2001.  Over-expression of STAT3 in MDA-MB-468 cells protected cells from SC-2001-induced apoptosis.  Moreover, SC-2001 enhanced the expression of protein tyrosine phosphatase SHP-1, a neg. regulator of STAT3.  Furthermore, the enhanced SHP-1 expression, in conjunction with increased SHP-1 phosphatase activity, was mediated by upregulated transcription by RFX-1.  Chromatin immunopptn. assay revealed that SC-2001 increased the binding capacity of RFX-1 to the SHP-1 promoter.  Knockdown of either RFX-1 or SHP-1 reduced SC-2001-induced apoptosis, whereas ectopic expression of RFX-1 increased SHP-1 expression and enhanced the apoptotic effect of SC-2001.  Importantly, SC-2001 suppressed tumor growth in assocn. with enhanced RFX-1 and SHP-1 expression and p-STAT3 downregulation in MDA-MB-468 xenograft tumors.  SC-2001 induced apoptosis in breast cancer cells, an effect that was mediated by RFX-1 upregulated SHP-1 expression and SHP-1-dependent STAT3 inactivation.  Our study indicates targeting STAT3 signaling pathway may be a useful approach for the development of targeted agents for anti-breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM2bpTu1PFBLVg90H21EOLACvtfcHk0lgraKbSGOoAwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFeks7k%253D&md5=bc0e1b8d3059dbeffef8048764e84ca9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs10549-014-3000-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-014-3000-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BY.%26aulast%3DSu%26aufirst%3DJ.%2BC.%26aulast%3DNi%26aufirst%3DM.%2BH.%26aulast%3DTseng%26aufirst%3DL.%2BM.%26aulast%3DChu%26aufirst%3DP.%2BY.%26aulast%3DWang%26aufirst%3DD.%2BS.%26aulast%3DTai%26aufirst%3DW.%2BT.%26aulast%3DKao%26aufirst%3DY.%2BP.%26aulast%3DHung%26aufirst%3DM.%2BH.%26aulast%3DShiau%26aufirst%3DC.%2BW.%26aulast%3DChen%26aufirst%3DK.%2BF.%26atitle%3DObatoclax%2520analog%2520SC-2001%2520inhibits%2520STAT3%2520phosphorylation%2520through%2520enhancing%2520SHP-1%2520expression%2520and%2520induces%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2014%26volume%3D146%26spage%3D71%26epage%3D84%26doi%3D10.1007%2Fs10549-014-3000-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wei, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.3892/ijo_00000848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.3892%2Fijo_00000848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21109950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVGgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=279-285&author=C.-C.+Weiauthor=S.+Ballauthor=L.+Linauthor=A.+Liuauthor=J.+R.+Fuchsauthor=P.-K.+Liauthor=C.+Liauthor=J.+Lin&title=Two+small+molecule+compounds%2C+LLL12+and+FLLL32%2C+exhibit+potent+inhibitory+activity+on+STAT3+in+human+rhabdomyosarcoma+cells&doi=10.3892%2Fijo_00000848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells</span></div><div class="casAuthors">Wei, Chang-Ching; Ball, Sarah; Lin, Li; Liu, Aiguo; Fuchs, James R.; Li, Pui-Kai; Li, Chenglong; Lin, Jiayuh</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">279-285</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Signal transducers and activators of transcription 3 (STAT3) signaling is persistently activated in many types of cancer cells, and represents a valid target for anticancer drug design.  However, few reports have described the constitutive activation of STAT3 in human sarcoma cells.  In this study, we demonstrate that the STAT3 signaling pathway is constitutively activated in human rhabodomyosarcoma cells (RH28, RH30, and RD2).  We also investigated the inhibitory effects of two newly developed small mols., LLL12 and FLLL32, on the STAT3 signaling pathway in human rhabodomyosarcoma cells.  Both LLL12 and FLLL32 downregulated STAT3 constitutively and interleukin-6 (IL-6) stimulated phosphorylated STAT3 (p-STAT3).  The inhibition of STAT3 via LLL12 and FLLL32 was confirmed by the inhibition of STAT3 DNA binding activity.  The downstream targets of STAT3, cyclin D1, Bcl-xL, and survivin were also down- regulated by LLL12 and FLLL 32 at both mRNA and protein levels.  The potency of LLL12 and FLLL32 to inhibit proliferation/viability in human rhabodomyosarcoma cells (RH28, RH30, and RD2) was higher than that of the 5 previously reported Janus kinase 2 (JAK2)/ STAT3 inhibitors (LLL3, WP1066, Stattic, S3I-201, and AG490) and curcumin.  Thus, in this study, we investigated the inhibitory effects of two STAT3 inhibitors, LLL12 and FLLL32, on the STAT3 signaling pathway in human rhabodomyosarcoma cells; we also demonstrated their higher potency in inhibiting proliferation on human rhabodomyosarcoma cells as compared to other five JAK2/STAT3 inhibitors and curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74pPXW0kFzrVg90H21EOLACvtfcHk0lhpADKTub4xfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVGgurw%253D&md5=4070e38336b697bf372fa387b7233812</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3892%2Fijo_00000848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo_00000848%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DC.-C.%26aulast%3DBall%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DTwo%2520small%2520molecule%2520compounds%252C%2520LLL12%2520and%2520FLLL32%252C%2520exhibit%2520potent%2520inhibitory%2520activity%2520on%2520STAT3%2520in%2520human%2520rhabdomyosarcoma%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3D279%26epage%3D285%26doi%3D10.3892%2Fijo_00000848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.ejmech.2014.05.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24904966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=195-203&author=H.+Chenauthor=Z.+Yangauthor=C.+Dingauthor=A.+Xiongauthor=C.+Wildauthor=L.+Wangauthor=N.+Yeauthor=G.+Caiauthor=R.+M.+Floresauthor=Y.+Dingauthor=Q.+Shenauthor=J.+Zhou&title=Discovery+of+potent+anticancer+agent+HJC0416%2C+an+orally+bioavailable+small+molecule+inhibitor+of+signal+transducer+and+activator+of+transcription+3+%28STAT3%29&doi=10.1016%2Fj.ejmech.2014.05.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)</span></div><div class="casAuthors">Chen, Haijun; Yang, Zhengduo; Ding, Chunyong; Xiong, Ailian; Wild, Christopher; Wang, Lili; Ye, Na; Cai, Guoshuai; Flores, Rudolfo M.; Ding, Ye; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In a continuing effort to develop orally bioavailable small-mol. STAT3 inhibitors as potential therapeutic agents for human cancer, a series of novel diversified analogs based on our identified lead compd. HJC0149 (5-chloro-N-(1,1-dioxo-1H-1λ6-benzo[b]thiophen-6-yl)-2-hydroxybenzamide) were synthesized and evaluated.  Mol. docking studies and biol. characterization supported our earlier findings that the O-alkylamino-tethered side chain on the hydroxyl group is an effective and essential structural determinant for improving biol. activities and druglike properties of these mols.  Compds. with such modifications exhibited potent antiproliferative effects against breast and pancreatic cancer cell lines with IC50 values from low micromolar to nanomolar range.  Among them, the newly discovered STAT3 inhibitor 12 (HJC0416) displayed an intriguing anticancer profile both in vitro and in vivo (i.p. & p.o.).  More importantly, HJC0416 is an orally bioavailable anticancer agent as a promising candidate for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhVjTbk7wREbVg90H21EOLACvtfcHk0lhpADKTub4xfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu73L&md5=4f0791ba9f6ed95c0199a345bb840537</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.049%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCai%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DR.%2BM.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520anticancer%2520agent%2520HJC0416%252C%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520%2528STAT3%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D195%26epage%3D203%26doi%3D10.1016%2Fj.ejmech.2014.05.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Targeting STAT3 in cancer: how successful are we?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1517/13543780802565791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1517%2F13543780802565791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=19053881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=45-56&author=P.+Yueauthor=J.+Turkson&title=Targeting+STAT3+in+cancer%3A+how+successful+are+we%3F&doi=10.1517%2F13543780802565791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting STAT3 in cancer: how successful are we?</span></div><div class="casAuthors">Yue, Peibin; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-56</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Aberrant activation of the signal transducer and activator of transcription (STAT)3 occurs in many human tumors.  Moreover, studies utilizing genetic and pharmacol. approaches to modulate constitutive STAT3 activity have provided compelling evidence for the crit. role of aberrant STAT3 activity in malignant transformation and tumor progression, and thereby validated STAT3 as a novel cancer drug target.  This review is intended to be a full coverage of the efforts to develop direct STAT3 inhibitors and will provide a discussion on the inhibitory modalities developed to date.  Review of the literature focused on the modalities and mechanisms that directly target and inhibit the STAT protein or its functions.  While a variety of STAT3 inhibitors have been identified that induce antitumor cell effects in vitro and in vivo, the landscape remains murky.  With a few exceptions, most of the STAT3 inhibitors reported to date have not undergone an in vivo efficacy, pharmacol. or toxicity testing.  Also, there is no evidence, per the published literature of an impending clin. development for the few agents that were reported to exhibit in vivo efficacy.  Overall, there is the need for a reassessment of the ongoing strategies to target STAT3 intended not only for refinement, but also for incorporating some new technologies to strengthen our efforts and ensure the success, sooner, rather than later, of identifying suitable anti-STAT3 agents for development into clin. useful anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGo96b-3KjRLVg90H21EOLACvtfcHk0lhpADKTub4xfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvO&md5=e0f4fe796305b7e28ff3020f57b5dc8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543780802565791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780802565791%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DP.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DTargeting%2520STAT3%2520in%2520cancer%253A%2520how%2520successful%2520are%2520we%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D45%26epage%3D56%26doi%3D10.1517%2F13543780802565791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bharadwaj, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckols, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolosov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasembeli, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrolecki, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creighton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweardy, D. J.</span><span> </span><span class="NLM_article-title">Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span><span class="refDoi"> DOI: 10.1038/onc.2014.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1038%2Fonc.2014.72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24681959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1341-1353&author=U.+Bharadwajauthor=T.+K.+Eckolsauthor=M.+Kolosovauthor=M.+M.+Kasembeliauthor=A.+Adamauthor=D.+Torresauthor=X.+Zhangauthor=L.+E.+Dobroleckiauthor=W.+Weiauthor=M.+T.+Lewisauthor=B.+Daveauthor=J.+C.+Changauthor=M.+D.+Landisauthor=C.+J.+Creightonauthor=M.+A.+Manciniauthor=D.+J.+Tweardy&title=Drug-repositioning+screening+identified+piperlongumine+as+a+direct+STAT3+inhibitor+with+potent+activity+against+breast+cancer&doi=10.1038%2Fonc.2014.72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer</span></div><div class="casAuthors">Bharadwaj, U.; Eckols, T. K.; Kolosov, M.; Kasembeli, M. M.; Adam, A.; Torres, D.; Zhang, X.; Dobrolecki, L. E.; Wei, W.; Lewis, M. T.; Dave, B.; Chang, J. C.; Landis, M. D.; Creighton, C. J.; Mancini, M. A.; Tweardy, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1341-1353</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Signal transducer and activator of transcription (STAT) 3 regulates many cardinal features of cancer including cancer cell growth, apoptosis resistance, DNA damage response, metastasis, immune escape, tumor angiogenesis, the Warburg effect and oncogene addiction and has been validated as a drug target for cancer therapy.  Several strategies have been used to identify agents that target Stat3 in breast cancer but none has yet entered into clin. use.  We used a high-throughput fluorescence microscopy search strategy to identify compds. in a drug-repositioning library (Prestwick library) that block ligand-induced nuclear translocation of Stat3 and identified piperlongumine (PL), a natural product isolated from the fruit of the pepper Piper longum.  PL inhibited Stat3 nuclear translocation, inhibited ligand-induced and constitutive Stat3 phosphorylation, and modulated expression of multiple Stat3-regulated genes.  Surface plasmon resonance assay revealed that PL directly inhibited binding of Stat3 to its phosphotyrosyl peptide ligand.  Phosphoprotein antibody array anal. revealed that PL does not modulate kinases known to activate Stat3 such as Janus kinases, Src kinase family members or receptor tyrosine kinases.  PL inhibited anchorage-independent and anchorage-dependent growth of multiple breast cancer cell lines having increased pStat3 or total Stat3, and induced apoptosis.  PL also inhibited mammosphere formation by tumor cells from patient-derived xenografts.  PL's antitumorigenic function was causally linked to its Stat3-inhibitory effect.  PL was non-toxic in mice up to a dose of 30 mg/kg/day for 14 days and caused regression of breast cancer cell line xenografts in nude mice.  Thus, PL represents a promising new agent for rapid entry into the clinic for use in treating breast cancer, as well as other cancers in which Stat3 has a role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxr6QTKIh08rVg90H21EOLACvtfcHk0liD9tM3rULkfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOhtbg%253D&md5=c03ddf0bca17890ec8b2b61264c019c1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.72%26sid%3Dliteratum%253Aachs%26aulast%3DBharadwaj%26aufirst%3DU.%26aulast%3DEckols%26aufirst%3DT.%2BK.%26aulast%3DKolosov%26aufirst%3DM.%26aulast%3DKasembeli%26aufirst%3DM.%2BM.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DTorres%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDobrolecki%26aufirst%3DL.%2BE.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DLewis%26aufirst%3DM.%2BT.%26aulast%3DDave%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26aulast%3DLandis%26aufirst%3DM.%2BD.%26aulast%3DCreighton%26aufirst%3DC.%2BJ.%26aulast%3DMancini%26aufirst%3DM.%2BA.%26aulast%3DTweardy%26aufirst%3DD.%2BJ.%26atitle%3DDrug-repositioning%2520screening%2520identified%2520piperlongumine%2520as%2520a%2520direct%2520STAT3%2520inhibitor%2520with%2520potent%2520activity%2520against%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D1341%26epage%3D1353%26doi%3D10.1038%2Fonc.2014.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ma, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, C. H.</span><span> </span><span class="NLM_article-title">Antagonizing STAT3 dimerization with a rhodium(III) complex</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">9178</span><span class="NLM_x">–</span> <span class="NLM_lpage">9182</span><span class="refDoi"> DOI: 10.1002/anie.201404686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fanie.201404686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVKlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=9178-9182&author=D.+L.+Maauthor=L.+J.+Liuauthor=K.+H.+Leungauthor=Y.+T.+Chenauthor=H.+J.+Zhongauthor=D.+S.+Chanauthor=H.+M.+Wangauthor=C.+H.+Leung&title=Antagonizing+STAT3+dimerization+with+a+rhodium%28III%29+complex&doi=10.1002%2Fanie.201404686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonizing STAT3 Dimerization with a Rhodium(III) Complex</span></div><div class="casAuthors">Ma, Dik-Lung; Liu, Li-Juan; Leung, Ka-Ho; Chen, Yen-Ting; Zhong, Hai-Jing; Chan, Daniel Shiu-Hin; Wang, Hui-Min David; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">9178-9182</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Kinetically inert metal complexes have arisen as promising alternatives to existing platinum and ruthenium chemotherapeutics.  Reported herein, to the knowledge, is the first example of a substitutionally inert, Group 9 organometallic compd. as a direct inhibitor of signal transducer and activator of transcription 3 (STAT3) dimerization.  From a series of cyclometalated rhodium(III) and iridium(III) complexes, a rhodium(III) complex emerged as a potent inhibitor of STAT3 that targeted the SH2 domain and inhibited STAT3 phosphorylation and dimerization.  Significantly, the complex exhibited potent antitumor activities in an in vivo mouse xenograft model of melanoma.  This study demonstrates that rhodium complexes may be developed as effective STAT3 inhibitors with potent antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomCWV-3XvfFbVg90H21EOLACvtfcHk0liD9tM3rULkfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVKlurs%253D&md5=6972af909d01a82ae3acabb013601bd9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fanie.201404686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201404686%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLiu%26aufirst%3DL.%2BJ.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DZhong%26aufirst%3DH.%2BJ.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DAntagonizing%2520STAT3%2520dimerization%2520with%2520a%2520rhodium%2528III%2529%2520complex%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D9178%26epage%3D9182%26doi%3D10.1002%2Fanie.201404686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namanja, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paladino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Orally bioavailable small-molecule inhibitor of transcription factor STAT3 regresses human breast and lung cancer xenografts</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">9623</span><span class="NLM_x">–</span> <span class="NLM_lpage">9628</span><span class="refDoi"> DOI: 10.1073/pnas.1121606109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.1121606109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=22623533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=9623-9628&author=X.+Zhangauthor=P.+Yueauthor=B.+D.+Pageauthor=T.+Liauthor=W.+Zhaoauthor=A.+T.+Namanjaauthor=D.+Paladinoauthor=J.+Zhaoauthor=Y.+Chenauthor=P.+T.+Gunningauthor=J.+Turkson&title=Orally+bioavailable+small-molecule+inhibitor+of+transcription+factor+STAT3+regresses+human+breast+and+lung+cancer+xenografts&doi=10.1073%2Fpnas.1121606109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts</span></div><div class="casAuthors">Zhang, Xiaolei; Yue, Peibin; Page, Brent D. G.; Li, Tianshu; Zhao, Wei; Namanja, Andrew T.; Paladino, David; Zhao, Jihe; Chen, Yuan; Gunning, Patrick T.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9623-9628, S9623/1-S9623/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Computer-aided lead optimization derives a unique, orally bioavailable inhibitor of the signal transducer and activator of transcription (Stat)3 Src homol. 2 domain.  BP-1-102 binds Stat3 with an affinity (KD) of 504 nM, blocks Stat3-phospho-tyrosine (pTyr) peptide interactions and Stat3 activation at 4-6.8 μM, and selectively inhibits growth, survival, migration, and invasion of Stat3-dependent tumor cells.  BP-1-102-mediated inhibition of aberrantly active Stat3 in tumor cells suppresses the expression of c-Myc, Cyclin D1, Bcl-xL, Survivin, VEGF, and Kruppel-like factor 8, which is identified as a Stat3 target gene that promotes Stat3-mediated breast tumor cell migration and invasion.  Treatment of breast cancer cells with BP-1-102 further blocks Stat3-NF-κB cross-talk, the release of granulocyte colony-stimulating factor, sol. intercellular adhesion mol. 1, macrophage migration-inhibitory factor/glycosylation-inhibiting factor, interleukin 1 receptor antagonist, and serine protease inhibitor protein 1, and the phosphorylation of focal adhesion kinase and paxillin, while enhancing E-cadherin expression.  I.v. or oral gavage delivery of BP-1-102 furnishes micromolar or microgram levels in tumor tissues and inhibits growth of human breast and lung tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrljEafjbznr7Vg90H21EOLACvtfcHk0liD9tM3rULkfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWjtLo%253D&md5=4da78174a7c00eacc1f1a1ce553c5aa7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121606109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121606109%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DNamanja%26aufirst%3DA.%2BT.%26aulast%3DPaladino%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DOrally%2520bioavailable%2520small-molecule%2520inhibitor%2520of%2520transcription%2520factor%2520STAT3%2520regresses%2520human%2520breast%2520and%2520lung%2520cancer%2520xenografts%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D9623%26epage%3D9628%26doi%3D10.1073%2Fpnas.1121606109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4402</span><span class="NLM_x">–</span> <span class="NLM_lpage">4412</span><span class="refDoi"> DOI: 10.1021/jm400080c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400080c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4402-4412&author=W.+Yuauthor=H.+Xiaoauthor=J.+Linauthor=C.+Li&title=Discovery+of+novel+STAT3+small+molecule+inhibitors+via+in+silico+site-directed+fragment-based+drug+design&doi=10.1021%2Fjm400080c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel STAT3 Small Molecule Inhibitors via in Silico Site-Directed Fragment-Based Drug Design</span></div><div class="casAuthors">Yu, Wenying; Xiao, Hui; Lin, Jiayuh; Li, Chenglong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4402-4412</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Constitutive activation of signal transducer and activator of transcription 3 (STAT3) has been validated as an attractive therapeutic target for cancer therapy.  To stop both STAT3 activation and dimerization, a viable strategy is to design inhibitors blocking its SH2 domain phosphotyrosine binding site that is responsible for both actions.  A new fragment-based drug design (FBDD) strategy, in silico site-directed FBDD, was applied in this study.  A designed novel compd., 5,8-dioxo-6-(pyridin-3-ylamino)-5,8-dihydronaphthalene-1-sulfonamide (LY5), was confirmed to bind to STAT3 SH2 by fluorescence polarization assay.  In addn., four out of the five chosen compds. have IC50 values lower than 5 μM for the U2OS cancer cells. 8 (LY5) has an IC50 range in 0.5-1.4 μM in various cancer cell lines. 8 also suppresses tumor growth in an in vivo mouse model.  This study has demonstrated the utility of this approach and could be used to other drug targets in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq76v3IMxJHwLVg90H21EOLACvtfcHk0ljYRBUDJiH3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOktbk%253D&md5=7231b2e9682f9e9046debcaa461a1d59</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm400080c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400080c%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520STAT3%2520small%2520molecule%2520inhibitors%2520via%2520in%2520silico%2520site-directed%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4402%26epage%3D4412%26doi%3D10.1021%2Fjm400080c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Schuringa, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellenga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruijer, W.</span><span> </span><span class="NLM_article-title">Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">495</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/S0014-5793(01)02354-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2FS0014-5793%2801%2902354-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=71-76&author=J.+J.+Schuringaauthor=H.+Schepersauthor=E.+Vellengaauthor=W.+Kruijer&title=Ser727-dependent+transcriptional+activation+by+association+of+p300+with+STAT3+upon+IL-6+stimulation&doi=10.1016%2FS0014-5793%2801%2902354-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2902354-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252902354-7%26sid%3Dliteratum%253Aachs%26aulast%3DSchuringa%26aufirst%3DJ.%2BJ.%26aulast%3DSchepers%26aufirst%3DH.%26aulast%3DVellenga%26aufirst%3DE.%26aulast%3DKruijer%26aufirst%3DW.%26atitle%3DSer727-dependent%2520transcriptional%2520activation%2520by%2520association%2520of%2520p300%2520with%2520STAT3%2520upon%2520IL-6%2520stimulation%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D495%26spage%3D71%26epage%3D76%26doi%3D10.1016%2FS0014-5793%2801%2902354-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoon, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">7765</span><span class="NLM_x">–</span> <span class="NLM_lpage">7769</span><span class="refDoi"> DOI: 10.1073/pnas.1205132109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.1205132109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=22547799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1Kntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=7765-7769&author=H.+Leeauthor=P.+Zhangauthor=A.+Herrmannauthor=C.+Yangauthor=H.+Xinauthor=Z.+Wangauthor=D.+S.+Hoonauthor=S.+J.+Formanauthor=R.+Joveauthor=A.+D.+Riggsauthor=H.+Yu&title=Acetylated+STAT3+is+crucial+for+methylation+of+tumor-suppressor+gene+promoters+and+inhibition+by+resveratrol+results+in+demethylation&doi=10.1073%2Fpnas.1205132109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation</span></div><div class="casAuthors">Lee, Heehyoung; Zhang, Peng; Herrmann, Andreas; Yang, Chunmei; Xin, Hong; Wang, Zhenghe; Hoon, Dave S. B.; Forman, Stephen J.; Jove, Richard; Riggs, Arthur D.; Yu, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7765-7769, S7765/1-S7765/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mechanisms underlying hypermethylation of tumor-suppressor gene promoters in cancer is not well understood.  Here, we report that lysine acetylation of the oncogenic transcription factor STAT3 is elevated in tumors.  We also show that genetically altering STAT3 at Lys685 reduces tumor growth, which is accompanied by demethylation and reactivation of several tumor-suppressor genes.  Moreover, mutating STAT3 at Lys685 disrupts DNA methyltransferase 1-STAT3 interactions in cultured tumor cells and in tumors.  These observations are confirmed by treatment with an acetylation inhibitor, resveratrol.  Furthermore, redn. of acetylated STAT3 in triple-neg. breast cancer cells leads to demethylation and activation of the estrogen receptor-α gene, sensitizing the tumor cells to antiestrogens.  Our results also demonstrate a correlation between STAT3 acetylation and methylation of estrogen receptor-a in melanoma, which predicts melanoma progression.  Taken together, these results suggest a role of STAT3 acetylation in regulating CpG island methylation, which may partially explain aberrant gene silencing in cancer.  These findings also provide a rationale for targeting acetylated STAT3 for chemoprevention and cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2L3nwZs04LVg90H21EOLACvtfcHk0ljYRBUDJiH3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1Kntrw%253D&md5=5ebf41ab98d7784ffe266ed32e3d7ed8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205132109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205132109%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHoon%26aufirst%3DD.%2BS.%26aulast%3DForman%26aufirst%3DS.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DRiggs%26aufirst%3DA.%2BD.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DAcetylated%2520STAT3%2520is%2520crucial%2520for%2520methylation%2520of%2520tumor-suppressor%2520gene%2520promoters%2520and%2520inhibition%2520by%2520resveratrol%2520results%2520in%2520demethylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D7765%26epage%3D7769%26doi%3D10.1073%2Fpnas.1205132109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Clevenger, C. V.</span><span> </span><span class="NLM_article-title">Roles and regulation of STAT family transcription factors in human breast cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1449</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)63403-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2FS0002-9440%2810%2963403-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=15509516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCgsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2004&pages=1449-1460&author=C.+V.+Clevenger&title=Roles+and+regulation+of+STAT+family+transcription+factors+in+human+breast+cancer&doi=10.1016%2FS0002-9440%2810%2963403-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Roles and regulation of Stat family transcription factors in human breast cancer</span></div><div class="casAuthors">Clevenger, Charles V.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1449-1460</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">A review.  Stats (for signal transducers and activators of transcription) are a family of transcription factors that regulate cell growth and differentiation.  Their activity is latent until phosphorylation by receptor-assocd. kinases.  A sizable body of data from cell lines, mouse models, and human tissues now implicates these transcription factors in the oncogenesis of breast cancer.  Because Stat activity is modulated by several post-translational modifications and protein-protein interactions, these transcription factors are capable of integrating inputs from multiple signaling networks.  Given this, the future utilization of Stats as prognostic markers and therapeutic targets in human breast cancer appears likely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbmPgc4RUfSLVg90H21EOLACvtfcHk0ljYRBUDJiH3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCgsLbF&md5=ae6d7cd695e98ee3485327bcf6bb9b93</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963403-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963403-7%26sid%3Dliteratum%253Aachs%26aulast%3DClevenger%26aufirst%3DC.%2BV.%26atitle%3DRoles%2520and%2520regulation%2520of%2520STAT%2520family%2520transcription%2520factors%2520in%2520human%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D165%26spage%3D1449%26epage%3D1460%26doi%3D10.1016%2FS0002-9440%2810%2963403-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mandal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birtwistle, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaluarachchi, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Potent and selective phosphopeptide mimetic prodrugs targeted to the src homology 2 (SH2) domain of signal transducer and activator of transcription 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3549</span><span class="NLM_x">–</span> <span class="NLM_lpage">3563</span><span class="refDoi"> DOI: 10.1021/jm2000882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2000882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3549-3563&author=P.+K.+Mandalauthor=F.+Gaoauthor=Z.+Luauthor=Z.+Renauthor=R.+Rameshauthor=J.+S.+Birtwistleauthor=K.+K.+Kaluarachchiauthor=X.+Chenauthor=R.+C.+Bastauthor=W.+S.+Liaoauthor=J.+S.+McMurray&title=Potent+and+selective+phosphopeptide+mimetic+prodrugs+targeted+to+the+src+homology+2+%28SH2%29+domain+of+signal+transducer+and+activator+of+transcription+3&doi=10.1021%2Fjm2000882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm2000882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2000882%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DBirtwistle%26aufirst%3DJ.%2BS.%26aulast%3DKaluarachchi%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBast%26aufirst%3DR.%2BC.%26aulast%3DLiao%26aufirst%3DW.%2BS.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DPotent%2520and%2520selective%2520phosphopeptide%2520mimetic%2520prodrugs%2520targeted%2520to%2520the%2520src%2520homology%25202%2520%2528SH2%2529%2520domain%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3549%26epage%3D3563%26doi%3D10.1021%2Fjm2000882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mandal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6141</span><span class="refDoi"> DOI: 10.1021/jm901105k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901105k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6126-6141&author=P.+K.+Mandalauthor=Z.+Renauthor=X.+Chenauthor=C.+Xiongauthor=J.+S.+McMurray&title=Structure-affinity+relationships+of+glutamine+mimics+incorporated+into+phosphopeptides+targeted+to+the+SH2+domain+of+signal+transducer+and+activator+of+transcription+3&doi=10.1021%2Fjm901105k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm901105k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901105k%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DStructure-affinity%2520relationships%2520of%2520glutamine%2520mimics%2520incorporated%2520into%2520phosphopeptides%2520targeted%2520to%2520the%2520SH2%2520domain%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6126%26epage%3D6141%26doi%3D10.1021%2Fjm901105k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A low-molecular-weight compound discovered through virtual database screening inhibits STAT3 function in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4700</span><span class="NLM_x">–</span> <span class="NLM_lpage">4705</span><span class="refDoi"> DOI: 10.1073/pnas.0409894102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.0409894102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=15781862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Oiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4700-4705&author=H.+Songauthor=R.+Wangauthor=S.+Wangauthor=J.+Lin&title=A+low-molecular-weight+compound+discovered+through+virtual+database+screening+inhibits+STAT3+function+in+breast+cancer+cells&doi=10.1073%2Fpnas.0409894102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A low-molecular-weight compound discovered through virtual database screening inhibits stat3 function in breast cancer cells</span></div><div class="casAuthors">Song, Hui; Wang, Renxiao; Wang, Shaomeng; Lin, Jiayuh</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4700-4705</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">This study focused on the screening of small-mol. inhibitors that target signal transducers and activators of transcription 3 (Stat3) in human breast carcinoma.  The constitutive activation of Stat3 is frequently detected in human breast cancer cell lines as well as clin. breast cancer specimens and may play an important role in the oncogenesis of breast carcinoma.  Activated Stat3 may participate in oncogenesis by stimulating cell proliferation, promoting tumor angiogenesis, and resisting apoptosis.  Because a variety of human cancers are assocd. with constitutively active Stat3, Stat3 represents an attractive target for cancer therapy.  In this study, of the nearly 429,000 compds. screened by virtual database screening, chem. samples of top 100 compds. identified as candidate small-mol. inhibitors of Stat3 were evaluated by using Stat3-dependent luciferase reporter as well as other cell-based assays.  Through serial functional evaluation based on our established cell-based assays, one compd., termed STA-21, was identified as the best match for our selection criteria.  Further investigation demonstrated that STA-21 inhibits Stat3 DNA binding activity, Stat3 dimerization, and Stat3-dependent luciferase activity.  Moreover, STA-21 reduces the survival of breast carcinoma cells with constitutive Stat3 signaling but has minimal effect on the cells in which constitutive Stat3 signaling is absent.  Together, these results demonstrate that STA-21 inhibits breast cancer cells that express constitutively active Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWe9nsAbh67Vg90H21EOLACvtfcHk0ljmAQDNKg9GtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Oiu78%253D&md5=fe7108bee9cddbcdd75a67dd93e19e63</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409894102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409894102%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520low-molecular-weight%2520compound%2520discovered%2520through%2520virtual%2520database%2520screening%2520inhibits%2520STAT3%2520function%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D4700%26epage%3D4705%26doi%3D10.1073%2Fpnas.0409894102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Siddiquee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Selective chemical probe inhibitor of STAT3, identified through structure-based virtual screening, induces antitumor activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">7391</span><span class="NLM_x">–</span> <span class="NLM_lpage">7396</span><span class="refDoi"> DOI: 10.1073/pnas.0609757104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.0609757104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=17463090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=7391-7396&author=K.+Siddiqueeauthor=S.+Zhangauthor=W.+C.+Guidaauthor=M.+A.+Blaskovichauthor=B.+Greedyauthor=H.+R.+Lawrenceauthor=M.+L.+Yipauthor=R.+Joveauthor=M.+M.+McLaughlinauthor=N.+J.+Lawrenceauthor=S.+M.+Sebtiauthor=J.+Turkson&title=Selective+chemical+probe+inhibitor+of+STAT3%2C+identified+through+structure-based+virtual+screening%2C+induces+antitumor+activity&doi=10.1073%2Fpnas.0609757104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Elective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity</span></div><div class="casAuthors">Siddiquee, Khandaker; Zhang, Shumin; Guida, Wayne C.; Blaskovich, Michelle A.; Greddy, Benjamin; Lawrence, Harshani R.; Yip, M. L. Richard; Jove, Richard; McLaughlin, Mark M.; Lawrence, Nicholas J.; Sebti, Said M.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7391-7396</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">531-201 (NSC 74859) is a chem. probe inhibitor of Stat3 activity, which was identified from the National Cancer Institute chem. libraries by using structure-based virtual screening with a computer model of the Stat3 SH2 domain bound to its Stat3 phosphotyrosine peptide derived from the x-ray crystal structure of the Stat3β homodimer.  S3I-201 inhibits Stat3 · Stat3 complex formation and Stat3 DNA-binding and transcriptional activities.  Furthermore, S3I-201 inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3.  Constitutively dimerized and active Stat3C and Stat3 SH2 domain rescue tumor cells from S3I-201-induced apoptosis.  Finally, S3I-201 inhibits the expression of the Stat3-regulated genes encoding cyclin D1, Bcl-xL, and surviving and inhibits the growth of human breast tumors in vivo.  These findings strongly suggest that the antitumor activity of S3I-201 is mediated in part through inhibition of aberrant Stat3 activation and provide the proof-of-concept for the potential clin. use of Stat3 inhibitors such as S3I-201 in tumors harboring aberrant Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfmqUniFENbVg90H21EOLACvtfcHk0ljmAQDNKg9GtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D&md5=85decf56fc7852990f56c6f64165ad9d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0609757104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0609757104%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiquee%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DGreedy%26aufirst%3DB.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DSelective%2520chemical%2520probe%2520inhibitor%2520of%2520STAT3%252C%2520identified%2520through%2520structure-based%2520virtual%2520screening%252C%2520induces%2520antitumor%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D7391%26epage%3D7396%26doi%3D10.1073%2Fpnas.0609757104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharmeen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Antagonism of the STAT3-STAT3 protein dimer with salicylic acid based small molecules</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1470</span><span class="refDoi"> DOI: 10.1002/cmdc.201100194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fcmdc.201100194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21618433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFOjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1459-1470&author=S.+Fletcherauthor=B.+D.+Pageauthor=X.+Zhangauthor=P.+Yueauthor=Z.+H.+Liauthor=S.+Sharmeenauthor=J.+Singhauthor=W.+Zhaoauthor=A.+D.+Schimmerauthor=S.+Trudelauthor=J.+Turksonauthor=P.+T.+Gunning&title=Antagonism+of+the+STAT3-STAT3+protein+dimer+with+salicylic+acid+based+small+molecules&doi=10.1002%2Fcmdc.201100194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of the Stat3-Stat3 Protein Dimer with Salicylic Acid Based Small Molecules</span></div><div class="casAuthors">Fletcher, Steven; Page, Brent D. G.; Zhang, Xialoei; Yue, Peibin; Li, Zhi Hua; Sharmeen, Sumaiya; Singh, Jagdeep; Zhao, Wei; Schimmer, Aaron D.; Trudel, Suzanne; Turkson, James; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1459-1470</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">More than 50 new inhibitors of the oncogenic Stat3 protein were identified through a structure-activity relationship (SAR) study based on the previously identified inhibitor S3I-201 (IC50=86 μM, Ki>300 μM).  A key structural feature of these inhibitors is a salicylic acid moiety, which, by acting as a phosphotyrosine mimetic, is believed to facilitate binding to the Stat3 SH2 domain.  Several of the analogs exhibit higher potency than the lead compd. in inhibiting Stat3 DNA binding activity, with an in vitro IC50 range of 18.7-51.9 μM, and disruption of Stat3-pTyr peptide interactions with Ki values in the 15.5-41 μM range.  One agent in particular exhibited potent inhibition of Stat3 phosphorylation in both breast and multiple myeloma tumor cells, suppressed the expression of Stat3 target genes, and induced antitumor effects in tumor cells harboring activated Stat3 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0FBfupE80LVg90H21EOLACvtfcHk0lgpdK7stKg5Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFOjtbg%253D&md5=ad6df40e36272bdf21215eb9cc3526ce</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100194%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DSharmeen%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DAntagonism%2520of%2520the%2520STAT3-STAT3%2520protein%2520dimer%2520with%2520salicylic%2520acid%2520based%2520small%2520molecules%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1459%26epage%3D1470%26doi%3D10.1002%2Fcmdc.201100194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Liu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, C. H.</span><span> </span><span class="NLM_article-title">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1293</span><span class="refDoi"> DOI: 10.1038/cddis.2014.250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1038%2Fcddis.2014.250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24922077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1293&author=L.+J.+Liuauthor=K.+H.+Leungauthor=D.+S.+Chanauthor=Y.+T.+Wangauthor=D.+L.+Maauthor=C.+H.+Leung&title=Identification+of+a+natural+product-like+STAT3+dimerization+inhibitor+by+structure-based+virtual+screening&doi=10.1038%2Fcddis.2014.250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span></div><div class="casAuthors">Liu, L-J.; Leung, K-H.; Chan, D. S-H.; Wang, Y-T.; Ma, D-L.; Leung, C-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1293</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">STAT3 regulates a variety of genes involved with cell proliferation, differentiation, apoptosis, angiogenesis, metastasis, inflammation, and immunity.  The purpose of this study was to apply mol. docking techniques to identify STAT3 inhibitors from a database of over 90 000 natural product and natural product-like compds.  The virtual screening campaign furnished 14 hit compds., from which compd. 1 emerged as a top candidate.  Compd. 1 inhibited STAT3 DNA-binding activity in vitro and attenuated STAT3-directed transcription in cellulo with selectivity over STAT1 and with comparable potency to the well-known STAT3 inhibitor S3I-201.  Furthermore, compd. 1 inhibited STAT3 dimerization and decreased STAT3 phosphorylation in cells without affecting STAT1 dimerization and phosphorylation.  Compd. 1 also exhibited selective anti-proliferative activity against cancer cells over normal cells in vitro.  Mol. docking anal. suggested that compd. 1 might putatively function as an inhibitor of STAT3 dimerization by binding to the SH2 domain.  This study also validates the use of in silico techniques to identify inhibitors of protein-protein interactions, which are typically considered difficult to target with small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFD1r2695sVrVg90H21EOLACvtfcHk0lgpdK7stKg5Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D&md5=aaf182350853d7020285bd47ea4126e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.250%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%2BJ.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DIdentification%2520of%2520a%2520natural%2520product-like%2520STAT3%2520dimerization%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1293%26doi%3D10.1038%2Fcddis.2014.250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Furqan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinleye, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span> </span><span class="NLM_article-title">STAT inhibitors for cancer therapy</span> <span class="citation_source-journal">J. Hematol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="refDoi"> DOI: 10.1186/1756-8722-6-90</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1186%2F1756-8722-6-90" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24308725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVCrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=90&author=M.+Furqanauthor=A.+Akinleyeauthor=N.+Mukhiauthor=V.+Mittalauthor=Y.+Chenauthor=D.+Liu&title=STAT+inhibitors+for+cancer+therapy&doi=10.1186%2F1756-8722-6-90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">STAT inhibitors for cancer therapy</span></div><div class="casAuthors">Furqan, Muhammad; Akinleye, Akintunde; Mukhi, Nikhil; Mittal, Varun; Chen, Yamei; Liu, Delong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90/1-90/11</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Signal Transducer and Activator of Transcription (STAT) proteins are a family of cytoplasmic transcription factors consisting of 7 members, STAT1 to STAT6, including STAT5a and STAT5b.  STAT proteins are thought to be ideal targets for anti-cancer therapy since cancer cells are more dependent on the STAT activity than their normal counterparts.  Inhibitors targeting STAT3 and STAT5 have been developed.  These included peptidomimetics, small mol. inhibitors and oligonucleotides.  This review summarized advances in preclin. and clin. development of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFFeRq3z4vrVg90H21EOLACvtfcHk0lgpdK7stKg5Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVCrtLo%253D&md5=18291bafacd393de82dcc9f9df80c0f9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-90%26sid%3Dliteratum%253Aachs%26aulast%3DFurqan%26aufirst%3DM.%26aulast%3DAkinleye%26aufirst%3DA.%26aulast%3DMukhi%26aufirst%3DN.%26aulast%3DMittal%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DSTAT%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D90%26doi%3D10.1186%2F1756-8722-6-90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">Phase I study of OPB-31121, an oral STAT3 inhibitor, in patients with advanced solid tumors</span> <span class="citation_source-journal">Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.4143/crt.2014.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.4143%2Fcrt.2014.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=25715763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A280%3ADC%252BC2MroslKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=607-615&author=D.+Y.+Ohauthor=S.+H.+Leeauthor=S.+W.+Hanauthor=M.+J.+Kimauthor=T.+M.+Kimauthor=T.+Y.+Kimauthor=D.+S.+Heoauthor=M.+Yuasaauthor=Y.+Yanagiharaauthor=Y.+J.+Bang&title=Phase+I+study+of+OPB-31121%2C+an+oral+STAT3+inhibitor%2C+in+patients+with+advanced+solid+tumors&doi=10.4143%2Fcrt.2014.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Oh Do-Youn; Lee Se-Hoon; Han Sae-Won; Kim Mi-Jung; Kim Tae-Min; Kim Tae-You; Heo Dae Seog; Bang Yung-Jue; Oh Do-Youn; Lee Se-Hoon; Han Sae-Won; Kim Mi-Jung; Kim Tae-Min; Kim Tae-You; Heo Dae Seog; Bang Yung-Jue; Yuasa Miyuki; Yanagihara Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research and treatment : official journal of Korean Cancer Association</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">607-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  OPB-31121 is an oral STAT3 inhibitor with a good preclinical antitumor activity.  This phase I dose-escalation study of OPB-31121 was conducted to determine maximum-tolerated dose (MTD), safety, pharmacokinetics, and preliminary antitumor efficacy in patients with advanced solid tumors.  MATERIALS AND METHODS:  Patients received OPB-31121 once daily for 28 days of each cycle followed by 2 weeks rest.  A standard 3+3 design was used for dose-escalation.  Safety and response were evaluated by the National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE) ver. 3.0 and Response Evaluation Criteria in Solid Tumor (RECIST) ver. 1.0, respectively.  RESULTS:  Twenty-five patients were treated with OPB-31121 at five dose levels: 100 mg (n=4), 200 mg (n=3), 400 mg (n=3), 600 mg (n=7), and 800 mg (n=8).  Seven patients discontinued treatment during cycle 1 for various reasons other than study drug-related adverse events.  Among 18 patients who were evaluable for dose-limiting toxicity (DLT), three DLTs were observed: one DLT (grade 3 vomiting) at 600 mg and two DLTs (grade 3 vomiting, grade 3 diarrhea) at 800 mg.  The MTD was determined as 800 mg/day.  Common adverse events were gastrointestinal adverse event including nausea (84%), vomiting (80%), and diarrhea (72%).  Pharmacokinetics did not demonstrate dose-proportionality of OPB-31121.  Eight patients had stable disease and 10 patients had disease progression.  Two patients (1 colon cancer, 1 rectal cancer) showed tumor shrinkage.  One gastric cancer patient continued treatment up to cycle 13 before disease progression.  CONCLUSION:  This study demonstrates feasibility of STAT3 inhibition in patients with advanced solid tumor.  OPB-31121, at the MTD of 800 mg/day, was safe and relatively well tolerated, and has a preliminary antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQO4HjIonre9iM8MEzWGjS9fW6udTcc2ebTHhVSG7zcXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MroslKgug%253D%253D&md5=499f3d1b07c7760b88d12e1be071d398</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4143%2Fcrt.2014.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4143%252Fcrt.2014.249%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DHeo%26aufirst%3DD.%2BS.%26aulast%3DYuasa%26aufirst%3DM.%26aulast%3DYanagihara%26aufirst%3DY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DPhase%2520I%2520study%2520of%2520OPB-31121%252C%2520an%2520oral%2520STAT3%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Res.%2520Treat.%26date%3D2015%26volume%3D47%26spage%3D607%26epage%3D615%26doi%3D10.4143%2Fcrt.2014.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/j.canlet.2013.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.canlet.2013.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=23402820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFCltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2013&pages=145-152&author=M.+J.+Kimauthor=H.+J.+Namauthor=H.+P.+Kimauthor=S.+W.+Hanauthor=S.+A.+Imauthor=T.+Y.+Kimauthor=D.+Y.+Ohauthor=Y.+J.+Bang&title=OPB-31121%2C+a+novel+small+molecular+inhibitor%2C+disrupts+the+JAK2%2FSTAT3+pathway+and+exhibits+an+antitumor+activity+in+gastric+cancer+cells&doi=10.1016%2Fj.canlet.2013.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells</span></div><div class="casAuthors">Kim, Mi-Jung; Nam, Hyun-Jin; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We investigated the mechanisms of action and antitumor effects of OPB-31121, a novel STAT3 inhibitor, in gastric cancer cells.  OPB-31121 downregulated JAK2 and gp130 expression and inhibited JAK2 phosphorylation which leads to inhibition of STAT3 phosphorylation.  OPB-31121 inhibited constitutively activated and IL-6-induced JAK/STAT signaling pathway.  OPB-31121 decreased cell proliferation in both gastric cancer cells and in a xenograft model, induced the apoptosis of gastric cancer cells, inhibited the expression of antiapoptotic proteins, and showed synergism with 5-fluorouracil and cisplatin.  Taken together, our study suggests that STAT3 inhibition with OPB-31121 can be tested in patients with gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW53W7Zb1lHbVg90H21EOLACvtfcHk0lgEpS8RXDsUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFCltbs%253D&md5=b96912c6bd814e45f0cadc88ef276240</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DNam%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BP.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DIm%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DOPB-31121%252C%2520a%2520novel%2520small%2520molecular%2520inhibitor%252C%2520disrupts%2520the%2520JAK2%252FSTAT3%2520pathway%2520and%2520exhibits%2520an%2520antitumor%2520activity%2520in%2520gastric%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D335%26spage%3D145%26epage%3D152%26doi%3D10.1016%2Fj.canlet.2013.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Okusaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokosuka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, K.</span><span> </span><span class="NLM_article-title">Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma</span> <span class="citation_source-journal">Hepatol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span><span class="refDoi"> DOI: 10.1111/hepr.12504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1111%2Fhepr.12504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=25676869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=1283-1291&author=T.+Okusakaauthor=H.+Uenoauthor=M.+Ikedaauthor=S.+Mitsunagaauthor=M.+Ozakaauthor=H.+Ishiiauthor=O.+Yokosukaauthor=Y.+Ookaauthor=R.+Yoshimotoauthor=Y.+Yanagiharaauthor=K.+Okita&title=Phase+1+and+pharmacological+trial+of+OPB-31121%2C+a+signal+transducer+and+activator+of+transcription-3+inhibitor%2C+in+patients+with+advanced+hepatocellular+carcinoma&doi=10.1111%2Fhepr.12504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma</span></div><div class="casAuthors">Okusaka, Takuji; Ueno, Hideki; Ikeda, Masafumi; Mitsunaga, Shuichi; Ozaka, Masato; Ishii, Hiroshi; Yokosuka, Osamu; Ooka, Yoshihiko; Yoshimoto, Ryo; Yanagihara, Yasuo; Okita, Kiwamu</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1283-1291</span>CODEN:
                <span class="NLM_cas:coden">HPRSFM</span>;
        ISSN:<span class="NLM_cas:issn">1386-6346</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim : To evaluate the safety, pharmacokinetics and antitumor activity of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma (HCC).  Methods : HCC patients of Child-Pugh A or B who progressed on, or were intolerant to, sorafenib were eligible for this phase 1 trial.  We used a std. 3 + 3 dose-escalation design with a 28-day cycle at dose levels of 50, 100, 200 and 400 mg/day.  Tumor responses were assessed using the modified Response Evaluation Criteria in Solid Tumors.  Results : Twenty-four patients were enrolled, of whom 23 received OPB-31121 (20 males; median age, 65 years).  The most common adverse drug reactions were nausea (87.0%), vomiting (82.6%), diarrhea (69.6%), fatigue/malaise (52.2%), anorexia (47.8%) and peripheral sensory neuropathy (26.1%).  The recommended dose for OPB-31121 was detd. to be 200 mg.  Six patients had stable disease for 8 wk or more, resulting in disease control rates of 25.0-42.9%.  In the 200-mg dose cohort, three of seven patients had stable disease and a median time to progression of 61.0 days.  The max. concn. and area under the plasma concn.-time curve of OPB-31121 were dose proportional.  Conclusion : OPB-31121 demonstrated insufficient antitumor activity for HCC.  Furthermore, peripheral nervous system-related toxicities may neg. affect long-term administration of OPB-31121.  Therefore, it was deemed difficult to continue the clin. development of OPB-31121 for treating advanced HCC and further investigation is expected in the agent with favorable profile in this category.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYU_Xm9vcDkrVg90H21EOLACvtfcHk0lgEpS8RXDsUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrt7zP&md5=576b55c63e52851a2aee30e8302355c0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fhepr.12504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fhepr.12504%26sid%3Dliteratum%253Aachs%26aulast%3DOkusaka%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DMitsunaga%26aufirst%3DS.%26aulast%3DOzaka%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DYokosuka%26aufirst%3DO.%26aulast%3DOoka%26aufirst%3DY.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DYanagihara%26aufirst%3DY.%26aulast%3DOkita%26aufirst%3DK.%26atitle%3DPhase%25201%2520and%2520pharmacological%2520trial%2520of%2520OPB-31121%252C%2520a%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription-3%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520hepatocellular%2520carcinoma%26jtitle%3DHepatol.%2520Res.%26date%3D2015%26volume%3D45%26spage%3D1283%26epage%3D1291%26doi%3D10.1111%2Fhepr.12504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bendell, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchook, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricmont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elekes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1007/s00280-014-2480-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1007%2Fs00280-014-2480-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24819685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvFCisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=125-130&author=J.+C.+Bendellauthor=D.+S.+Hongauthor=H.+A.+Burrisauthor=A.+Naingauthor=S.+F.+Jonesauthor=G.+Falchookauthor=P.+Bricmontauthor=A.+Elekesauthor=E.+P.+Rockauthor=R.+Kurzrock&title=Phase+1%2C+open-label%2C+dose-escalation%2C+and+pharmacokinetic+study+of+STAT3+inhibitor+OPB-31121+in+subjects+with+advanced+solid+tumors&doi=10.1007%2Fs00280-014-2480-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors</span></div><div class="casAuthors">Bendell, Johanna C.; Hong, David S.; Burris, Howard A., III; Naing, Aung; Jones, Suzanne F.; Falchook, Gerald; Bricmont, Patricia; Elekes, Agnes; Rock, Edwin P.; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-130</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To det. the max. tolerated dose (MTD) and biol. activity of OPB-31121, an oral inhibitor of STAT3, administered twice daily (BID) to subjects with advanced solid tumors.  Methods: .  Subjects received escalating doses of OPB-31121 BID for the first 21 days of each 28-day cycle in a std. 3 + 3 design.  Dose-limiting toxicities (DLTs), safety, pharmacokinetics, and antitumor activity were assessed.  Results: Thirty subjects were treated twice daily with OPB-31121 at 6 dose levels: 50 mg (n = 4); 70 mg (n = 3); 140 mg (n = 3); 200 mg (n = 4); 300 mg (n = 9); 350 mg (n = 7).  There were no DLTs obsd. until 300 mg BID (Grade 3 lactic acidosis).  At the next dose level (350 mg BID), two subjects had DLTs (Grade 3 vomiting and Grade 3 diarrhea).  Thus, 300 mg BID was declared the MTD.  OPB-31121-related adverse events included nausea (80 %), vomiting (73 %), diarrhea (63 %), and fatigue (33 %), all of which were primarily grade 1/2.  Pharmacokinetics demonstrated high inter-subject variability with exposures 146- to 4,788-fold lower than target concns. from tumor-bearing mouse models.  No objective responses were obsd., and all subjects who completed two cycles of treatment had disease progression at their first assessment.  Conclusions: Twice-daily administration of OPB-31121 was feasible up to doses of 300 mg.  The pharmacokinetic profile was unfavorable, and no objective responses were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3-0uiCzM9V7Vg90H21EOLACvtfcHk0lhdxd7QXM7a1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvFCisLo%253D&md5=b3e9de791b6bcd79368a006c08641cf5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00280-014-2480-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-014-2480-2%26sid%3Dliteratum%253Aachs%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DNaing%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DFalchook%26aufirst%3DG.%26aulast%3DBricmont%26aufirst%3DP.%26aulast%3DElekes%26aufirst%3DA.%26aulast%3DRock%26aufirst%3DE.%2BP.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DPhase%25201%252C%2520open-label%252C%2520dose-escalation%252C%2520and%2520pharmacokinetic%2520study%2520of%2520STAT3%2520inhibitor%2520OPB-31121%2520in%2520subjects%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2014%26volume%3D74%26spage%3D125%26epage%3D130%26doi%3D10.1007%2Fs00280-014-2480-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hayakawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, T.</span><span> </span><span class="NLM_article-title">A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases</span> <span class="citation_source-journal">Blood Cancer J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e166</span><span class="refDoi"> DOI: 10.1038/bcj.2013.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1038%2Fbcj.2013.63" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e166&author=F.+Hayakawaauthor=K.+Sugimotoauthor=Y.+Haradaauthor=N.+Hashimotoauthor=N.+Ohiauthor=S.+Kurahashiauthor=T.+Naoe&title=A+novel+STAT+inhibitor%2C+OPB-31121%2C+has+a+significant+antitumor+effect+on+leukemia+with+STAT-addictive+oncokinases&doi=10.1038%2Fbcj.2013.63"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2013.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2013.63%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DF.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DOhi%26aufirst%3DN.%26aulast%3DKurahashi%26aufirst%3DS.%26aulast%3DNaoe%26aufirst%3DT.%26atitle%3DA%2520novel%2520STAT%2520inhibitor%252C%2520OPB-31121%252C%2520has%2520a%2520significant%2520antitumor%2520effect%2520on%2520leukemia%2520with%2520STAT-addictive%2520oncokinases%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2013%26volume%3D3%26spage%3De166%26doi%3D10.1038%2Fbcj.2013.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zhong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, C. H.</span><span> </span><span class="NLM_article-title">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">5400</span><span class="NLM_x">–</span> <span class="NLM_lpage">5408</span><span class="refDoi"> DOI: 10.1039/C5SC02321A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1039%2FC5SC02321A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=28757943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=5400-5408&author=H.+J.+Zhongauthor=L.+H.+Luauthor=K.+H.+Leungauthor=C.+C.+L.+Wongauthor=C.+Pengauthor=S.+C.+Yanauthor=D.+L.+Maauthor=Z.+W.+Caiauthor=H.+M.+D.+Wangauthor=C.+H.+Leung&title=An+iridium%28III%29-based+irreversible+protein-protein+interaction+inhibitor+of+BRD4+as+a+potent+anticancer+agent&doi=10.1039%2FC5SC02321A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span></div><div class="casAuthors">Zhong, Hai-Jing; Lu, Lihua; Leung, Ka-Ho; Wong, Catherine C. L.; Peng, Chao; Yan, Siu-Cheong; Ma, Dik-Lung; Cai, Zongwei; David Wang, Hui-Min; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5400-5408</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bromodomain-contg. protein 4 (BRD4) has recently emerged as an attractive epigenetic target for anticancer therapy.  In this study, an iridium(III) complex is reported as the first metal-based, irreversible inhibitor of BRD4.  Complex 1a is able to antagonize the BRD4-acetylated histone protein-protein interaction (PPI) in vitro, and to bind BRD4 and down-regulate c-myc oncogenic expression in cellulo.  Chromatin immunopptn. (ChIP) anal. revealed that 1a could modulate the interaction between BRD4 and chromatin in melanoma cells, particular at the MYC promoter.  Finally, the complex showed potent activity against melanoma xenografts in an in vivo mouse model.  To our knowledge, this is the first report of a Group 9 metal complex inhibiting the PPI of a member of the bromodomain and extraterminal domain (BET) family.  We envision that complex 1a may serve as a useful scaffold for the development of more potent epigenetic agents against cancers such as melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMXspNfXFlbVg90H21EOLACvtfcHk0lhdxd7QXM7a1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E&md5=ae176cbfd3621dd7939c234d643db84e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC5SC02321A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC02321A%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%2BJ.%26aulast%3DLu%26aufirst%3DL.%2BH.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DWong%26aufirst%3DC.%2BC.%2BL.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DS.%2BC.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DWang%26aufirst%3DH.%2BM.%2BD.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DAn%2520iridium%2528III%2529-based%2520irreversible%2520protein-protein%2520interaction%2520inhibitor%2520of%2520BRD4%2520as%2520a%2520potent%2520anticancer%2520agent%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D5400%26epage%3D5408%26doi%3D10.1039%2FC5SC02321A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Leung, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D. L.</span><span> </span><span class="NLM_article-title">A natural product-like inhibitor of NEDD8-activating enzyme</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2511</span><span class="NLM_x">–</span> <span class="NLM_lpage">2513</span><span class="refDoi"> DOI: 10.1039/c0cc04927a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1039%2Fc0cc04927a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21240405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2511-2513&author=C.+H.+Leungauthor=D.+S.+Chanauthor=H.+Yangauthor=R.+Abagyanauthor=S.+M.+Leeauthor=G.+Y.+Zhuauthor=W.+F.+Fongauthor=D.+L.+Ma&title=A+natural+product-like+inhibitor+of+NEDD8-activating+enzyme&doi=10.1039%2Fc0cc04927a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A natural product-like inhibitor of NEDD8-activating enzyme</span></div><div class="casAuthors">Leung, Chung-Hang; Chan, Daniel Shiu-Hin; Yang, Hui; Abagyan, Ruben; Lee, Simon Ming-Yuen; Zhu, Guo-Yuan; Fong, Wang-Fun; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2511-2513</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The natural product-like 6,6''-biapigenin has been identified as only the second inhibitor of NEDD8-activating enzyme using virtual screening.  This compd. was active in enzyme and cell-based assays, with potency in the micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIgh-oaWCxuLVg90H21EOLACvtfcHk0lhl35GkjlqDxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D&md5=8783a238deaf9306f1bdaca88ab0575e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc0cc04927a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc04927a%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BH.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DG.%2BY.%26aulast%3DFong%26aufirst%3DW.%2BF.%26aulast%3DMa%26aufirst%3DD.%2BL.%26atitle%3DA%2520natural%2520product-like%2520inhibitor%2520of%2520NEDD8-activating%2520enzyme%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D2511%26epage%3D2513%26doi%3D10.1039%2Fc0cc04927a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Computer-aided drug discovery</span> <span class="citation_source-journal">F1000Research</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="refDoi"> DOI: 10.12688/f1000research.6653.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.12688%2Ff1000research.6653.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=630&author=J.+Bajorath&title=Computer-aided+drug+discovery&doi=10.12688%2Ff1000research.6653.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided drug discovery [version 1; referees: 3 approved]</span></div><div class="casAuthors">Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">630/1-630/8</span>CODEN:
                <span class="NLM_cas:coden">FRESJL</span>;
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    
            (<span class="NLM_cas:orgname">F1000 Research Ltd.</span>)
        </div><div class="casAbstract">Computational approaches are an integral part of interdisciplinary drug discovery research.  Understanding the science behind computational tools, their opportunities, and limitations is essential to make a true impact on drug discovery at different levels.  If applied in a scientifically meaningful way, computational methods improve the ability to identify and evaluate potential drug mols., but there remain weaknesses in the methods that preclude na.ovrddot.ive applications.  Herein, current trends in computer-aided drug discovery are reviewed, and selected computational areas are discussed.  Approaches are highlighted that aid in the identification and optimization of new drug candidates.  Emphasis is put on the presentation and discussion of computational concepts and methods, rather than case studies or application examples.  As such, this contribution aims to provide an overview of the current methodol. spectrum of computational drug discovery for a broad audience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8_WWMna927Vg90H21EOLACvtfcHk0lhl35GkjlqDxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D&md5=8766cd816d41aa01356ffce757026720</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.6653.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.6653.1%26sid%3Dliteratum%253Aachs%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputer-aided%2520drug%2520discovery%26jtitle%3DF1000Research%26date%3D2015%26volume%3D4%26spage%3D630%26doi%3D10.12688%2Ff1000research.6653.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Computational exploration of molecular scaffolds in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4062</span><span class="NLM_x">–</span> <span class="NLM_lpage">4076</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVygur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4062-4076&author=Y.+Huauthor=D.+Stumpfeauthor=J.+Bajorath&title=Computational+exploration+of+molecular+scaffolds+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b01746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Exploration of Molecular Scaffolds in Medicinal Chemistry</span></div><div class="casAuthors">Hu, Ye; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4062-4076</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The scaffold concept is widely applied in medicinal chem.  Scaffolds are mostly used to represent core structures of bioactive compds.  Although the scaffold concept has limitations and is often viewed differently from a chem. and computational perspective, it has provided a basis for systematic investigations of mol. cores and building blocks, going far beyond the consideration of individual compd. series.  Over the past 2 decades, alternative scaffold definitions and organization schemes have been introduced and scaffolds have been studied in a variety of ways and increasingly on a large scale.  Major applications of the scaffold concept include the generation of mol. hierarchies, structural classification, assocn. of scaffolds with biol. activities, and activity prediction.  This contribution discusses computational approaches for scaffold generation and anal., with emphasis on recent developments impacting medicinal chem.  A variety of scaffold-based studies are discussed, and a perspective on scaffold methods is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMic25FvCi3LVg90H21EOLACvtfcHk0lhl35GkjlqDxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVygur4%253D&md5=4f3af64c39e7a2844350fb9b73452b98</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01746%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputational%2520exploration%2520of%2520molecular%2520scaffolds%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4062%26epage%3D4076%26doi%3D10.1021%2Facs.jmedchem.5b01746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">A novel small-molecule disrupts STAT3 SH2 domain-phosphotyrosine interactions and STAT3-dependent tumor processes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.bcp.2010.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=20067773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVCnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1398-1409&author=X.+Zhangauthor=P.+Yueauthor=S.+Fletcherauthor=W.+Zhaoauthor=P.+T.+Gunningauthor=J.+Turkson&title=A+novel+small-molecule+disrupts+STAT3+SH2+domain-phosphotyrosine+interactions+and+STAT3-dependent+tumor+processes&doi=10.1016%2Fj.bcp.2010.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes</span></div><div class="casAuthors">Zhang, Xiaolei; Yue, Peibin; Fletcher, Steven; Zhao, Wei; Gunning, Patrick T.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1398-1409</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mol. modeling of the phosphotyrosine (pTyr)-SH2 domain interaction in the Stat3:Stat3 dimerization, combined with in silico structural anal. of the Stat3 dimerization disruptor, S3I-201, has furnished a diverse set of analogs.  We present evidence from in vitro biochem. and biophys. studies that the structural analog, S3I-201.1066 (I) directly interacts with Stat3 or the SH2 domain, with an affinity (KD) of 2.74 μM, and disrupts the binding of Stat3 to the cognate pTyr-peptide, GpYLPQTV-NH2, with an IC50 of 23 μM.  Moreover, I selectively blocks the assocn. of Stat3 with the epidermal growth factor receptor (EGFR), and inhibits Stat3 tyrosine phosphorylation and nuclear translocation in EGF-stimulated mouse fibroblasts.  In cancer cells that harbor aberrant Stat3 activity, I inhibits constitutive Stat3 DNA-binding and transcriptional activities.  By contrast, I has no effect on Src activation or the EGFR-mediated activation of the Erk1/2MAPK pathway.  I selectively suppresses the viability, survival, and malignant transformation of the human breast and pancreatic cancer lines and the v-Src-transformed mouse fibroblasts harboring persistently active Stat3.  Treatment with I of malignant cells harboring aberrantly active Stat3 down-regulated the expression of c-Myc, Bcl-xL, Survivin, the matrix metalloproteinase 9, and VEGF.  The in vivo administration of I-induced significant antitumor response in mouse models of human breast cancer, which correlates with the inhibition of constitutively active Stat3 and the suppression of known Stat3-regulated genes.  Our studies identify a novel small-mol. that binds with a high affinity to Stat3, blocks Stat3 activation and function, and thereby induces antitumor response in human breast tumor xenografts harboring persistently active Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxJzIoqCaQHbVg90H21EOLACvtfcHk0lhl35GkjlqDxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVCnsL8%253D&md5=4a196103d1d0f6d057715ff4cd2d7498</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small-molecule%2520disrupts%2520STAT3%2520SH2%2520domain-phosphotyrosine%2520interactions%2520and%2520STAT3-dependent%2520tumor%2520processes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1398%26epage%3D1409%26doi%3D10.1016%2Fj.bcp.2010.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutzen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foust, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhasin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1593/neo.91196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1593%2Fneo.91196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=39-50&author=L.+Linauthor=B.+Hutzenauthor=P.+K.+Liauthor=S.+Ballauthor=M.+Zuoauthor=S.+DeAngelisauthor=E.+Foustauthor=M.+Soboauthor=L.+Friedmanauthor=D.+Bhasinauthor=L.+Cenauthor=C.+Liauthor=J.+Lin&title=A+novel+small+molecule%2C+LLL12%2C+inhibits+STAT3+phosphorylation+and+activities+and+exhibits+potent+growth-suppressive+activity+in+human+cancer+cells&doi=10.1593%2Fneo.91196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1593%2Fneo.91196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.91196%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DHutzen%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DBall%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DM.%26aulast%3DDeAngelis%26aufirst%3DS.%26aulast%3DFoust%26aufirst%3DE.%26aulast%3DSobo%26aufirst%3DM.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DCen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small%2520molecule%252C%2520LLL12%252C%2520inhibits%2520STAT3%2520phosphorylation%2520and%2520activities%2520and%2520exhibits%2520potent%2520growth-suppressive%2520activity%2520in%2520human%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D39%26epage%3D50%26doi%3D10.1593%2Fneo.91196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Szelag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwoniec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesoly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluyssen, H. A.</span><span> </span><span class="NLM_article-title">Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116688</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1371%2Fjournal.pone.0116688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=25710482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ClsrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116688&author=M.+Szelagauthor=A.+Czerwoniecauthor=J.+Wesolyauthor=H.+A.+Bluyssen&title=Identification+of+STAT1+and+STAT3+specific+inhibitors+using+comparative+virtual+screening+and+docking+validation&doi=10.1371%2Fjournal.pone.0116688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation</span></div><div class="casAuthors">Szelag, Malgorzata; Czerwoniec, Anna; Wesoly, Joanna; Bluyssen, Hans A. R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0116688/1-e0116688/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Signal transducers and activators of transcription (STATs) facilitate action of cytokines, growth factors and pathogens.  STAT activation is mediated by a highly conserved SH2 domain, which interacts with phosphotyrosine motifs for specific STAT-receptor contacts and STAT dimerization.  The active dimers induce gene transcription in the nucleus by binding to a specific DNA-response element in the promoter of target genes.  Abnormal activation of STAT signaling pathways is implicated in many human diseases, like cancer, inflammation and auto-immunity.  Searches for STAT-targeting compds., exploring the phosphotyrosine (pTyr)-SH2 interaction site, yielded many small mols. for STAT3 but sparsely for other STATs.  However, many of these inhibitors seem not STAT3-specific, thereby questioning the present modeling and selection strategies of SH2 domain-based STAT inhibitors.  We generated new 3D structure models for all human (h)STATs and developed a comparative in silico docking strategy to obtain further insight into STAT-SH2 cross-binding specificity of a selection of previously identified STAT3 inhibitors.  Indeed, by primarily targeting the highly conserved pTyr-SH2 binding pocket the majority of these compds. exhibited similar binding affinity and tendency scores for all STATs.  By comparative screening of a natural product library we provided initial proof for the possibility to identify STAT1 as well as STAT3-specific inhibitors, introducing the 'STAT-comparative binding affinity value' and 'ligand binding pose variation' as selection criteria.  In silico screening of a multi-million clean leads (CL) compd. library for binding of all STATs, likewise identified potential specific inhibitors for STAT1 and STAT3 after docking validation.  Based on comparative virtual screening and docking validation, we developed a novel STAT inhibitor screening tool that allows identification of specific STAT1 and STAT3 inhibitory compds.  This could increase our understanding of the functional role of these STATs in different diseases and benefit the clin. need for more drugable STAT inhibitors with high specificity, potency and excellent bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-INvAZE2X7Vg90H21EOLACvtfcHk0ljXUIu4cY1z1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ClsrbL&md5=db30348a06c759470c20a5ffe346367e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116688%26sid%3Dliteratum%253Aachs%26aulast%3DSzelag%26aufirst%3DM.%26aulast%3DCzerwoniec%26aufirst%3DA.%26aulast%3DWesoly%26aufirst%3DJ.%26aulast%3DBluyssen%26aufirst%3DH.%2BA.%26atitle%3DIdentification%2520of%2520STAT1%2520and%2520STAT3%2520specific%2520inhibitors%2520using%2520comparative%2520virtual%2520screening%2520and%2520docking%2520validation%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116688%26doi%3D10.1371%2Fjournal.pone.0116688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bohm, H. J.</span><span> </span><span class="NLM_article-title">The computer program LUDI: a new method for the de novo design of enzyme inhibitors</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1007/BF00124387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1007%2FBF00124387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1583540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A280%3ADyaK383mtVarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=61-78&author=H.+J.+Bohm&title=The+computer+program+LUDI%3A+a+new+method+for+the+de+novo+design+of+enzyme+inhibitors&doi=10.1007%2FBF00124387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The computer program LUDI: a new method for the de novo design of enzyme inhibitors</span></div><div class="casAuthors">Bohm H J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-78</span>
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    </div><div class="casAbstract">A new computer program is described, which positions small molecules into clefts of protein structures (e.g. an active site of an enzyme) in such a way that hydrogen bonds can be formed with the enzyme and hydrophobic pockets are filled with hydrophobic groups.  The program works in three steps.  First it calculates interaction sites, which are discrete positions in space suitable to form hydrogen bonds or to fill a hydrophobic pocket.  The interaction sites are derived from distributions of nonbonded contacts generated by a search through the Cambridge Structural Database.  An alternative route to generate the interaction sites is the use of rules.  The second step is the fit of molecular fragments onto the interaction sites.  Currently we use a library of 600 fragments for the fitting.  The final step in the present program is the connection of some or all of the fitted fragments to a single molecule.  This is done by bridge fragments.  Applications are presented for the crystal packing of benzoic acid and the enzymes dihydrofolate reductase and trypsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaYlhxlen0XYvKgEt20y1XfW6udTcc2eYaUrx4FdR-zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383mtVarsw%253D%253D&md5=430014acc628395868a68729410b09c0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2FBF00124387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00124387%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520computer%2520program%2520LUDI%253A%2520a%2520new%2520method%2520for%2520the%2520de%2520novo%2520design%2520of%2520enzyme%2520inhibitors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1992%26volume%3D6%26spage%3D61%26epage%3D78%26doi%3D10.1007%2FBF00124387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Multiple ligand simultaneous docking: orchestrated dancing of ligands in binding sites of protein</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2014</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span><span class="refDoi"> DOI: 10.1002/jcc.21486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fjcc.21486" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=2014-2022&author=H.+Liauthor=C.+Li&title=Multiple+ligand+simultaneous+docking%3A+orchestrated+dancing+of+ligands+in+binding+sites+of+protein&doi=10.1002%2Fjcc.21486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21486%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DMultiple%2520ligand%2520simultaneous%2520docking%253A%2520orchestrated%2520dancing%2520of%2520ligands%2520in%2520binding%2520sites%2520of%2520protein%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D2014%26epage%3D2022%26doi%3D10.1002%2Fjcc.21486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">Schrödinger Release 2015-2:</p></div><div class="NLM_citation" id="cit33"><span>LigPrep, version 3.4; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+3.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">Schrödinger Release 2015-2:</p></div><div class="NLM_citation" id="cit34"><span>Canvas, version 2.4; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Canvas%2C+version+2.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCanvas%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Bhasin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etter, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chettiar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span> </span><span class="NLM_article-title">Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6864</span><span class="NLM_x">–</span> <span class="NLM_lpage">6867</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.bmcl.2013.09.098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6864-6867&author=D.+Bhasinauthor=J.+P.+Etterauthor=S.+N.+Chettiarauthor=M.+Mokauthor=P.+K.+Li&title=Antiproliferative+activities+and+SAR+studies+of+substituted+anthraquinones+and+1%2C4-naphthoquinones&doi=10.1016%2Fj.bmcl.2013.09.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.098%26sid%3Dliteratum%253Aachs%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DEtter%26aufirst%3DJ.%2BP.%26aulast%3DChettiar%26aufirst%3DS.%2BN.%26aulast%3DMok%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%2BK.%26atitle%3DAntiproliferative%2520activities%2520and%2520SAR%2520studies%2520of%2520substituted%2520anthraquinones%2520and%25201%252C4-naphthoquinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6864%26epage%3D6867%26doi%3D10.1016%2Fj.bmcl.2013.09.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">Schrödinger Release 2015-2:</p></div><div class="NLM_citation" id="cit36a"><span>Protein Preparation Wizard;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Preparation+Wizard%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Preparation%2520Wizard" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span>Epik, version 3.2;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+3.2%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpik" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36c"><span>Impact, version 6.7;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%2C+version+6.7%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DImpact" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36"><span>Prime, version 4.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+4.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span><span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=Autodock4+and+AutoDockTools4%3A+automated+docking+with+selective+receptor+flexiblity&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljIdlyarFDdpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutodock4%2520and%2520AutoDockTools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexiblity%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Regioselective one-pot C-N coupling of substituted naphthoquinones: selective intramolecular ring fusion of sulfonamides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1016/j.tet.2013.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.tet.2013.11.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=459-464&author=W.+Yuauthor=C.+Li&title=Regioselective+one-pot+C-N+coupling+of+substituted+naphthoquinones%3A+selective+intramolecular+ring+fusion+of+sulfonamides&doi=10.1016%2Fj.tet.2013.11.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2013.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2013.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DRegioselective%2520one-pot%2520C-N%2520coupling%2520of%2520substituted%2520naphthoquinones%253A%2520selective%2520intramolecular%2520ring%2520fusion%2520of%2520sulfonamides%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26spage%3D459%26epage%3D464%26doi%3D10.1016%2Fj.tet.2013.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/j.ab.2008.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.ab.2008.01.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=249-254&author=J.+Mullerauthor=J.+Schustauthor=T.+Berg&title=A+high-throughput+assay+for+signal+transducer+and+activator+of+transcription+5b+based+on+fluorescence+polarization&doi=10.1016%2Fj.ab.2008.01.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2008.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2008.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DSchust%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DA%2520high-throughput%2520assay%2520for%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25205b%2520based%2520on%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D375%26spage%3D249%26epage%3D254%26doi%3D10.1016%2Fj.ab.2008.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">A cell-permeable STAT3 SH2 domain mimetic inhibits STAT3 activation and induces antitumor cell effects in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">35855</span><span class="NLM_x">–</span> <span class="NLM_lpage">35865</span><span class="refDoi"> DOI: 10.1074/jbc.M110.154088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1074%2Fjbc.M110.154088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=20807764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35855-35865&author=W.+Zhaoauthor=S.+Jaganathanauthor=J.+Turkson&title=A+cell-permeable+STAT3+SH2+domain+mimetic+inhibits+STAT3+activation+and+induces+antitumor+cell+effects+in+vitro&doi=10.1074%2Fjbc.M110.154088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro</span></div><div class="casAuthors">Zhao, Wei; Jaganathan, Soumya; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">35855-35865</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Given the role of constitutively active Signal Transducer and Activator of Transcription (Stat) 3 in human tumors, Stat3 inhibitors would be useful as novel therapeutics and as tools for probing Stat3-mediated tumor processes.  We herein report that a 28-mer peptide, SPI, derived from the Stat3 SH2 domain, replicates Stat3 biochem. properties.  Studies show SPI and Stat3 (or Stat3 SH2 domain) bind with similar affinities to known Stat3-binding phosphotyrosine (pY) peptide motifs, including those of the epidermal growth factor receptor (EGFR) and the high-affinity, IL-6R/gp130-derived pY-peptide, GpYLPQTV-NH2.  Consequently, SPI functions as a potent and selective inhibitor of Stat3 SH2 domain:pTyr interactions and disrupts the binding of Stat3 to the IL-6R/gp130 peptide, GpYLPQTV-NH2.  Fluorescence imaging and immunofluorescence staining/laser-scanning confocal microscopy show SPI is cell membrane-permeable, assocs. with the cytoplasmic tail of EGFR in NIH3T3/hEGFR, and is present in the cytoplasm, but strongly localized at the plasma membrane and in the nucleus in malignant cells harboring persistently active Stat3.  Moreover, SPI specifically blocks constitutive Stat3 phosphorylation, DNA binding activity, and transcriptional function in malignant cells, with little or no effect on the induction of Stat1, Stat5, and Erk1/2MAPK pathways, or on general pTyr profile at the concns. that inhibit Stat3 activity.  Significantly, treatment with SPI of human breast, pancreatic, prostate, and non-small cell lung cancer cells harboring constitutively active Stat3 induced extensive morphol. changes, assocd. with viability loss and apoptosis.  Our study identifies SPI as a novel mol. probe for interrogating Stat3 signaling and that functions as a selective inhibitor of Stat3 activation with antitumor cell effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5xNMqd5Ho5rVg90H21EOLACvtfcHk0ljIdlyarFDdpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLfL&md5=a1ac33150ab27d501fdb519800a3b406</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.154088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.154088%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DJaganathan%26aufirst%3DS.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DA%2520cell-permeable%2520STAT3%2520SH2%2520domain%2520mimetic%2520inhibits%2520STAT3%2520activation%2520and%2520induces%2520antitumor%2520cell%2520effects%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D35855%26epage%3D35865%26doi%3D10.1074%2Fjbc.M110.154088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Shahani, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharmeen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhai, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.bmc.2010.12.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1823-1838&author=V.+M.+Shahaniauthor=P.+Yueauthor=S.+Fletcherauthor=S.+Sharmeenauthor=M.+A.+Sukhaiauthor=D.+P.+Luuauthor=X.+Zhangauthor=H.+Sunauthor=W.+Zhaoauthor=A.+D.+Schimmerauthor=J.+Turksonauthor=P.+T.+Gunning&title=Design%2C+synthesis%2C+and+in+vitro+characterization+of+novel+hybrid+peptidomimetic+inhibitors+of+STAT3+protein&doi=10.1016%2Fj.bmc.2010.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DShahani%26aufirst%3DV.%2BM.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DSharmeen%26aufirst%3DS.%26aulast%3DSukhai%26aufirst%3DM.%2BA.%26aulast%3DLuu%26aufirst%3DD.%2BP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520characterization%2520of%2520novel%2520hybrid%2520peptidomimetic%2520inhibitors%2520of%2520STAT3%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1823%26epage%3D1838%26doi%3D10.1016%2Fj.bmc.2010.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2011.01932.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1111%2Fj.1349-7006.2011.01932.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21435102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlShsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2011&pages=1381-1387&author=A.+Liuauthor=Y.+Liuauthor=Z.+Xuauthor=W.+Yuauthor=H.+Wangauthor=C.+Liauthor=J.+Lin&title=Novel+small+molecule%2C+XZH-5%2C+inhibits+constitutive+and+interleukin-6-induced+STAT3+phosphorylation+in+human+rhabdomyosarcoma+cells&doi=10.1111%2Fj.1349-7006.2011.01932.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells</span></div><div class="casAuthors">Liu, Aiguo; Liu, Yan; Xu, Zhenghu; Yu, Wenying; Wang, Hong; Li, Chenglong; Lin, Jiayuh</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1381-1387</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Signal transducers and activators of transcription 3 (STAT3) signaling is constitutively activated in many types of human cancers and cancer cell lines and represents a promising target for cancer therapy.  We previously reported that the STAT3 signaling pathway is constitutively activated in human rhabodomyosarcoma cell lines (RH28, RH30 and RD2).  We also demonstrated that inhibition of the STAT3 pathway led to apoptosis in human rhabdomyosarcoma cells.  In the present study, we investigated the inhibitory effects of a novel small mol., XZH-5, on the STAT3 signaling pathway in human rhabdomyosarcoma cells.  XZH-5 was designed based on STAT3 structure, and our idea was to design peptide mimics to bind to the phosphorylated Tyr705 site and the side pocket.  We found that XZH-5 downregulated STAT3 phosphorylation.  The inhibition of STAT3 by XZH-5 was confirmed by the inhibition of STAT3 DNA binding ability and the downregulation of STAT3 downstream genes, such as Bcl-2, Bcl-xL, Cyclin D1 and Survivin; we also demonstrated that blockade of STAT3 phosphorylation in human rhabdomyosarcoma cells with XZH-5 caused apoptosis and suppressed colony-forming ability and cell migration.  In addn. to reducing constitutive STAT3 phosphorylation, XZH-5 also exhibited the potency to block interleukin-6 (IL-6)-induced STAT3 phosphorylation and nuclear translocation but did not inhibit the stimulation of STAT1 phosphorylation by interferon (IFN)-γ.  Our findings indicate that XZH-5 has the potential for targeting human rhabdomyosarcoma cells expressing constitutive STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaOC1XRYzhHLVg90H21EOLACvtfcHk0ljps8uL4j1Wtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlShsr8%253D&md5=29479872d0d577206c1e99d81df85d76</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2011.01932.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2011.01932.x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DNovel%2520small%2520molecule%252C%2520XZH-5%252C%2520inhibits%2520constitutive%2520and%2520interleukin-6-induced%2520STAT3%2520phosphorylation%2520in%2520human%2520rhabdomyosarcoma%2520cells%26jtitle%3DCancer%2520Sci.%26date%3D2011%26volume%3D102%26spage%3D1381%26epage%3D1387%26doi%3D10.1111%2Fj.1349-7006.2011.01932.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span> </span><span class="NLM_article-title">The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3190</span><span class="NLM_x">–</span> <span class="NLM_lpage">3202</span><span class="refDoi"> DOI: 10.1128/MCB.00159-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1128%2FMCB.00159-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=22665497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2itrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=3190-3202&author=H.+Wangauthor=M.+Jiangauthor=H.+Cuiauthor=M.+Chenauthor=R.+Buttyanauthor=S.+W.+Haywardauthor=T.+Haiauthor=Z.+Wangauthor=C.+Yan&title=The+stress+response+mediator+ATF3+represses+androgen+signaling+by+binding+the+androgen+receptor&doi=10.1128%2FMCB.00159-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor</span></div><div class="casAuthors">Wang, Hongbo; Jiang, Ming; Cui, Hongmei; Chen, Mengqian; Buttyan, Ralph; Hayward, Simon W.; Hai, Tsonwin; Wang, Zhengxin; Yan, Chunhong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3190-3202</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Activating transcription factor 3 (ATF3) is a common mediator of cellular stress response signaling and is often aberrantly expressed in prostate cancer.  The authors report that ATF3 can directly bind the androgen receptor (AR) and consequently repress AR-mediated gene expression.  The ATF3-AR interaction requires the leucine zipper domain of ATF3 that independently binds the DNA-binding and ligand-binding domains of AR, and the interaction prevents AR from binding to cis-acting elements required for expression of androgen-dependent genes while inhibiting the AR N- and C-terminal interaction.  The functional consequences of the loss of ATF3 expression include increased transcription of androgen-dependent genes in prostate cancer cells that correlates with increased ability to grow in low-androgen-contg. medium and increased proliferative activity of the prostate epithelium in ATF3 knockout mice that is assocd. with prostatic hyperplasia.  The authors' results thus demonstrate that ATF3 is a novel repressor of androgen signaling that can inhibit AR functions, allowing prostate cells to restore homeostasis and maintain integrity in the face of a broad spectrum of intrinsic and environmental insults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaTv9uACvuvbVg90H21EOLACvtfcHk0ljps8uL4j1Wtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2itrjK&md5=a6b63480303c69c660803b5022504bec</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FMCB.00159-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00159-12%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DButtyan%26aufirst%3DR.%26aulast%3DHayward%26aufirst%3DS.%2BW.%26aulast%3DHai%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DC.%26atitle%3DThe%2520stress%2520response%2520mediator%2520ATF3%2520represses%2520androgen%2520signaling%2520by%2520binding%2520the%2520androgen%2520receptor%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2012%26volume%3D32%26spage%3D3190%26epage%3D3202%26doi%3D10.1128%2FMCB.00159-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b','cit36c','cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yuhao Ren, Shanshan Li, Ren Zhu, Chengying Wan, Dongmei Song, Jiawen Zhu, Guiping Cai, Sihui Long, Lingyi Kong, <span class="NLM_string-name hlFld-ContribAuthor">Wenying Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7468-7482. <a href="https://doi.org/10.1021/acs.jmedchem.1c00136" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00136%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSTAT3%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BDual-Pathway%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BSolid%252BCancer%26aulast%3DRen%26aufirst%3DYuhao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D24012021%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7468%26epage%3D7482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rizhen Huang, Xiaoteng Jing, Xiaochao Huang, Yingming Pan, Yilin Fang, Guibin Liang, Zhixin Liao, Hengshan Wang, Zhenfeng Chen, <span class="NLM_string-name hlFld-ContribAuthor">Ye Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1544-1563. <a href="https://doi.org/10.1021/acs.jmedchem.9b01386" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01386%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252BNaphthoquinone%252BAromatic%252BAmide-Oxime%252BDerivatives%252BExert%252BCombined%252BImmunotherapeutic%252Band%252BAntitumor%252BEffects%252Bthrough%252BSimultaneous%252BTargeting%252Bof%252BIndoleamine-2%25252C3-dioxygenase%252Band%252BSignal%252BTransducer%252Band%252BActivator%252Bof%252BTranscription%252B3%26aulast%3DHuang%26aufirst%3DRizhen%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D22082019%26date%3D17022020%26date%3D30012020%26volume%3D63%26issue%3D4%26spage%3D1544%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shaoyong Lu, Xinheng He, Duan Ni, <span class="NLM_string-name hlFld-ContribAuthor">Jian Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulator Discovery: From Serendipity to Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6405-6421. <a href="https://doi.org/10.1021/acs.jmedchem.8b01749" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01749%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulator%252BDiscovery%25253A%252BFrom%252BSerendipity%252Bto%252BStructure-Based%252BDesign%26aulast%3DLu%26aufirst%3DShaoyong%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D11112018%26date%3D07032019%26date%3D28022019%26volume%3D62%26issue%3D14%26spage%3D6405%26epage%3D6421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hauke Löcken, Cinzia Clamor, <span class="NLM_string-name hlFld-ContribAuthor">Klaus Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2018,</strong> <em>81 </em>
                                    (7)
                                     , 1636-1644. <a href="https://doi.org/10.1021/acs.jnatprod.8b00247" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.8b00247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.8b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.8b00247%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DNapabucasin%252Band%252BRelated%252BHeterocycle-Fused%252BNaphthoquinones%252Bas%252BSTAT3%252BInhibitors%252Bwith%252BAntiproliferative%252BActivity%252Bagainst%252BCancer%252BCells%26aulast%3DL%25C3%25B6cken%26aufirst%3DHauke%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22032018%26date%3D13072018%26volume%3D81%26issue%3D7%26spage%3D1636%26epage%3D1644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Francisco Lopez-Tapia, Christine Brotherton-Pleiss, Peibin Yue, Heide Murakami, Ana Carolina Costa Araujo, Bruna Reis dos Santos, Erin Ichinotsubo, Anna Rabkin, Raj Shah, Megan Lantz, Suzie Chen, Marcus A. Tius, <span class="NLM_string-name hlFld-ContribAuthor">James Turkson</span>. </span><span class="cited-content_cbyCitation_article-title">Linker Variation and Structure–Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 250-255. <a href="https://doi.org/10.1021/acsmedchemlett.7b00544" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00544%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLinker%252BVariation%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BAnalyses%252Bof%252BCarboxylic%252BAcid-based%252BSmall%252BMolecule%252BSTAT3%252BInhibitors%26aulast%3DLopez-Tapia%26aufirst%3DFrancisco%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D28122017%26date%3D16022018%26date%3D22022018%26date%3D16022018%26volume%3D9%26issue%3D3%26spage%3D250%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florent  Chevillard</span>, <span class="hlFld-ContribAuthor ">Helena  Rimmer</span>, <span class="hlFld-ContribAuthor ">Cecilia  Betti</span>, <span class="hlFld-ContribAuthor ">Els  Pardon</span>, <span class="hlFld-ContribAuthor ">Steven  Ballet</span>, <span class="hlFld-ContribAuthor ">Niek  van Hilten</span>, <span class="hlFld-ContribAuthor ">Jan  Steyaert</span>, <span class="hlFld-ContribAuthor ">Wibke E.  Diederich</span>, and <span class="hlFld-ContribAuthor ">Peter  Kolb</span>  . </span><span class="cited-content_cbyCitation_article-title">Binding-Site Compatible Fragment Growing Applied to the Design of β2-Adrenergic Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1118-1129. <a href="https://doi.org/10.1021/acs.jmedchem.7b01558" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01558%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBinding-Site%252BCompatible%252BFragment%252BGrowing%252BApplied%252Bto%252Bthe%252BDesign%252Bof%252B%2525CE%2525B22-Adrenergic%252BReceptor%252BLigands%26aulast%3DChevillard%26aufirst%3DFlorent%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30102017%26date%3D24012018%26date%3D08022018%26volume%3D61%26issue%3D3%26spage%3D1118%26epage%3D1129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Pan</span>, <span class="hlFld-ContribAuthor ">Jia  Wei</span>, <span class="hlFld-ContribAuthor ">Ruijie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaozhi  Yang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Song</span>, <span class="hlFld-ContribAuthor ">Ren-Yuan  Bai</span>, <span class="hlFld-ContribAuthor ">Shengling  Fu</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Pierson</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Finlay</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-85888-x" title="DOI URL">https://doi.org/10.1038/s41598-021-85888-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-85888-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-85888-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DLLL12B%25252C%252Ba%252Bsmall%252Bmolecule%252BSTAT3%252Binhibitor%25252C%252Binduces%252Bgrowth%252Barrest%25252C%252Bapoptosis%25252C%252Band%252Benhances%252Bcisplatin-mediated%252Bcytotoxicity%252Bin%252Bmedulloblastoma%252Bcells%26aulast%3DChen%26aufirst%3DXiang%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guodong  Li</span>, <span class="hlFld-ContribAuthor ">Chun  Wu</span>, <span class="hlFld-ContribAuthor ">Dik-Lung  Ma</span>, <span class="hlFld-ContribAuthor ">Chung-Hang  Leung</span>. </span><span class="cited-content_cbyCitation_article-title">Drug screening strategies using metal-based luminescent probes. </span><span class="cited-content_cbyCitation_journal-name">TrAC Trends in Analytical Chemistry</span><span> <strong>2021,</strong> <em>139 </em>, 116270. <a href="https://doi.org/10.1016/j.trac.2021.116270" title="DOI URL">https://doi.org/10.1016/j.trac.2021.116270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trac.2021.116270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trac.2021.116270%26sid%3Dliteratum%253Aachs%26jtitle%3DTrAC%2520Trends%2520in%2520Analytical%2520Chemistry%26atitle%3DDrug%252Bscreening%252Bstrategies%252Busing%252Bmetal-based%252Bluminescent%252Bprobes%26aulast%3DLi%26aufirst%3DGuodong%26date%3D2021%26volume%3D139%26spage%3D116270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Hui  Zhong</span>, <span class="hlFld-ContribAuthor ">Kun  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1016/j.apsb.2021.02.023" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DGains%252Bfrom%252Bno%252Breal%252BPAINS%25253A%252BWhere%252B%2525E2%252580%252598Fair%252BTrial%252BStrategy%2525E2%252580%252599%252Bstands%252Bin%252Bthe%252Bdevelopment%252Bof%252Bmulti-target%252Bligands%26aulast%3DSun%26aufirst%3DJianbo%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Rui  Feng</span>, <span class="hlFld-ContribAuthor ">Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Xin-Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Yun-Xuan  Tan</span>, <span class="hlFld-ContribAuthor ">Jia-Ying  Zhao</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qing-Hua  Li</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Lin</span>, <span class="hlFld-ContribAuthor ">Dingding  Gao</span>, <span class="hlFld-ContribAuthor ">Ping  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112428. <a href="https://doi.org/10.1016/j.ejmech.2020.112428" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112428%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpotent%252BSTAT3%252Binhibitors%252Bbased%252Bon%252BBBI608%252Bfor%252Bcancer%252Btherapy%26aulast%3DFeng%26aufirst%3DKai-Rui%26date%3D2020%26volume%3D201%26spage%3D112428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan-Zhu  Xie</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Luo</span>, <span class="hlFld-ContribAuthor ">Li-Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Zi-Zheng  Zou</span>, <span class="hlFld-ContribAuthor ">Hong-Dou  Liu</span>, <span class="hlFld-ContribAuthor ">Fan-Rong  Kong</span>, <span class="hlFld-ContribAuthor ">Ying  Hao</span>, <span class="hlFld-ContribAuthor ">Jin-Lei  Gao</span>, <span class="hlFld-ContribAuthor ">Liu-Liu  Wang</span>, <span class="hlFld-ContribAuthor ">Da-You  Ma</span>, <span class="hlFld-ContribAuthor ">Su-You  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (16)
                                     , 127286. <a href="https://doi.org/10.1016/j.bmcl.2020.127286" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127286%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bisothiazoloquinoline%252Bquinone%252Banalogues%26aulast%3DChen%26aufirst%3DLing%26date%3D2020%26volume%3D30%26issue%3D16%26spage%3D127286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongmei  Song</span>, <span class="hlFld-ContribAuthor ">Wenying  Yu</span>, <span class="hlFld-ContribAuthor ">Yuhao  Ren</span>, <span class="hlFld-ContribAuthor ">Jiawen  Zhu</span>, <span class="hlFld-ContribAuthor ">Chengying  Wan</span>, <span class="hlFld-ContribAuthor ">Guiping  Cai</span>, <span class="hlFld-ContribAuthor ">Jianpeng  Guo</span>, <span class="hlFld-ContribAuthor ">Wenda  Zhang</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of bazedoxifene analogues targeting glycoprotein 130. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112375. <a href="https://doi.org/10.1016/j.ejmech.2020.112375" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112375%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbazedoxifene%252Banalogues%252Btargeting%252Bglycoprotein%252B130%26aulast%3DSong%26aufirst%3DDongmei%26date%3D2020%26volume%3D199%26spage%3D112375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Cerulli</span>, <span class="hlFld-ContribAuthor ">Livia  Shehaj</span>, <span class="hlFld-ContribAuthor ">Isidora  Tosic</span>, <span class="hlFld-ContribAuthor ">Kevin  Jiang</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">David A.  Frank</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Kritzer</span>. </span><span class="cited-content_cbyCitation_article-title">Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (12)
                                     , 115542. <a href="https://doi.org/10.1016/j.bmc.2020.115542" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115542%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCytosolic%252Bdelivery%252Bof%252Bpeptidic%252BSTAT3%252BSH2%252Bdomain%252Binhibitors%26aulast%3DCerulli%26aufirst%3DRobert%2BA.%26date%3D2020%26volume%3D28%26issue%3D12%26spage%3D115542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Pan</span>, <span class="hlFld-ContribAuthor ">Xiang  Chen</span>, <span class="hlFld-ContribAuthor ">Shengling  Fu</span>, <span class="hlFld-ContribAuthor ">Wenying  Yu</span>, <span class="hlFld-ContribAuthor ">Chenglong  Li</span>, <span class="hlFld-ContribAuthor ">Tiffany  Wang</span>, <span class="hlFld-ContribAuthor ">Hui-Wen  Lo</span>, <span class="hlFld-ContribAuthor ">Jiayuh  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2020,</strong> <em>181 </em>
                                    (1)
                                     , 31-41. <a href="https://doi.org/10.1007/s10549-020-05613-6" title="DOI URL">https://doi.org/10.1007/s10549-020-05613-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-020-05613-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-020-05613-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DLLY17%25252C%252Ba%252Bnovel%252Bsmall%252Bmolecule%252BSTAT3%252Binhibitor%252Binduces%252Bapoptosis%252Band%252Bsuppresses%252Bcell%252Bmigration%252Band%252Btumor%252Bgrowth%252Bin%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DPan%26aufirst%3DLi%26date%3D2020%26date%3D2020%26volume%3D181%26issue%3D1%26spage%3D31%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuyao  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhong</span>, <span class="hlFld-ContribAuthor ">Hui  Dong</span>, <span class="hlFld-ContribAuthor ">Qiyao  Zheng</span>, <span class="hlFld-ContribAuthor ">Shuo  Shi</span>, <span class="hlFld-ContribAuthor ">Kai  Zhu</span>, <span class="hlFld-ContribAuthor ">Xinming  Qu</span>, <span class="hlFld-ContribAuthor ">Wenhao  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111922. <a href="https://doi.org/10.1016/j.ejmech.2019.111922" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111922%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevisiting%252Bsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252B%252528STAT3%252529%252Bas%252Ban%252Banticancer%252Btarget%252Band%252Bits%252Binhibitor%252Bdiscovery%25253A%252BWhere%252Bare%252Bwe%252Band%252Bwhere%252Bshould%252Bwe%252Bgo%25253F%26aulast%3DHuang%26aufirst%3DQiuyao%26date%3D2020%26volume%3D187%26spage%3D111922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Po-Chang  Shih</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2020,</strong> <em>242 </em>, 117241. <a href="https://doi.org/10.1016/j.lfs.2019.117241" title="DOI URL">https://doi.org/10.1016/j.lfs.2019.117241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2019.117241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2019.117241%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DRevisiting%252Bthe%252Bdevelopment%252Bof%252Bsmall%252Bmolecular%252Binhibitors%252Bthat%252Bdirectly%252Btarget%252Bthe%252Bsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252B%252528STAT3%252529%252Bdomains%26aulast%3DShih%26aufirst%3DPo-Chang%26date%3D2020%26volume%3D242%26spage%3D117241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Cerulli</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Kritzer</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphotyrosine isosteres: past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (4)
                                     , 583-605. <a href="https://doi.org/10.1039/C9OB01998G" title="DOI URL">https://doi.org/10.1039/C9OB01998G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01998G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01998G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPhosphotyrosine%252Bisosteres%25253A%252Bpast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DCerulli%26aufirst%3DRobert%2BA.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D583%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamer S.  Kaoud</span>, <span class="hlFld-ContribAuthor ">Aliaa M.  Mohassab</span>, <span class="hlFld-ContribAuthor ">Heba A.  Hassan</span>, <span class="hlFld-ContribAuthor ">Chunli  Yan</span>, <span class="hlFld-ContribAuthor ">Sabrina X.  Van Ravenstein</span>, <span class="hlFld-ContribAuthor ">Dalia  Abdelhamid</span>, <span class="hlFld-ContribAuthor ">Kevin N.  Dalby</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abdel-Aziz</span>. </span><span class="cited-content_cbyCitation_article-title">NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111885. <a href="https://doi.org/10.1016/j.ejmech.2019.111885" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111885%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNO-releasing%252BSTAT3%252Binhibitors%252Bsuppress%252BBRAF-mutant%252Bmelanoma%252Bgrowth%26aulast%3DKaoud%26aufirst%3DTamer%2BS.%26date%3D2020%26volume%3D186%26spage%3D111885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Liu</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Lingnan  Guan</span>, <span class="hlFld-ContribAuthor ">Chong  Lai</span>, <span class="hlFld-ContribAuthor ">Wenying  Yu</span>, <span class="hlFld-ContribAuthor ">Maode  Lai</span>. </span><span class="cited-content_cbyCitation_article-title">LL1, a novel and highly selective STAT3 inhibitor, displays anti‐colorectal cancer activities
              in v
              itro and
              in vivo. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (2)
                                     , 298-313. <a href="https://doi.org/10.1111/bph.14863" title="DOI URL">https://doi.org/10.1111/bph.14863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14863%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DLL1%25252C%252Ba%252Bnovel%252Band%252Bhighly%252Bselective%252BSTAT3%252Binhibitor%25252C%252Bdisplays%252Banti%2525E2%252580%252590colorectal%252Bcancer%252Bactivities%252Bin%252Bv%252Bitro%252Band%252Bin%252Bvivo%26aulast%3DLiu%26aufirst%3DZhe%26date%3D2020%26date%3D2019%26volume%3D177%26issue%3D2%26spage%3D298%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuebao  Wang</span>, <span class="hlFld-ContribAuthor ">Qin  He</span>, <span class="hlFld-ContribAuthor ">Kaiqi  Wu</span>, <span class="hlFld-ContribAuthor ">Taoning  Guo</span>, <span class="hlFld-ContribAuthor ">Xuze  Du</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Longcheng  Fang</span>, <span class="hlFld-ContribAuthor ">Nan  Zheng</span>, <span class="hlFld-ContribAuthor ">Qihong  Zhang</span>, <span class="hlFld-ContribAuthor ">Faqing  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 218-232. <a href="https://doi.org/10.1016/j.ejmech.2019.06.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bactivity%252Bof%252Bnovel%252B2%25252C6-disubstituted%252Bpurine%252Bderivatives%25252C%252Bpotential%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%26aulast%3DWang%26aufirst%3DXuebao%26date%3D2019%26volume%3D179%26spage%3D218%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hailun  Zheng</span>, <span class="hlFld-ContribAuthor ">Lehe  Yang</span>, <span class="hlFld-ContribAuthor ">Yanting  Kang</span>, <span class="hlFld-ContribAuthor ">Min  Chen</span>, <span class="hlFld-ContribAuthor ">Shichong  Lin</span>, <span class="hlFld-ContribAuthor ">Youqun  Xiang</span>, <span class="hlFld-ContribAuthor ">Caleb  Li</span>, <span class="hlFld-ContribAuthor ">Xuanxuan  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Huang</span>, <span class="hlFld-ContribAuthor ">Guang  Liang</span>, <span class="hlFld-ContribAuthor ">Chengguang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling. </span><span class="cited-content_cbyCitation_journal-name">Molecular Carcinogenesis</span><span> <strong>2019,</strong> <em>58 </em>
                                    (4)
                                     , 565-576. <a href="https://doi.org/10.1002/mc.22951" title="DOI URL">https://doi.org/10.1002/mc.22951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mc.22951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmc.22951%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Carcinogenesis%26atitle%3DAlantolactone%252Bsensitizes%252Bhuman%252Bpancreatic%252Bcancer%252Bcells%252Bto%252BEGFR%252Binhibitors%252Bthrough%252Bthe%252Binhibition%252Bof%252BSTAT3%252Bsignaling%26aulast%3DZheng%26aufirst%3DHailun%26date%3D2019%26date%3D2019%26volume%3D58%26issue%3D4%26spage%3D565%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mam Y.  Mboge</span>, <span class="hlFld-ContribAuthor ">Zhijuan  Chen</span>, <span class="hlFld-ContribAuthor ">Alyssa  Wolff</span>, <span class="hlFld-ContribAuthor ">John V.  Mathias</span>, <span class="hlFld-ContribAuthor ">Chingkuang  Tu</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Brown</span>, <span class="hlFld-ContribAuthor ">Murat  Bozdag</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Robert  McKenna</span>, <span class="hlFld-ContribAuthor ">Susan C.  Frost</span>, . </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (11)
                                     , e0207417. <a href="https://doi.org/10.1371/journal.pone.0207417" title="DOI URL">https://doi.org/10.1371/journal.pone.0207417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0207417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0207417%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DSelective%252Binhibition%252Bof%252Bcarbonic%252Banhydrase%252BIX%252Bover%252Bcarbonic%252Banhydrase%252BXII%252Bin%252Bbreast%252Bcancer%252Bcells%252Busing%252Bbenzene%252Bsulfonamides%25253A%252BDisconnect%252Bbetween%252Bactivity%252Band%252Bgrowth%252Binhibition%26aulast%3DMboge%26aufirst%3DMam%2BY.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D11%26spage%3De0207417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Po-Chang  Shih</span>, <span class="hlFld-ContribAuthor ">Yiwen  Yang</span>, <span class="hlFld-ContribAuthor ">Gary N.  Parkinson</span>, <span class="hlFld-ContribAuthor ">Andrew  Wilderspin</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Wells</span>. </span><span class="cited-content_cbyCitation_article-title">A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3). </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (66)
                                     , 32690-32701. <a href="https://doi.org/10.18632/oncotarget.26013" title="DOI URL">https://doi.org/10.18632/oncotarget.26013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.26013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.26013%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DA%252Bhigh-throughput%252Bfluorescence%252Bpolarization%252Bassay%252Bfor%252Bdiscovering%252Binhibitors%252Btargeting%252Bthe%252BDNA-binding%252Bdomain%252Bof%252Bsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252B%252528STAT3%252529%26aulast%3DShih%26aufirst%3DPo-Chang%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D66%26spage%3D32690%26epage%3D32701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacopo  Sgrignani</span>, <span class="hlFld-ContribAuthor ">Maura  Garofalo</span>, <span class="hlFld-ContribAuthor ">Milos  Matkovic</span>, <span class="hlFld-ContribAuthor ">Jessica  Merulla</span>, <span class="hlFld-ContribAuthor ">Carlo V.  Catapano</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (6)
                                     , 1591. <a href="https://doi.org/10.3390/ijms19061591" title="DOI URL">https://doi.org/10.3390/ijms19061591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19061591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19061591%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DStructural%252BBiology%252Bof%252BSTAT3%252Band%252BIts%252BImplications%252Bfor%252BAnticancer%252BTherapies%252BDevelopment%26aulast%3DSgrignani%26aufirst%3DJacopo%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D6%26spage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianpeng  Guo</span>, <span class="hlFld-ContribAuthor ">Wenying  Yu</span>, <span class="hlFld-ContribAuthor ">Guiping  Cai</span>, <span class="hlFld-ContribAuthor ">Wenda  Zhang</span>, <span class="hlFld-ContribAuthor ">Shanshan  Li</span>, <span class="hlFld-ContribAuthor ">Jiawen  Zhu</span>, <span class="hlFld-ContribAuthor ">Dongmei  Song</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 752-764. <a href="https://doi.org/10.1016/j.ejmech.2018.03.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bbenzensulfonamide%252Bderivatives%252Bas%252Btripedal%252BSTAT3%252Binhibitors%26aulast%3DGuo%26aufirst%3DJianpeng%26date%3D2018%26volume%3D151%26spage%3D752%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Woong-Hee  Shin</span>, <span class="hlFld-ContribAuthor ">Charles W.  Christoffer</span>, <span class="hlFld-ContribAuthor ">Daisuke  Kihara</span>. </span><span class="cited-content_cbyCitation_article-title">In silico structure-based approaches to discover protein-protein interaction-targeting drugs. </span><span class="cited-content_cbyCitation_journal-name">Methods</span><span> <strong>2017,</strong> <em>131 </em>, 22-32. <a href="https://doi.org/10.1016/j.ymeth.2017.08.006" title="DOI URL">https://doi.org/10.1016/j.ymeth.2017.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymeth.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymeth.2017.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DMethods%26atitle%3DIn%252Bsilico%252Bstructure-based%252Bapproaches%252Bto%252Bdiscover%252Bprotein-protein%252Binteraction-targeting%252Bdrugs%26aulast%3DShin%26aufirst%3DWoong-Hee%26date%3D2017%26volume%3D131%26spage%3D22%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy of AMLSD for the STAT3 target: (1) Fragment <b>1</b> is paired with each fragment from the polar fragment libraries to form a new library of fragment combinations (FCs), which are simultaneously docked to the pY705 and pY+X sites of the STAT3 protein (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>) and scored by PSO/LGA functions. (2) The best-scoring FCs are linked according to the analysis of their docking modes and redocked to the STAT3 protein. (3) The top-scoring linked compounds are repositioned to their docking modes of the unlinked FCs. Final hits are selected on the basis of the both their repositioned docking modes and scored energies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representative small-molecule STAT3 inhibitors. <b>9</b> was designed in this study, and fragment <b>1</b> is colored in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking modes of the 25 FCs selected by AMLSD, labeled by their screening numbers in the library of FCs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Possible linear linkers connecting C6 or C7 of fragment <b>1</b> to a heavy atom of the other fragment. The lengths of the linkers are in the range of 3–5 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of the linked compounds designed by AMLSD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Linked compound <b>9</b> was repositioned to the docking mode of its FC to compare their overlaps. The shortest distance between the two fragments was 3.671 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0019.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Designed Inhibitors <b>2</b>, <b>5</b>, <b>7</b>, and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu(OAc)<sub>2</sub>·H<sub>2</sub>O, AcOH/H<sub>2</sub>O (1:10 v/v), 65 °C; (ii) TFA, 50 °C.</p></p></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. IC<sub>50</sub> values of <b>9</b> and positive control <b>14</b> against multiple cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Interactions between <b>9</b> and key residues of STAT3 protein. (B) Interactions between the native peptide and the pY705 site. (C) Docking mode of <b>9</b> to the same binding site as the native peptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) <b>9</b> competitively and selectively inhibited the binding of fluorescence-labeled peptide to the pY705 site of STAT3 as determined by FP assays. (B) <b>9</b> directly bound to the STAT3 protein as shown by MST assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <b>9</b> was docked to the crystal structures of STAT1 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF5">1BF5</a>), STAT3 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>), and STAT5 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U">1Y1U</a>). Their docking energies are marked in red. In each structure, the region circled in yellow is the pY site of the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A, B) Immunoblots of p-STAT3(Y705), p-STAT3(S727), total STAT3 (T-STAT3), Ac-STAT3, p-STAT1(Y701), T-STAT1, SHP-1, and GAPDH from whole-cell lysates from MDA-MB-231 cells were treated with <b>9</b>. (C) MDA-MB-231 cells were treated with <b>9</b> and <b>14</b>, probing for p-AKT, T-AKT, cleaved caspase 3, and GAPDH. (D) Western blot results from (B) were calculated and are presented as the percent of control. (*, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A, B) MDA-MB-231 cancer cells were treated with IL-6, IFN-γ, and <b>9</b>, probing for p-STAT3(Y705), T-STAT3, p-STAT1(Y701), T-STAT1, and β-actin. (C) MDA-MB-231 cells were treated with <b>9</b> at 5 μM for 0–24 h or IFN-γ and different concentrations of <b>9</b> by EMSA assays. (D) The expression of MMP9 and CDK2 genes treated with <b>9</b> was measured by RT-PCR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. MDA-MB-231 cells were stimulated with IL-6. The migration of p-STAT3 to the nucleus was treated with <b>9</b> and <b>14</b> (5 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (A) Anatomical nude mice’s tumor tissues untreated or treated with <b>9</b>. (B) Inhibition percentage of mice’s tumor weight upon treatment with <b>9</b>. (C) Growth curve of tumor volume upon treatment with <b>9</b>. (D) Growth curve of mice’s body weight upon treatment with <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0015.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Anatomical mice’s tumor tissues treated with <b>9</b> and doxorubicin. (B) Anatomical major organs (liver, spleen, and kidney) treated with <b>9</b> and doxorubicin. (C) Growth curves of mice’s tumor volume. (E) Inhibition percentages of mice’s tumor weight. (D, F) Growth curves and inhibition percentages of mice’s body weight.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0016.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. IHC analysis of p-STAT3 in tumor tissues treated with <b>9</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0017.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Immunoblots of p-STAT3(Y705), T-STAT3, and GAPDH from whole-cell lysates from tumor tissues treated with 2.5, 5, or 10 mg/kg compound <b>9</b>. Positions of proteins in the gel are shown with the control lane.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/medium/jm-2016-01489h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0018.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Plasma concentration–time profiles of <b>9</b> in rats following i.v. and p.o. administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-7/acs.jmedchem.6b01489/20170407/images/large/jm-2016-01489h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01489&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i53">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Liu, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiau, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. F.</span><span> </span><span class="NLM_article-title">Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1007/s10549-014-3000-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1007%2Fs10549-014-3000-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24903225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFeks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2014&pages=71-84&author=C.+Y.+Liuauthor=J.+C.+Suauthor=M.+H.+Niauthor=L.+M.+Tsengauthor=P.+Y.+Chuauthor=D.+S.+Wangauthor=W.+T.+Taiauthor=Y.+P.+Kaoauthor=M.+H.+Hungauthor=C.+W.+Shiauauthor=K.+F.+Chen&title=Obatoclax+analog+SC-2001+inhibits+STAT3+phosphorylation+through+enhancing+SHP-1+expression+and+induces+apoptosis+in+human+breast+cancer+cells&doi=10.1007%2Fs10549-014-3000-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells</span></div><div class="casAuthors">Liu, Chun-Yu; Su, Jung-Chen; Ni, Mei-Huei; Tseng, Ling-Ming; Chu, Pei-Yi; Wang, Duen-Shian; Tai, Wei-Tien; Kao, Yuan-Ping; Hung, Man-Hsin; Shiau, Chung-Wai; Chen, Kuen-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-84</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Interfering oncogenic STAT3 signaling is a promising anti-cancer strategy.  We examd. the efficacy and drug mechanism of an obatoclax analog SC-2001, a novel STAT3 inhibitor, in human breast cancer cells.  Human breast cancer cell lines were used for in vitro studies.  Apoptosis was examd. by both flow cytometry and western blot.  Signaling pathways were assessed by western blot.  In vivo efficacy of SC-2001 was tested in xenograft nude mice.  SC-2001 inhibited cell growth and induced apoptosis in assocn. with downregulation of p-STAT3 (Tyr 705) in breast cancer cells.  STAT3-regulated proteins, including Mcl-1, survivin, and cyclin D1, were repressed by SC-2001.  Over-expression of STAT3 in MDA-MB-468 cells protected cells from SC-2001-induced apoptosis.  Moreover, SC-2001 enhanced the expression of protein tyrosine phosphatase SHP-1, a neg. regulator of STAT3.  Furthermore, the enhanced SHP-1 expression, in conjunction with increased SHP-1 phosphatase activity, was mediated by upregulated transcription by RFX-1.  Chromatin immunopptn. assay revealed that SC-2001 increased the binding capacity of RFX-1 to the SHP-1 promoter.  Knockdown of either RFX-1 or SHP-1 reduced SC-2001-induced apoptosis, whereas ectopic expression of RFX-1 increased SHP-1 expression and enhanced the apoptotic effect of SC-2001.  Importantly, SC-2001 suppressed tumor growth in assocn. with enhanced RFX-1 and SHP-1 expression and p-STAT3 downregulation in MDA-MB-468 xenograft tumors.  SC-2001 induced apoptosis in breast cancer cells, an effect that was mediated by RFX-1 upregulated SHP-1 expression and SHP-1-dependent STAT3 inactivation.  Our study indicates targeting STAT3 signaling pathway may be a useful approach for the development of targeted agents for anti-breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM2bpTu1PFBLVg90H21EOLACvtfcHk0liyYgkZHrT2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFeks7k%253D&md5=bc0e1b8d3059dbeffef8048764e84ca9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs10549-014-3000-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-014-3000-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BY.%26aulast%3DSu%26aufirst%3DJ.%2BC.%26aulast%3DNi%26aufirst%3DM.%2BH.%26aulast%3DTseng%26aufirst%3DL.%2BM.%26aulast%3DChu%26aufirst%3DP.%2BY.%26aulast%3DWang%26aufirst%3DD.%2BS.%26aulast%3DTai%26aufirst%3DW.%2BT.%26aulast%3DKao%26aufirst%3DY.%2BP.%26aulast%3DHung%26aufirst%3DM.%2BH.%26aulast%3DShiau%26aufirst%3DC.%2BW.%26aulast%3DChen%26aufirst%3DK.%2BF.%26atitle%3DObatoclax%2520analog%2520SC-2001%2520inhibits%2520STAT3%2520phosphorylation%2520through%2520enhancing%2520SHP-1%2520expression%2520and%2520induces%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2014%26volume%3D146%26spage%3D71%26epage%3D84%26doi%3D10.1007%2Fs10549-014-3000-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wei, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span><span class="refDoi"> DOI: 10.3892/ijo_00000848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.3892%2Fijo_00000848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21109950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVGgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=279-285&author=C.-C.+Weiauthor=S.+Ballauthor=L.+Linauthor=A.+Liuauthor=J.+R.+Fuchsauthor=P.-K.+Liauthor=C.+Liauthor=J.+Lin&title=Two+small+molecule+compounds%2C+LLL12+and+FLLL32%2C+exhibit+potent+inhibitory+activity+on+STAT3+in+human+rhabdomyosarcoma+cells&doi=10.3892%2Fijo_00000848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells</span></div><div class="casAuthors">Wei, Chang-Ching; Ball, Sarah; Lin, Li; Liu, Aiguo; Fuchs, James R.; Li, Pui-Kai; Li, Chenglong; Lin, Jiayuh</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">279-285</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Signal transducers and activators of transcription 3 (STAT3) signaling is persistently activated in many types of cancer cells, and represents a valid target for anticancer drug design.  However, few reports have described the constitutive activation of STAT3 in human sarcoma cells.  In this study, we demonstrate that the STAT3 signaling pathway is constitutively activated in human rhabodomyosarcoma cells (RH28, RH30, and RD2).  We also investigated the inhibitory effects of two newly developed small mols., LLL12 and FLLL32, on the STAT3 signaling pathway in human rhabodomyosarcoma cells.  Both LLL12 and FLLL32 downregulated STAT3 constitutively and interleukin-6 (IL-6) stimulated phosphorylated STAT3 (p-STAT3).  The inhibition of STAT3 via LLL12 and FLLL32 was confirmed by the inhibition of STAT3 DNA binding activity.  The downstream targets of STAT3, cyclin D1, Bcl-xL, and survivin were also down- regulated by LLL12 and FLLL 32 at both mRNA and protein levels.  The potency of LLL12 and FLLL32 to inhibit proliferation/viability in human rhabodomyosarcoma cells (RH28, RH30, and RD2) was higher than that of the 5 previously reported Janus kinase 2 (JAK2)/ STAT3 inhibitors (LLL3, WP1066, Stattic, S3I-201, and AG490) and curcumin.  Thus, in this study, we investigated the inhibitory effects of two STAT3 inhibitors, LLL12 and FLLL32, on the STAT3 signaling pathway in human rhabodomyosarcoma cells; we also demonstrated their higher potency in inhibiting proliferation on human rhabodomyosarcoma cells as compared to other five JAK2/STAT3 inhibitors and curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74pPXW0kFzrVg90H21EOLACvtfcHk0liyYgkZHrT2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVGgurw%253D&md5=4070e38336b697bf372fa387b7233812</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3892%2Fijo_00000848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo_00000848%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DC.-C.%26aulast%3DBall%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DTwo%2520small%2520molecule%2520compounds%252C%2520LLL12%2520and%2520FLLL32%252C%2520exhibit%2520potent%2520inhibitory%2520activity%2520on%2520STAT3%2520in%2520human%2520rhabdomyosarcoma%2520cells%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3D279%26epage%3D285%26doi%3D10.3892%2Fijo_00000848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.ejmech.2014.05.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24904966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=195-203&author=H.+Chenauthor=Z.+Yangauthor=C.+Dingauthor=A.+Xiongauthor=C.+Wildauthor=L.+Wangauthor=N.+Yeauthor=G.+Caiauthor=R.+M.+Floresauthor=Y.+Dingauthor=Q.+Shenauthor=J.+Zhou&title=Discovery+of+potent+anticancer+agent+HJC0416%2C+an+orally+bioavailable+small+molecule+inhibitor+of+signal+transducer+and+activator+of+transcription+3+%28STAT3%29&doi=10.1016%2Fj.ejmech.2014.05.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)</span></div><div class="casAuthors">Chen, Haijun; Yang, Zhengduo; Ding, Chunyong; Xiong, Ailian; Wild, Christopher; Wang, Lili; Ye, Na; Cai, Guoshuai; Flores, Rudolfo M.; Ding, Ye; Shen, Qiang; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">195-203</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In a continuing effort to develop orally bioavailable small-mol. STAT3 inhibitors as potential therapeutic agents for human cancer, a series of novel diversified analogs based on our identified lead compd. HJC0149 (5-chloro-N-(1,1-dioxo-1H-1λ6-benzo[b]thiophen-6-yl)-2-hydroxybenzamide) were synthesized and evaluated.  Mol. docking studies and biol. characterization supported our earlier findings that the O-alkylamino-tethered side chain on the hydroxyl group is an effective and essential structural determinant for improving biol. activities and druglike properties of these mols.  Compds. with such modifications exhibited potent antiproliferative effects against breast and pancreatic cancer cell lines with IC50 values from low micromolar to nanomolar range.  Among them, the newly discovered STAT3 inhibitor 12 (HJC0416) displayed an intriguing anticancer profile both in vitro and in vivo (i.p. & p.o.).  More importantly, HJC0416 is an orally bioavailable anticancer agent as a promising candidate for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhVjTbk7wREbVg90H21EOLACvtfcHk0liyYgkZHrT2Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu73L&md5=4f0791ba9f6ed95c0199a345bb840537</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.049%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DA.%26aulast%3DWild%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DN.%26aulast%3DCai%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DR.%2BM.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520anticancer%2520agent%2520HJC0416%252C%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520%2528STAT3%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D195%26epage%3D203%26doi%3D10.1016%2Fj.ejmech.2014.05.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Targeting STAT3 in cancer: how successful are we?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1517/13543780802565791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1517%2F13543780802565791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=19053881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=45-56&author=P.+Yueauthor=J.+Turkson&title=Targeting+STAT3+in+cancer%3A+how+successful+are+we%3F&doi=10.1517%2F13543780802565791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting STAT3 in cancer: how successful are we?</span></div><div class="casAuthors">Yue, Peibin; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-56</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Aberrant activation of the signal transducer and activator of transcription (STAT)3 occurs in many human tumors.  Moreover, studies utilizing genetic and pharmacol. approaches to modulate constitutive STAT3 activity have provided compelling evidence for the crit. role of aberrant STAT3 activity in malignant transformation and tumor progression, and thereby validated STAT3 as a novel cancer drug target.  This review is intended to be a full coverage of the efforts to develop direct STAT3 inhibitors and will provide a discussion on the inhibitory modalities developed to date.  Review of the literature focused on the modalities and mechanisms that directly target and inhibit the STAT protein or its functions.  While a variety of STAT3 inhibitors have been identified that induce antitumor cell effects in vitro and in vivo, the landscape remains murky.  With a few exceptions, most of the STAT3 inhibitors reported to date have not undergone an in vivo efficacy, pharmacol. or toxicity testing.  Also, there is no evidence, per the published literature of an impending clin. development for the few agents that were reported to exhibit in vivo efficacy.  Overall, there is the need for a reassessment of the ongoing strategies to target STAT3 intended not only for refinement, but also for incorporating some new technologies to strengthen our efforts and ensure the success, sooner, rather than later, of identifying suitable anti-STAT3 agents for development into clin. useful anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGo96b-3KjRLVg90H21EOLACvtfcHk0lgBiKbHPHYLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVGhtbvO&md5=e0f4fe796305b7e28ff3020f57b5dc8e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543780802565791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780802565791%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DP.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DTargeting%2520STAT3%2520in%2520cancer%253A%2520how%2520successful%2520are%2520we%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D45%26epage%3D56%26doi%3D10.1517%2F13543780802565791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bharadwaj, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckols, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolosov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasembeli, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrolecki, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creighton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweardy, D. J.</span><span> </span><span class="NLM_article-title">Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span><span class="refDoi"> DOI: 10.1038/onc.2014.72</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1038%2Fonc.2014.72" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24681959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1341-1353&author=U.+Bharadwajauthor=T.+K.+Eckolsauthor=M.+Kolosovauthor=M.+M.+Kasembeliauthor=A.+Adamauthor=D.+Torresauthor=X.+Zhangauthor=L.+E.+Dobroleckiauthor=W.+Weiauthor=M.+T.+Lewisauthor=B.+Daveauthor=J.+C.+Changauthor=M.+D.+Landisauthor=C.+J.+Creightonauthor=M.+A.+Manciniauthor=D.+J.+Tweardy&title=Drug-repositioning+screening+identified+piperlongumine+as+a+direct+STAT3+inhibitor+with+potent+activity+against+breast+cancer&doi=10.1038%2Fonc.2014.72"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer</span></div><div class="casAuthors">Bharadwaj, U.; Eckols, T. K.; Kolosov, M.; Kasembeli, M. M.; Adam, A.; Torres, D.; Zhang, X.; Dobrolecki, L. E.; Wei, W.; Lewis, M. T.; Dave, B.; Chang, J. C.; Landis, M. D.; Creighton, C. J.; Mancini, M. A.; Tweardy, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1341-1353</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Signal transducer and activator of transcription (STAT) 3 regulates many cardinal features of cancer including cancer cell growth, apoptosis resistance, DNA damage response, metastasis, immune escape, tumor angiogenesis, the Warburg effect and oncogene addiction and has been validated as a drug target for cancer therapy.  Several strategies have been used to identify agents that target Stat3 in breast cancer but none has yet entered into clin. use.  We used a high-throughput fluorescence microscopy search strategy to identify compds. in a drug-repositioning library (Prestwick library) that block ligand-induced nuclear translocation of Stat3 and identified piperlongumine (PL), a natural product isolated from the fruit of the pepper Piper longum.  PL inhibited Stat3 nuclear translocation, inhibited ligand-induced and constitutive Stat3 phosphorylation, and modulated expression of multiple Stat3-regulated genes.  Surface plasmon resonance assay revealed that PL directly inhibited binding of Stat3 to its phosphotyrosyl peptide ligand.  Phosphoprotein antibody array anal. revealed that PL does not modulate kinases known to activate Stat3 such as Janus kinases, Src kinase family members or receptor tyrosine kinases.  PL inhibited anchorage-independent and anchorage-dependent growth of multiple breast cancer cell lines having increased pStat3 or total Stat3, and induced apoptosis.  PL also inhibited mammosphere formation by tumor cells from patient-derived xenografts.  PL's antitumorigenic function was causally linked to its Stat3-inhibitory effect.  PL was non-toxic in mice up to a dose of 30 mg/kg/day for 14 days and caused regression of breast cancer cell line xenografts in nude mice.  Thus, PL represents a promising new agent for rapid entry into the clinic for use in treating breast cancer, as well as other cancers in which Stat3 has a role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxr6QTKIh08rVg90H21EOLACvtfcHk0lgBiKbHPHYLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOhtbg%253D&md5=c03ddf0bca17890ec8b2b61264c019c1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.72%26sid%3Dliteratum%253Aachs%26aulast%3DBharadwaj%26aufirst%3DU.%26aulast%3DEckols%26aufirst%3DT.%2BK.%26aulast%3DKolosov%26aufirst%3DM.%26aulast%3DKasembeli%26aufirst%3DM.%2BM.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DTorres%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDobrolecki%26aufirst%3DL.%2BE.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DLewis%26aufirst%3DM.%2BT.%26aulast%3DDave%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26aulast%3DLandis%26aufirst%3DM.%2BD.%26aulast%3DCreighton%26aufirst%3DC.%2BJ.%26aulast%3DMancini%26aufirst%3DM.%2BA.%26aulast%3DTweardy%26aufirst%3DD.%2BJ.%26atitle%3DDrug-repositioning%2520screening%2520identified%2520piperlongumine%2520as%2520a%2520direct%2520STAT3%2520inhibitor%2520with%2520potent%2520activity%2520against%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D1341%26epage%3D1353%26doi%3D10.1038%2Fonc.2014.72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ma, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, C. H.</span><span> </span><span class="NLM_article-title">Antagonizing STAT3 dimerization with a rhodium(III) complex</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">9178</span><span class="NLM_x">–</span> <span class="NLM_lpage">9182</span><span class="refDoi"> DOI: 10.1002/anie.201404686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fanie.201404686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVKlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=9178-9182&author=D.+L.+Maauthor=L.+J.+Liuauthor=K.+H.+Leungauthor=Y.+T.+Chenauthor=H.+J.+Zhongauthor=D.+S.+Chanauthor=H.+M.+Wangauthor=C.+H.+Leung&title=Antagonizing+STAT3+dimerization+with+a+rhodium%28III%29+complex&doi=10.1002%2Fanie.201404686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonizing STAT3 Dimerization with a Rhodium(III) Complex</span></div><div class="casAuthors">Ma, Dik-Lung; Liu, Li-Juan; Leung, Ka-Ho; Chen, Yen-Ting; Zhong, Hai-Jing; Chan, Daniel Shiu-Hin; Wang, Hui-Min David; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">9178-9182</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Kinetically inert metal complexes have arisen as promising alternatives to existing platinum and ruthenium chemotherapeutics.  Reported herein, to the knowledge, is the first example of a substitutionally inert, Group 9 organometallic compd. as a direct inhibitor of signal transducer and activator of transcription 3 (STAT3) dimerization.  From a series of cyclometalated rhodium(III) and iridium(III) complexes, a rhodium(III) complex emerged as a potent inhibitor of STAT3 that targeted the SH2 domain and inhibited STAT3 phosphorylation and dimerization.  Significantly, the complex exhibited potent antitumor activities in an in vivo mouse xenograft model of melanoma.  This study demonstrates that rhodium complexes may be developed as effective STAT3 inhibitors with potent antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomCWV-3XvfFbVg90H21EOLACvtfcHk0lgBiKbHPHYLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVKlurs%253D&md5=6972af909d01a82ae3acabb013601bd9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fanie.201404686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201404686%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLiu%26aufirst%3DL.%2BJ.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DZhong%26aufirst%3DH.%2BJ.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DAntagonizing%2520STAT3%2520dimerization%2520with%2520a%2520rhodium%2528III%2529%2520complex%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D9178%26epage%3D9182%26doi%3D10.1002%2Fanie.201404686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namanja, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paladino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Orally bioavailable small-molecule inhibitor of transcription factor STAT3 regresses human breast and lung cancer xenografts</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">9623</span><span class="NLM_x">–</span> <span class="NLM_lpage">9628</span><span class="refDoi"> DOI: 10.1073/pnas.1121606109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.1121606109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=22623533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=9623-9628&author=X.+Zhangauthor=P.+Yueauthor=B.+D.+Pageauthor=T.+Liauthor=W.+Zhaoauthor=A.+T.+Namanjaauthor=D.+Paladinoauthor=J.+Zhaoauthor=Y.+Chenauthor=P.+T.+Gunningauthor=J.+Turkson&title=Orally+bioavailable+small-molecule+inhibitor+of+transcription+factor+STAT3+regresses+human+breast+and+lung+cancer+xenografts&doi=10.1073%2Fpnas.1121606109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts</span></div><div class="casAuthors">Zhang, Xiaolei; Yue, Peibin; Page, Brent D. G.; Li, Tianshu; Zhao, Wei; Namanja, Andrew T.; Paladino, David; Zhao, Jihe; Chen, Yuan; Gunning, Patrick T.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9623-9628, S9623/1-S9623/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Computer-aided lead optimization derives a unique, orally bioavailable inhibitor of the signal transducer and activator of transcription (Stat)3 Src homol. 2 domain.  BP-1-102 binds Stat3 with an affinity (KD) of 504 nM, blocks Stat3-phospho-tyrosine (pTyr) peptide interactions and Stat3 activation at 4-6.8 μM, and selectively inhibits growth, survival, migration, and invasion of Stat3-dependent tumor cells.  BP-1-102-mediated inhibition of aberrantly active Stat3 in tumor cells suppresses the expression of c-Myc, Cyclin D1, Bcl-xL, Survivin, VEGF, and Kruppel-like factor 8, which is identified as a Stat3 target gene that promotes Stat3-mediated breast tumor cell migration and invasion.  Treatment of breast cancer cells with BP-1-102 further blocks Stat3-NF-κB cross-talk, the release of granulocyte colony-stimulating factor, sol. intercellular adhesion mol. 1, macrophage migration-inhibitory factor/glycosylation-inhibiting factor, interleukin 1 receptor antagonist, and serine protease inhibitor protein 1, and the phosphorylation of focal adhesion kinase and paxillin, while enhancing E-cadherin expression.  I.v. or oral gavage delivery of BP-1-102 furnishes micromolar or microgram levels in tumor tissues and inhibits growth of human breast and lung tumor xenografts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrljEafjbznr7Vg90H21EOLACvtfcHk0ljxxFUBM7dFxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWjtLo%253D&md5=4da78174a7c00eacc1f1a1ce553c5aa7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121606109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121606109%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DNamanja%26aufirst%3DA.%2BT.%26aulast%3DPaladino%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DOrally%2520bioavailable%2520small-molecule%2520inhibitor%2520of%2520transcription%2520factor%2520STAT3%2520regresses%2520human%2520breast%2520and%2520lung%2520cancer%2520xenografts%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D9623%26epage%3D9628%26doi%3D10.1073%2Fpnas.1121606109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4402</span><span class="NLM_x">–</span> <span class="NLM_lpage">4412</span><span class="refDoi"> DOI: 10.1021/jm400080c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400080c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4402-4412&author=W.+Yuauthor=H.+Xiaoauthor=J.+Linauthor=C.+Li&title=Discovery+of+novel+STAT3+small+molecule+inhibitors+via+in+silico+site-directed+fragment-based+drug+design&doi=10.1021%2Fjm400080c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel STAT3 Small Molecule Inhibitors via in Silico Site-Directed Fragment-Based Drug Design</span></div><div class="casAuthors">Yu, Wenying; Xiao, Hui; Lin, Jiayuh; Li, Chenglong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4402-4412</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Constitutive activation of signal transducer and activator of transcription 3 (STAT3) has been validated as an attractive therapeutic target for cancer therapy.  To stop both STAT3 activation and dimerization, a viable strategy is to design inhibitors blocking its SH2 domain phosphotyrosine binding site that is responsible for both actions.  A new fragment-based drug design (FBDD) strategy, in silico site-directed FBDD, was applied in this study.  A designed novel compd., 5,8-dioxo-6-(pyridin-3-ylamino)-5,8-dihydronaphthalene-1-sulfonamide (LY5), was confirmed to bind to STAT3 SH2 by fluorescence polarization assay.  In addn., four out of the five chosen compds. have IC50 values lower than 5 μM for the U2OS cancer cells. 8 (LY5) has an IC50 range in 0.5-1.4 μM in various cancer cell lines. 8 also suppresses tumor growth in an in vivo mouse model.  This study has demonstrated the utility of this approach and could be used to other drug targets in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq76v3IMxJHwLVg90H21EOLACvtfcHk0ljxxFUBM7dFxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOktbk%253D&md5=7231b2e9682f9e9046debcaa461a1d59</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm400080c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400080c%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520STAT3%2520small%2520molecule%2520inhibitors%2520via%2520in%2520silico%2520site-directed%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4402%26epage%3D4412%26doi%3D10.1021%2Fjm400080c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Schuringa, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schepers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellenga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruijer, W.</span><span> </span><span class="NLM_article-title">Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">495</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/S0014-5793(01)02354-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2FS0014-5793%2801%2902354-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=71-76&author=J.+J.+Schuringaauthor=H.+Schepersauthor=E.+Vellengaauthor=W.+Kruijer&title=Ser727-dependent+transcriptional+activation+by+association+of+p300+with+STAT3+upon+IL-6+stimulation&doi=10.1016%2FS0014-5793%2801%2902354-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2902354-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252902354-7%26sid%3Dliteratum%253Aachs%26aulast%3DSchuringa%26aufirst%3DJ.%2BJ.%26aulast%3DSchepers%26aufirst%3DH.%26aulast%3DVellenga%26aufirst%3DE.%26aulast%3DKruijer%26aufirst%3DW.%26atitle%3DSer727-dependent%2520transcriptional%2520activation%2520by%2520association%2520of%2520p300%2520with%2520STAT3%2520upon%2520IL-6%2520stimulation%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D495%26spage%3D71%26epage%3D76%26doi%3D10.1016%2FS0014-5793%2801%2902354-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoon, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">7765</span><span class="NLM_x">–</span> <span class="NLM_lpage">7769</span><span class="refDoi"> DOI: 10.1073/pnas.1205132109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.1205132109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=22547799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1Kntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=7765-7769&author=H.+Leeauthor=P.+Zhangauthor=A.+Herrmannauthor=C.+Yangauthor=H.+Xinauthor=Z.+Wangauthor=D.+S.+Hoonauthor=S.+J.+Formanauthor=R.+Joveauthor=A.+D.+Riggsauthor=H.+Yu&title=Acetylated+STAT3+is+crucial+for+methylation+of+tumor-suppressor+gene+promoters+and+inhibition+by+resveratrol+results+in+demethylation&doi=10.1073%2Fpnas.1205132109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation</span></div><div class="casAuthors">Lee, Heehyoung; Zhang, Peng; Herrmann, Andreas; Yang, Chunmei; Xin, Hong; Wang, Zhenghe; Hoon, Dave S. B.; Forman, Stephen J.; Jove, Richard; Riggs, Arthur D.; Yu, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7765-7769, S7765/1-S7765/5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The mechanisms underlying hypermethylation of tumor-suppressor gene promoters in cancer is not well understood.  Here, we report that lysine acetylation of the oncogenic transcription factor STAT3 is elevated in tumors.  We also show that genetically altering STAT3 at Lys685 reduces tumor growth, which is accompanied by demethylation and reactivation of several tumor-suppressor genes.  Moreover, mutating STAT3 at Lys685 disrupts DNA methyltransferase 1-STAT3 interactions in cultured tumor cells and in tumors.  These observations are confirmed by treatment with an acetylation inhibitor, resveratrol.  Furthermore, redn. of acetylated STAT3 in triple-neg. breast cancer cells leads to demethylation and activation of the estrogen receptor-α gene, sensitizing the tumor cells to antiestrogens.  Our results also demonstrate a correlation between STAT3 acetylation and methylation of estrogen receptor-a in melanoma, which predicts melanoma progression.  Taken together, these results suggest a role of STAT3 acetylation in regulating CpG island methylation, which may partially explain aberrant gene silencing in cancer.  These findings also provide a rationale for targeting acetylated STAT3 for chemoprevention and cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2L3nwZs04LVg90H21EOLACvtfcHk0ljxxFUBM7dFxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1Kntrw%253D&md5=5ebf41ab98d7784ffe266ed32e3d7ed8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205132109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205132109%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHoon%26aufirst%3DD.%2BS.%26aulast%3DForman%26aufirst%3DS.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DRiggs%26aufirst%3DA.%2BD.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DAcetylated%2520STAT3%2520is%2520crucial%2520for%2520methylation%2520of%2520tumor-suppressor%2520gene%2520promoters%2520and%2520inhibition%2520by%2520resveratrol%2520results%2520in%2520demethylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D7765%26epage%3D7769%26doi%3D10.1073%2Fpnas.1205132109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Clevenger, C. V.</span><span> </span><span class="NLM_article-title">Roles and regulation of STAT family transcription factors in human breast cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1449</span><span class="NLM_x">–</span> <span class="NLM_lpage">1460</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)63403-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2FS0002-9440%2810%2963403-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=15509516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCgsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2004&pages=1449-1460&author=C.+V.+Clevenger&title=Roles+and+regulation+of+STAT+family+transcription+factors+in+human+breast+cancer&doi=10.1016%2FS0002-9440%2810%2963403-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Roles and regulation of Stat family transcription factors in human breast cancer</span></div><div class="casAuthors">Clevenger, Charles V.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1449-1460</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">A review.  Stats (for signal transducers and activators of transcription) are a family of transcription factors that regulate cell growth and differentiation.  Their activity is latent until phosphorylation by receptor-assocd. kinases.  A sizable body of data from cell lines, mouse models, and human tissues now implicates these transcription factors in the oncogenesis of breast cancer.  Because Stat activity is modulated by several post-translational modifications and protein-protein interactions, these transcription factors are capable of integrating inputs from multiple signaling networks.  Given this, the future utilization of Stats as prognostic markers and therapeutic targets in human breast cancer appears likely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbmPgc4RUfSLVg90H21EOLACvtfcHk0lh0I1DYKw3EAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCgsLbF&md5=ae6d7cd695e98ee3485327bcf6bb9b93</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963403-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963403-7%26sid%3Dliteratum%253Aachs%26aulast%3DClevenger%26aufirst%3DC.%2BV.%26atitle%3DRoles%2520and%2520regulation%2520of%2520STAT%2520family%2520transcription%2520factors%2520in%2520human%2520breast%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D165%26spage%3D1449%26epage%3D1460%26doi%3D10.1016%2FS0002-9440%2810%2963403-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mandal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birtwistle, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaluarachchi, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Potent and selective phosphopeptide mimetic prodrugs targeted to the src homology 2 (SH2) domain of signal transducer and activator of transcription 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3549</span><span class="NLM_x">–</span> <span class="NLM_lpage">3563</span><span class="refDoi"> DOI: 10.1021/jm2000882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2000882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3549-3563&author=P.+K.+Mandalauthor=F.+Gaoauthor=Z.+Luauthor=Z.+Renauthor=R.+Rameshauthor=J.+S.+Birtwistleauthor=K.+K.+Kaluarachchiauthor=X.+Chenauthor=R.+C.+Bastauthor=W.+S.+Liaoauthor=J.+S.+McMurray&title=Potent+and+selective+phosphopeptide+mimetic+prodrugs+targeted+to+the+src+homology+2+%28SH2%29+domain+of+signal+transducer+and+activator+of+transcription+3&doi=10.1021%2Fjm2000882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm2000882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2000882%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DBirtwistle%26aufirst%3DJ.%2BS.%26aulast%3DKaluarachchi%26aufirst%3DK.%2BK.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBast%26aufirst%3DR.%2BC.%26aulast%3DLiao%26aufirst%3DW.%2BS.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DPotent%2520and%2520selective%2520phosphopeptide%2520mimetic%2520prodrugs%2520targeted%2520to%2520the%2520src%2520homology%25202%2520%2528SH2%2529%2520domain%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3549%26epage%3D3563%26doi%3D10.1021%2Fjm2000882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mandal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurray, J. S.</span><span> </span><span class="NLM_article-title">Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6141</span><span class="refDoi"> DOI: 10.1021/jm901105k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901105k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6126-6141&author=P.+K.+Mandalauthor=Z.+Renauthor=X.+Chenauthor=C.+Xiongauthor=J.+S.+McMurray&title=Structure-affinity+relationships+of+glutamine+mimics+incorporated+into+phosphopeptides+targeted+to+the+SH2+domain+of+signal+transducer+and+activator+of+transcription+3&doi=10.1021%2Fjm901105k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm901105k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901105k%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%2BK.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXiong%26aufirst%3DC.%26aulast%3DMcMurray%26aufirst%3DJ.%2BS.%26atitle%3DStructure-affinity%2520relationships%2520of%2520glutamine%2520mimics%2520incorporated%2520into%2520phosphopeptides%2520targeted%2520to%2520the%2520SH2%2520domain%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6126%26epage%3D6141%26doi%3D10.1021%2Fjm901105k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A low-molecular-weight compound discovered through virtual database screening inhibits STAT3 function in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4700</span><span class="NLM_x">–</span> <span class="NLM_lpage">4705</span><span class="refDoi"> DOI: 10.1073/pnas.0409894102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.0409894102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=15781862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Oiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=4700-4705&author=H.+Songauthor=R.+Wangauthor=S.+Wangauthor=J.+Lin&title=A+low-molecular-weight+compound+discovered+through+virtual+database+screening+inhibits+STAT3+function+in+breast+cancer+cells&doi=10.1073%2Fpnas.0409894102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A low-molecular-weight compound discovered through virtual database screening inhibits stat3 function in breast cancer cells</span></div><div class="casAuthors">Song, Hui; Wang, Renxiao; Wang, Shaomeng; Lin, Jiayuh</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4700-4705</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">This study focused on the screening of small-mol. inhibitors that target signal transducers and activators of transcription 3 (Stat3) in human breast carcinoma.  The constitutive activation of Stat3 is frequently detected in human breast cancer cell lines as well as clin. breast cancer specimens and may play an important role in the oncogenesis of breast carcinoma.  Activated Stat3 may participate in oncogenesis by stimulating cell proliferation, promoting tumor angiogenesis, and resisting apoptosis.  Because a variety of human cancers are assocd. with constitutively active Stat3, Stat3 represents an attractive target for cancer therapy.  In this study, of the nearly 429,000 compds. screened by virtual database screening, chem. samples of top 100 compds. identified as candidate small-mol. inhibitors of Stat3 were evaluated by using Stat3-dependent luciferase reporter as well as other cell-based assays.  Through serial functional evaluation based on our established cell-based assays, one compd., termed STA-21, was identified as the best match for our selection criteria.  Further investigation demonstrated that STA-21 inhibits Stat3 DNA binding activity, Stat3 dimerization, and Stat3-dependent luciferase activity.  Moreover, STA-21 reduces the survival of breast carcinoma cells with constitutive Stat3 signaling but has minimal effect on the cells in which constitutive Stat3 signaling is absent.  Together, these results demonstrate that STA-21 inhibits breast cancer cells that express constitutively active Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWe9nsAbh67Vg90H21EOLACvtfcHk0lh0I1DYKw3EAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Oiu78%253D&md5=fe7108bee9cddbcdd75a67dd93e19e63</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409894102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409894102%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520low-molecular-weight%2520compound%2520discovered%2520through%2520virtual%2520database%2520screening%2520inhibits%2520STAT3%2520function%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D4700%26epage%3D4705%26doi%3D10.1073%2Fpnas.0409894102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Siddiquee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Selective chemical probe inhibitor of STAT3, identified through structure-based virtual screening, induces antitumor activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">7391</span><span class="NLM_x">–</span> <span class="NLM_lpage">7396</span><span class="refDoi"> DOI: 10.1073/pnas.0609757104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1073%2Fpnas.0609757104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=17463090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=7391-7396&author=K.+Siddiqueeauthor=S.+Zhangauthor=W.+C.+Guidaauthor=M.+A.+Blaskovichauthor=B.+Greedyauthor=H.+R.+Lawrenceauthor=M.+L.+Yipauthor=R.+Joveauthor=M.+M.+McLaughlinauthor=N.+J.+Lawrenceauthor=S.+M.+Sebtiauthor=J.+Turkson&title=Selective+chemical+probe+inhibitor+of+STAT3%2C+identified+through+structure-based+virtual+screening%2C+induces+antitumor+activity&doi=10.1073%2Fpnas.0609757104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Elective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity</span></div><div class="casAuthors">Siddiquee, Khandaker; Zhang, Shumin; Guida, Wayne C.; Blaskovich, Michelle A.; Greddy, Benjamin; Lawrence, Harshani R.; Yip, M. L. Richard; Jove, Richard; McLaughlin, Mark M.; Lawrence, Nicholas J.; Sebti, Said M.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7391-7396</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">531-201 (NSC 74859) is a chem. probe inhibitor of Stat3 activity, which was identified from the National Cancer Institute chem. libraries by using structure-based virtual screening with a computer model of the Stat3 SH2 domain bound to its Stat3 phosphotyrosine peptide derived from the x-ray crystal structure of the Stat3β homodimer.  S3I-201 inhibits Stat3 · Stat3 complex formation and Stat3 DNA-binding and transcriptional activities.  Furthermore, S3I-201 inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3.  Constitutively dimerized and active Stat3C and Stat3 SH2 domain rescue tumor cells from S3I-201-induced apoptosis.  Finally, S3I-201 inhibits the expression of the Stat3-regulated genes encoding cyclin D1, Bcl-xL, and surviving and inhibits the growth of human breast tumors in vivo.  These findings strongly suggest that the antitumor activity of S3I-201 is mediated in part through inhibition of aberrant Stat3 activation and provide the proof-of-concept for the potential clin. use of Stat3 inhibitors such as S3I-201 in tumors harboring aberrant Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfmqUniFENbVg90H21EOLACvtfcHk0liBNqZ7l94utw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D&md5=85decf56fc7852990f56c6f64165ad9d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0609757104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0609757104%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiquee%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DGreedy%26aufirst%3DB.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DSelective%2520chemical%2520probe%2520inhibitor%2520of%2520STAT3%252C%2520identified%2520through%2520structure-based%2520virtual%2520screening%252C%2520induces%2520antitumor%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D7391%26epage%3D7396%26doi%3D10.1073%2Fpnas.0609757104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharmeen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Antagonism of the STAT3-STAT3 protein dimer with salicylic acid based small molecules</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1470</span><span class="refDoi"> DOI: 10.1002/cmdc.201100194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fcmdc.201100194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21618433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFOjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1459-1470&author=S.+Fletcherauthor=B.+D.+Pageauthor=X.+Zhangauthor=P.+Yueauthor=Z.+H.+Liauthor=S.+Sharmeenauthor=J.+Singhauthor=W.+Zhaoauthor=A.+D.+Schimmerauthor=S.+Trudelauthor=J.+Turksonauthor=P.+T.+Gunning&title=Antagonism+of+the+STAT3-STAT3+protein+dimer+with+salicylic+acid+based+small+molecules&doi=10.1002%2Fcmdc.201100194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of the Stat3-Stat3 Protein Dimer with Salicylic Acid Based Small Molecules</span></div><div class="casAuthors">Fletcher, Steven; Page, Brent D. G.; Zhang, Xialoei; Yue, Peibin; Li, Zhi Hua; Sharmeen, Sumaiya; Singh, Jagdeep; Zhao, Wei; Schimmer, Aaron D.; Trudel, Suzanne; Turkson, James; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1459-1470</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">More than 50 new inhibitors of the oncogenic Stat3 protein were identified through a structure-activity relationship (SAR) study based on the previously identified inhibitor S3I-201 (IC50=86 μM, Ki>300 μM).  A key structural feature of these inhibitors is a salicylic acid moiety, which, by acting as a phosphotyrosine mimetic, is believed to facilitate binding to the Stat3 SH2 domain.  Several of the analogs exhibit higher potency than the lead compd. in inhibiting Stat3 DNA binding activity, with an in vitro IC50 range of 18.7-51.9 μM, and disruption of Stat3-pTyr peptide interactions with Ki values in the 15.5-41 μM range.  One agent in particular exhibited potent inhibition of Stat3 phosphorylation in both breast and multiple myeloma tumor cells, suppressed the expression of Stat3 target genes, and induced antitumor effects in tumor cells harboring activated Stat3 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0FBfupE80LVg90H21EOLACvtfcHk0liBNqZ7l94utw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFOjtbg%253D&md5=ad6df40e36272bdf21215eb9cc3526ce</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100194%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DSharmeen%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DAntagonism%2520of%2520the%2520STAT3-STAT3%2520protein%2520dimer%2520with%2520salicylic%2520acid%2520based%2520small%2520molecules%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1459%26epage%3D1470%26doi%3D10.1002%2Fcmdc.201100194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Liu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, C. H.</span><span> </span><span class="NLM_article-title">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1293</span><span class="refDoi"> DOI: 10.1038/cddis.2014.250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1038%2Fcddis.2014.250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24922077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1293&author=L.+J.+Liuauthor=K.+H.+Leungauthor=D.+S.+Chanauthor=Y.+T.+Wangauthor=D.+L.+Maauthor=C.+H.+Leung&title=Identification+of+a+natural+product-like+STAT3+dimerization+inhibitor+by+structure-based+virtual+screening&doi=10.1038%2Fcddis.2014.250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening</span></div><div class="casAuthors">Liu, L-J.; Leung, K-H.; Chan, D. S-H.; Wang, Y-T.; Ma, D-L.; Leung, C-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1293</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">STAT3 regulates a variety of genes involved with cell proliferation, differentiation, apoptosis, angiogenesis, metastasis, inflammation, and immunity.  The purpose of this study was to apply mol. docking techniques to identify STAT3 inhibitors from a database of over 90 000 natural product and natural product-like compds.  The virtual screening campaign furnished 14 hit compds., from which compd. 1 emerged as a top candidate.  Compd. 1 inhibited STAT3 DNA-binding activity in vitro and attenuated STAT3-directed transcription in cellulo with selectivity over STAT1 and with comparable potency to the well-known STAT3 inhibitor S3I-201.  Furthermore, compd. 1 inhibited STAT3 dimerization and decreased STAT3 phosphorylation in cells without affecting STAT1 dimerization and phosphorylation.  Compd. 1 also exhibited selective anti-proliferative activity against cancer cells over normal cells in vitro.  Mol. docking anal. suggested that compd. 1 might putatively function as an inhibitor of STAT3 dimerization by binding to the SH2 domain.  This study also validates the use of in silico techniques to identify inhibitors of protein-protein interactions, which are typically considered difficult to target with small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFD1r2695sVrVg90H21EOLACvtfcHk0liBNqZ7l94utw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCgs7w%253D&md5=aaf182350853d7020285bd47ea4126e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.250%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%2BJ.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DIdentification%2520of%2520a%2520natural%2520product-like%2520STAT3%2520dimerization%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1293%26doi%3D10.1038%2Fcddis.2014.250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Furqan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinleye, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span> </span><span class="NLM_article-title">STAT inhibitors for cancer therapy</span> <span class="citation_source-journal">J. Hematol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="refDoi"> DOI: 10.1186/1756-8722-6-90</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1186%2F1756-8722-6-90" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24308725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVCrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2013&pages=90&author=M.+Furqanauthor=A.+Akinleyeauthor=N.+Mukhiauthor=V.+Mittalauthor=Y.+Chenauthor=D.+Liu&title=STAT+inhibitors+for+cancer+therapy&doi=10.1186%2F1756-8722-6-90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">STAT inhibitors for cancer therapy</span></div><div class="casAuthors">Furqan, Muhammad; Akinleye, Akintunde; Mukhi, Nikhil; Mittal, Varun; Chen, Yamei; Liu, Delong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90/1-90/11</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Signal Transducer and Activator of Transcription (STAT) proteins are a family of cytoplasmic transcription factors consisting of 7 members, STAT1 to STAT6, including STAT5a and STAT5b.  STAT proteins are thought to be ideal targets for anti-cancer therapy since cancer cells are more dependent on the STAT activity than their normal counterparts.  Inhibitors targeting STAT3 and STAT5 have been developed.  These included peptidomimetics, small mol. inhibitors and oligonucleotides.  This review summarized advances in preclin. and clin. development of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFFeRq3z4vrVg90H21EOLACvtfcHk0lglrCYZZMMIeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVCrtLo%253D&md5=18291bafacd393de82dcc9f9df80c0f9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2F1756-8722-6-90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8722-6-90%26sid%3Dliteratum%253Aachs%26aulast%3DFurqan%26aufirst%3DM.%26aulast%3DAkinleye%26aufirst%3DA.%26aulast%3DMukhi%26aufirst%3DN.%26aulast%3DMittal%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DSTAT%2520inhibitors%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2013%26volume%3D6%26spage%3D90%26doi%3D10.1186%2F1756-8722-6-90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuasa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">Phase I study of OPB-31121, an oral STAT3 inhibitor, in patients with advanced solid tumors</span> <span class="citation_source-journal">Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.4143/crt.2014.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.4143%2Fcrt.2014.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=25715763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A280%3ADC%252BC2MroslKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=607-615&author=D.+Y.+Ohauthor=S.+H.+Leeauthor=S.+W.+Hanauthor=M.+J.+Kimauthor=T.+M.+Kimauthor=T.+Y.+Kimauthor=D.+S.+Heoauthor=M.+Yuasaauthor=Y.+Yanagiharaauthor=Y.+J.+Bang&title=Phase+I+study+of+OPB-31121%2C+an+oral+STAT3+inhibitor%2C+in+patients+with+advanced+solid+tumors&doi=10.4143%2Fcrt.2014.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Oh Do-Youn; Lee Se-Hoon; Han Sae-Won; Kim Mi-Jung; Kim Tae-Min; Kim Tae-You; Heo Dae Seog; Bang Yung-Jue; Oh Do-Youn; Lee Se-Hoon; Han Sae-Won; Kim Mi-Jung; Kim Tae-Min; Kim Tae-You; Heo Dae Seog; Bang Yung-Jue; Yuasa Miyuki; Yanagihara Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer research and treatment : official journal of Korean Cancer Association</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">607-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  OPB-31121 is an oral STAT3 inhibitor with a good preclinical antitumor activity.  This phase I dose-escalation study of OPB-31121 was conducted to determine maximum-tolerated dose (MTD), safety, pharmacokinetics, and preliminary antitumor efficacy in patients with advanced solid tumors.  MATERIALS AND METHODS:  Patients received OPB-31121 once daily for 28 days of each cycle followed by 2 weeks rest.  A standard 3+3 design was used for dose-escalation.  Safety and response were evaluated by the National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE) ver. 3.0 and Response Evaluation Criteria in Solid Tumor (RECIST) ver. 1.0, respectively.  RESULTS:  Twenty-five patients were treated with OPB-31121 at five dose levels: 100 mg (n=4), 200 mg (n=3), 400 mg (n=3), 600 mg (n=7), and 800 mg (n=8).  Seven patients discontinued treatment during cycle 1 for various reasons other than study drug-related adverse events.  Among 18 patients who were evaluable for dose-limiting toxicity (DLT), three DLTs were observed: one DLT (grade 3 vomiting) at 600 mg and two DLTs (grade 3 vomiting, grade 3 diarrhea) at 800 mg.  The MTD was determined as 800 mg/day.  Common adverse events were gastrointestinal adverse event including nausea (84%), vomiting (80%), and diarrhea (72%).  Pharmacokinetics did not demonstrate dose-proportionality of OPB-31121.  Eight patients had stable disease and 10 patients had disease progression.  Two patients (1 colon cancer, 1 rectal cancer) showed tumor shrinkage.  One gastric cancer patient continued treatment up to cycle 13 before disease progression.  CONCLUSION:  This study demonstrates feasibility of STAT3 inhibition in patients with advanced solid tumor.  OPB-31121, at the MTD of 800 mg/day, was safe and relatively well tolerated, and has a preliminary antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQO4HjIonre9iM8MEzWGjS9fW6udTcc2eYo-RStr2GNz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MroslKgug%253D%253D&md5=499f3d1b07c7760b88d12e1be071d398</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4143%2Fcrt.2014.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4143%252Fcrt.2014.249%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DHeo%26aufirst%3DD.%2BS.%26aulast%3DYuasa%26aufirst%3DM.%26aulast%3DYanagihara%26aufirst%3DY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DPhase%2520I%2520study%2520of%2520OPB-31121%252C%2520an%2520oral%2520STAT3%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Res.%2520Treat.%26date%3D2015%26volume%3D47%26spage%3D607%26epage%3D615%26doi%3D10.4143%2Fcrt.2014.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kim, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1016/j.canlet.2013.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.canlet.2013.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=23402820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFCltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2013&pages=145-152&author=M.+J.+Kimauthor=H.+J.+Namauthor=H.+P.+Kimauthor=S.+W.+Hanauthor=S.+A.+Imauthor=T.+Y.+Kimauthor=D.+Y.+Ohauthor=Y.+J.+Bang&title=OPB-31121%2C+a+novel+small+molecular+inhibitor%2C+disrupts+the+JAK2%2FSTAT3+pathway+and+exhibits+an+antitumor+activity+in+gastric+cancer+cells&doi=10.1016%2Fj.canlet.2013.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells</span></div><div class="casAuthors">Kim, Mi-Jung; Nam, Hyun-Jin; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We investigated the mechanisms of action and antitumor effects of OPB-31121, a novel STAT3 inhibitor, in gastric cancer cells.  OPB-31121 downregulated JAK2 and gp130 expression and inhibited JAK2 phosphorylation which leads to inhibition of STAT3 phosphorylation.  OPB-31121 inhibited constitutively activated and IL-6-induced JAK/STAT signaling pathway.  OPB-31121 decreased cell proliferation in both gastric cancer cells and in a xenograft model, induced the apoptosis of gastric cancer cells, inhibited the expression of antiapoptotic proteins, and showed synergism with 5-fluorouracil and cisplatin.  Taken together, our study suggests that STAT3 inhibition with OPB-31121 can be tested in patients with gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW53W7Zb1lHbVg90H21EOLACvtfcHk0lglrCYZZMMIeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFCltbs%253D&md5=b96912c6bd814e45f0cadc88ef276240</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DNam%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BP.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DIm%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DOPB-31121%252C%2520a%2520novel%2520small%2520molecular%2520inhibitor%252C%2520disrupts%2520the%2520JAK2%252FSTAT3%2520pathway%2520and%2520exhibits%2520an%2520antitumor%2520activity%2520in%2520gastric%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2013%26volume%3D335%26spage%3D145%26epage%3D152%26doi%3D10.1016%2Fj.canlet.2013.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Okusaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokosuka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okita, K.</span><span> </span><span class="NLM_article-title">Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma</span> <span class="citation_source-journal">Hepatol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span><span class="refDoi"> DOI: 10.1111/hepr.12504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1111%2Fhepr.12504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=25676869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVCrt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=1283-1291&author=T.+Okusakaauthor=H.+Uenoauthor=M.+Ikedaauthor=S.+Mitsunagaauthor=M.+Ozakaauthor=H.+Ishiiauthor=O.+Yokosukaauthor=Y.+Ookaauthor=R.+Yoshimotoauthor=Y.+Yanagiharaauthor=K.+Okita&title=Phase+1+and+pharmacological+trial+of+OPB-31121%2C+a+signal+transducer+and+activator+of+transcription-3+inhibitor%2C+in+patients+with+advanced+hepatocellular+carcinoma&doi=10.1111%2Fhepr.12504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma</span></div><div class="casAuthors">Okusaka, Takuji; Ueno, Hideki; Ikeda, Masafumi; Mitsunaga, Shuichi; Ozaka, Masato; Ishii, Hiroshi; Yokosuka, Osamu; Ooka, Yoshihiko; Yoshimoto, Ryo; Yanagihara, Yasuo; Okita, Kiwamu</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1283-1291</span>CODEN:
                <span class="NLM_cas:coden">HPRSFM</span>;
        ISSN:<span class="NLM_cas:issn">1386-6346</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim : To evaluate the safety, pharmacokinetics and antitumor activity of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma (HCC).  Methods : HCC patients of Child-Pugh A or B who progressed on, or were intolerant to, sorafenib were eligible for this phase 1 trial.  We used a std. 3 + 3 dose-escalation design with a 28-day cycle at dose levels of 50, 100, 200 and 400 mg/day.  Tumor responses were assessed using the modified Response Evaluation Criteria in Solid Tumors.  Results : Twenty-four patients were enrolled, of whom 23 received OPB-31121 (20 males; median age, 65 years).  The most common adverse drug reactions were nausea (87.0%), vomiting (82.6%), diarrhea (69.6%), fatigue/malaise (52.2%), anorexia (47.8%) and peripheral sensory neuropathy (26.1%).  The recommended dose for OPB-31121 was detd. to be 200 mg.  Six patients had stable disease for 8 wk or more, resulting in disease control rates of 25.0-42.9%.  In the 200-mg dose cohort, three of seven patients had stable disease and a median time to progression of 61.0 days.  The max. concn. and area under the plasma concn.-time curve of OPB-31121 were dose proportional.  Conclusion : OPB-31121 demonstrated insufficient antitumor activity for HCC.  Furthermore, peripheral nervous system-related toxicities may neg. affect long-term administration of OPB-31121.  Therefore, it was deemed difficult to continue the clin. development of OPB-31121 for treating advanced HCC and further investigation is expected in the agent with favorable profile in this category.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYU_Xm9vcDkrVg90H21EOLACvtfcHk0lhGwDXGshhEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVCrt7zP&md5=576b55c63e52851a2aee30e8302355c0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fhepr.12504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fhepr.12504%26sid%3Dliteratum%253Aachs%26aulast%3DOkusaka%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DMitsunaga%26aufirst%3DS.%26aulast%3DOzaka%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DYokosuka%26aufirst%3DO.%26aulast%3DOoka%26aufirst%3DY.%26aulast%3DYoshimoto%26aufirst%3DR.%26aulast%3DYanagihara%26aufirst%3DY.%26aulast%3DOkita%26aufirst%3DK.%26atitle%3DPhase%25201%2520and%2520pharmacological%2520trial%2520of%2520OPB-31121%252C%2520a%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription-3%2520inhibitor%252C%2520in%2520patients%2520with%2520advanced%2520hepatocellular%2520carcinoma%26jtitle%3DHepatol.%2520Res.%26date%3D2015%26volume%3D45%26spage%3D1283%26epage%3D1291%26doi%3D10.1111%2Fhepr.12504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bendell, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchook, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricmont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elekes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rock, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurzrock, R.</span><span> </span><span class="NLM_article-title">Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1007/s00280-014-2480-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1007%2Fs00280-014-2480-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=24819685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvFCisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=125-130&author=J.+C.+Bendellauthor=D.+S.+Hongauthor=H.+A.+Burrisauthor=A.+Naingauthor=S.+F.+Jonesauthor=G.+Falchookauthor=P.+Bricmontauthor=A.+Elekesauthor=E.+P.+Rockauthor=R.+Kurzrock&title=Phase+1%2C+open-label%2C+dose-escalation%2C+and+pharmacokinetic+study+of+STAT3+inhibitor+OPB-31121+in+subjects+with+advanced+solid+tumors&doi=10.1007%2Fs00280-014-2480-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors</span></div><div class="casAuthors">Bendell, Johanna C.; Hong, David S.; Burris, Howard A., III; Naing, Aung; Jones, Suzanne F.; Falchook, Gerald; Bricmont, Patricia; Elekes, Agnes; Rock, Edwin P.; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-130</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To det. the max. tolerated dose (MTD) and biol. activity of OPB-31121, an oral inhibitor of STAT3, administered twice daily (BID) to subjects with advanced solid tumors.  Methods: .  Subjects received escalating doses of OPB-31121 BID for the first 21 days of each 28-day cycle in a std. 3 + 3 design.  Dose-limiting toxicities (DLTs), safety, pharmacokinetics, and antitumor activity were assessed.  Results: Thirty subjects were treated twice daily with OPB-31121 at 6 dose levels: 50 mg (n = 4); 70 mg (n = 3); 140 mg (n = 3); 200 mg (n = 4); 300 mg (n = 9); 350 mg (n = 7).  There were no DLTs obsd. until 300 mg BID (Grade 3 lactic acidosis).  At the next dose level (350 mg BID), two subjects had DLTs (Grade 3 vomiting and Grade 3 diarrhea).  Thus, 300 mg BID was declared the MTD.  OPB-31121-related adverse events included nausea (80 %), vomiting (73 %), diarrhea (63 %), and fatigue (33 %), all of which were primarily grade 1/2.  Pharmacokinetics demonstrated high inter-subject variability with exposures 146- to 4,788-fold lower than target concns. from tumor-bearing mouse models.  No objective responses were obsd., and all subjects who completed two cycles of treatment had disease progression at their first assessment.  Conclusions: Twice-daily administration of OPB-31121 was feasible up to doses of 300 mg.  The pharmacokinetic profile was unfavorable, and no objective responses were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3-0uiCzM9V7Vg90H21EOLACvtfcHk0lhGwDXGshhEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvFCisLo%253D&md5=b3e9de791b6bcd79368a006c08641cf5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00280-014-2480-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-014-2480-2%26sid%3Dliteratum%253Aachs%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DHong%26aufirst%3DD.%2BS.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DNaing%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DFalchook%26aufirst%3DG.%26aulast%3DBricmont%26aufirst%3DP.%26aulast%3DElekes%26aufirst%3DA.%26aulast%3DRock%26aufirst%3DE.%2BP.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DPhase%25201%252C%2520open-label%252C%2520dose-escalation%252C%2520and%2520pharmacokinetic%2520study%2520of%2520STAT3%2520inhibitor%2520OPB-31121%2520in%2520subjects%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2014%26volume%3D74%26spage%3D125%26epage%3D130%26doi%3D10.1007%2Fs00280-014-2480-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hayakawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurahashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, T.</span><span> </span><span class="NLM_article-title">A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases</span> <span class="citation_source-journal">Blood Cancer J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e166</span><span class="refDoi"> DOI: 10.1038/bcj.2013.63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1038%2Fbcj.2013.63" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e166&author=F.+Hayakawaauthor=K.+Sugimotoauthor=Y.+Haradaauthor=N.+Hashimotoauthor=N.+Ohiauthor=S.+Kurahashiauthor=T.+Naoe&title=A+novel+STAT+inhibitor%2C+OPB-31121%2C+has+a+significant+antitumor+effect+on+leukemia+with+STAT-addictive+oncokinases&doi=10.1038%2Fbcj.2013.63"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fbcj.2013.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbcj.2013.63%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DF.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DN.%26aulast%3DOhi%26aufirst%3DN.%26aulast%3DKurahashi%26aufirst%3DS.%26aulast%3DNaoe%26aufirst%3DT.%26atitle%3DA%2520novel%2520STAT%2520inhibitor%252C%2520OPB-31121%252C%2520has%2520a%2520significant%2520antitumor%2520effect%2520on%2520leukemia%2520with%2520STAT-addictive%2520oncokinases%26jtitle%3DBlood%2520Cancer%2520J.%26date%3D2013%26volume%3D3%26spage%3De166%26doi%3D10.1038%2Fbcj.2013.63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zhong, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, C. H.</span><span> </span><span class="NLM_article-title">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">5400</span><span class="NLM_x">–</span> <span class="NLM_lpage">5408</span><span class="refDoi"> DOI: 10.1039/C5SC02321A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1039%2FC5SC02321A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=28757943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=5400-5408&author=H.+J.+Zhongauthor=L.+H.+Luauthor=K.+H.+Leungauthor=C.+C.+L.+Wongauthor=C.+Pengauthor=S.+C.+Yanauthor=D.+L.+Maauthor=Z.+W.+Caiauthor=H.+M.+D.+Wangauthor=C.+H.+Leung&title=An+iridium%28III%29-based+irreversible+protein-protein+interaction+inhibitor+of+BRD4+as+a+potent+anticancer+agent&doi=10.1039%2FC5SC02321A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent</span></div><div class="casAuthors">Zhong, Hai-Jing; Lu, Lihua; Leung, Ka-Ho; Wong, Catherine C. L.; Peng, Chao; Yan, Siu-Cheong; Ma, Dik-Lung; Cai, Zongwei; David Wang, Hui-Min; Leung, Chung-Hang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5400-5408</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Bromodomain-contg. protein 4 (BRD4) has recently emerged as an attractive epigenetic target for anticancer therapy.  In this study, an iridium(III) complex is reported as the first metal-based, irreversible inhibitor of BRD4.  Complex 1a is able to antagonize the BRD4-acetylated histone protein-protein interaction (PPI) in vitro, and to bind BRD4 and down-regulate c-myc oncogenic expression in cellulo.  Chromatin immunopptn. (ChIP) anal. revealed that 1a could modulate the interaction between BRD4 and chromatin in melanoma cells, particular at the MYC promoter.  Finally, the complex showed potent activity against melanoma xenografts in an in vivo mouse model.  To our knowledge, this is the first report of a Group 9 metal complex inhibiting the PPI of a member of the bromodomain and extraterminal domain (BET) family.  We envision that complex 1a may serve as a useful scaffold for the development of more potent epigenetic agents against cancers such as melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMXspNfXFlbVg90H21EOLACvtfcHk0ljf31yTtoRFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Grtr7E&md5=ae176cbfd3621dd7939c234d643db84e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2FC5SC02321A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC02321A%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%2BJ.%26aulast%3DLu%26aufirst%3DL.%2BH.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DWong%26aufirst%3DC.%2BC.%2BL.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DS.%2BC.%26aulast%3DMa%26aufirst%3DD.%2BL.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DWang%26aufirst%3DH.%2BM.%2BD.%26aulast%3DLeung%26aufirst%3DC.%2BH.%26atitle%3DAn%2520iridium%2528III%2529-based%2520irreversible%2520protein-protein%2520interaction%2520inhibitor%2520of%2520BRD4%2520as%2520a%2520potent%2520anticancer%2520agent%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D5400%26epage%3D5408%26doi%3D10.1039%2FC5SC02321A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Leung, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D. L.</span><span> </span><span class="NLM_article-title">A natural product-like inhibitor of NEDD8-activating enzyme</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2511</span><span class="NLM_x">–</span> <span class="NLM_lpage">2513</span><span class="refDoi"> DOI: 10.1039/c0cc04927a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1039%2Fc0cc04927a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21240405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2511-2513&author=C.+H.+Leungauthor=D.+S.+Chanauthor=H.+Yangauthor=R.+Abagyanauthor=S.+M.+Leeauthor=G.+Y.+Zhuauthor=W.+F.+Fongauthor=D.+L.+Ma&title=A+natural+product-like+inhibitor+of+NEDD8-activating+enzyme&doi=10.1039%2Fc0cc04927a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A natural product-like inhibitor of NEDD8-activating enzyme</span></div><div class="casAuthors">Leung, Chung-Hang; Chan, Daniel Shiu-Hin; Yang, Hui; Abagyan, Ruben; Lee, Simon Ming-Yuen; Zhu, Guo-Yuan; Fong, Wang-Fun; Ma, Dik-Lung</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2511-2513</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The natural product-like 6,6''-biapigenin has been identified as only the second inhibitor of NEDD8-activating enzyme using virtual screening.  This compd. was active in enzyme and cell-based assays, with potency in the micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIgh-oaWCxuLVg90H21EOLACvtfcHk0ljf31yTtoRFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVCmt7s%253D&md5=8783a238deaf9306f1bdaca88ab0575e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc0cc04927a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0cc04927a%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DC.%2BH.%26aulast%3DChan%26aufirst%3DD.%2BS.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DG.%2BY.%26aulast%3DFong%26aufirst%3DW.%2BF.%26aulast%3DMa%26aufirst%3DD.%2BL.%26atitle%3DA%2520natural%2520product-like%2520inhibitor%2520of%2520NEDD8-activating%2520enzyme%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D2511%26epage%3D2513%26doi%3D10.1039%2Fc0cc04927a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Computer-aided drug discovery</span> <span class="citation_source-journal">F1000Research</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="refDoi"> DOI: 10.12688/f1000research.6653.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.12688%2Ff1000research.6653.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=630&author=J.+Bajorath&title=Computer-aided+drug+discovery&doi=10.12688%2Ff1000research.6653.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided drug discovery [version 1; referees: 3 approved]</span></div><div class="casAuthors">Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">F1000Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">630/1-630/8</span>CODEN:
                <span class="NLM_cas:coden">FRESJL</span>;
        ISSN:<span class="NLM_cas:issn">2046-1402</span>.
    
            (<span class="NLM_cas:orgname">F1000 Research Ltd.</span>)
        </div><div class="casAbstract">Computational approaches are an integral part of interdisciplinary drug discovery research.  Understanding the science behind computational tools, their opportunities, and limitations is essential to make a true impact on drug discovery at different levels.  If applied in a scientifically meaningful way, computational methods improve the ability to identify and evaluate potential drug mols., but there remain weaknesses in the methods that preclude na.ovrddot.ive applications.  Herein, current trends in computer-aided drug discovery are reviewed, and selected computational areas are discussed.  Approaches are highlighted that aid in the identification and optimization of new drug candidates.  Emphasis is put on the presentation and discussion of computational concepts and methods, rather than case studies or application examples.  As such, this contribution aims to provide an overview of the current methodol. spectrum of computational drug discovery for a broad audience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol8_WWMna927Vg90H21EOLACvtfcHk0ljf31yTtoRFhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsFOitbo%253D&md5=8766cd816d41aa01356ffce757026720</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.6653.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.6653.1%26sid%3Dliteratum%253Aachs%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputer-aided%2520drug%2520discovery%26jtitle%3DF1000Research%26date%3D2015%26volume%3D4%26spage%3D630%26doi%3D10.12688%2Ff1000research.6653.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Computational exploration of molecular scaffolds in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4062</span><span class="NLM_x">–</span> <span class="NLM_lpage">4076</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVygur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4062-4076&author=Y.+Huauthor=D.+Stumpfeauthor=J.+Bajorath&title=Computational+exploration+of+molecular+scaffolds+in+medicinal+chemistry&doi=10.1021%2Facs.jmedchem.5b01746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Exploration of Molecular Scaffolds in Medicinal Chemistry</span></div><div class="casAuthors">Hu, Ye; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4062-4076</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The scaffold concept is widely applied in medicinal chem.  Scaffolds are mostly used to represent core structures of bioactive compds.  Although the scaffold concept has limitations and is often viewed differently from a chem. and computational perspective, it has provided a basis for systematic investigations of mol. cores and building blocks, going far beyond the consideration of individual compd. series.  Over the past 2 decades, alternative scaffold definitions and organization schemes have been introduced and scaffolds have been studied in a variety of ways and increasingly on a large scale.  Major applications of the scaffold concept include the generation of mol. hierarchies, structural classification, assocn. of scaffolds with biol. activities, and activity prediction.  This contribution discusses computational approaches for scaffold generation and anal., with emphasis on recent developments impacting medicinal chem.  A variety of scaffold-based studies are discussed, and a perspective on scaffold methods is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMic25FvCi3LVg90H21EOLACvtfcHk0lhAcEa1VfsI7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVygur4%253D&md5=4f3af64c39e7a2844350fb9b73452b98</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01746%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputational%2520exploration%2520of%2520molecular%2520scaffolds%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4062%26epage%3D4076%26doi%3D10.1021%2Facs.jmedchem.5b01746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">A novel small-molecule disrupts STAT3 SH2 domain-phosphotyrosine interactions and STAT3-dependent tumor processes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.bcp.2010.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=20067773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVCnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1398-1409&author=X.+Zhangauthor=P.+Yueauthor=S.+Fletcherauthor=W.+Zhaoauthor=P.+T.+Gunningauthor=J.+Turkson&title=A+novel+small-molecule+disrupts+STAT3+SH2+domain-phosphotyrosine+interactions+and+STAT3-dependent+tumor+processes&doi=10.1016%2Fj.bcp.2010.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes</span></div><div class="casAuthors">Zhang, Xiaolei; Yue, Peibin; Fletcher, Steven; Zhao, Wei; Gunning, Patrick T.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1398-1409</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The mol. modeling of the phosphotyrosine (pTyr)-SH2 domain interaction in the Stat3:Stat3 dimerization, combined with in silico structural anal. of the Stat3 dimerization disruptor, S3I-201, has furnished a diverse set of analogs.  We present evidence from in vitro biochem. and biophys. studies that the structural analog, S3I-201.1066 (I) directly interacts with Stat3 or the SH2 domain, with an affinity (KD) of 2.74 μM, and disrupts the binding of Stat3 to the cognate pTyr-peptide, GpYLPQTV-NH2, with an IC50 of 23 μM.  Moreover, I selectively blocks the assocn. of Stat3 with the epidermal growth factor receptor (EGFR), and inhibits Stat3 tyrosine phosphorylation and nuclear translocation in EGF-stimulated mouse fibroblasts.  In cancer cells that harbor aberrant Stat3 activity, I inhibits constitutive Stat3 DNA-binding and transcriptional activities.  By contrast, I has no effect on Src activation or the EGFR-mediated activation of the Erk1/2MAPK pathway.  I selectively suppresses the viability, survival, and malignant transformation of the human breast and pancreatic cancer lines and the v-Src-transformed mouse fibroblasts harboring persistently active Stat3.  Treatment with I of malignant cells harboring aberrantly active Stat3 down-regulated the expression of c-Myc, Bcl-xL, Survivin, the matrix metalloproteinase 9, and VEGF.  The in vivo administration of I-induced significant antitumor response in mouse models of human breast cancer, which correlates with the inhibition of constitutively active Stat3 and the suppression of known Stat3-regulated genes.  Our studies identify a novel small-mol. that binds with a high affinity to Stat3, blocks Stat3 activation and function, and thereby induces antitumor response in human breast tumor xenografts harboring persistently active Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxJzIoqCaQHbVg90H21EOLACvtfcHk0lhAcEa1VfsI7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVCnsL8%253D&md5=4a196103d1d0f6d057715ff4cd2d7498</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small-molecule%2520disrupts%2520STAT3%2520SH2%2520domain-phosphotyrosine%2520interactions%2520and%2520STAT3-dependent%2520tumor%2520processes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1398%26epage%3D1409%26doi%3D10.1016%2Fj.bcp.2010.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutzen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foust, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhasin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1593/neo.91196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1593%2Fneo.91196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=39-50&author=L.+Linauthor=B.+Hutzenauthor=P.+K.+Liauthor=S.+Ballauthor=M.+Zuoauthor=S.+DeAngelisauthor=E.+Foustauthor=M.+Soboauthor=L.+Friedmanauthor=D.+Bhasinauthor=L.+Cenauthor=C.+Liauthor=J.+Lin&title=A+novel+small+molecule%2C+LLL12%2C+inhibits+STAT3+phosphorylation+and+activities+and+exhibits+potent+growth-suppressive+activity+in+human+cancer+cells&doi=10.1593%2Fneo.91196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1593%2Fneo.91196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.91196%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DHutzen%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DBall%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DM.%26aulast%3DDeAngelis%26aufirst%3DS.%26aulast%3DFoust%26aufirst%3DE.%26aulast%3DSobo%26aufirst%3DM.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DCen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small%2520molecule%252C%2520LLL12%252C%2520inhibits%2520STAT3%2520phosphorylation%2520and%2520activities%2520and%2520exhibits%2520potent%2520growth-suppressive%2520activity%2520in%2520human%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2010%26volume%3D12%26spage%3D39%26epage%3D50%26doi%3D10.1593%2Fneo.91196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Szelag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerwoniec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesoly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluyssen, H. A.</span><span> </span><span class="NLM_article-title">Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0116688</span><span class="refDoi"> DOI: 10.1371/journal.pone.0116688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1371%2Fjournal.pone.0116688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=25710482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ClsrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0116688&author=M.+Szelagauthor=A.+Czerwoniecauthor=J.+Wesolyauthor=H.+A.+Bluyssen&title=Identification+of+STAT1+and+STAT3+specific+inhibitors+using+comparative+virtual+screening+and+docking+validation&doi=10.1371%2Fjournal.pone.0116688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation</span></div><div class="casAuthors">Szelag, Malgorzata; Czerwoniec, Anna; Wesoly, Joanna; Bluyssen, Hans A. R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0116688/1-e0116688/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Signal transducers and activators of transcription (STATs) facilitate action of cytokines, growth factors and pathogens.  STAT activation is mediated by a highly conserved SH2 domain, which interacts with phosphotyrosine motifs for specific STAT-receptor contacts and STAT dimerization.  The active dimers induce gene transcription in the nucleus by binding to a specific DNA-response element in the promoter of target genes.  Abnormal activation of STAT signaling pathways is implicated in many human diseases, like cancer, inflammation and auto-immunity.  Searches for STAT-targeting compds., exploring the phosphotyrosine (pTyr)-SH2 interaction site, yielded many small mols. for STAT3 but sparsely for other STATs.  However, many of these inhibitors seem not STAT3-specific, thereby questioning the present modeling and selection strategies of SH2 domain-based STAT inhibitors.  We generated new 3D structure models for all human (h)STATs and developed a comparative in silico docking strategy to obtain further insight into STAT-SH2 cross-binding specificity of a selection of previously identified STAT3 inhibitors.  Indeed, by primarily targeting the highly conserved pTyr-SH2 binding pocket the majority of these compds. exhibited similar binding affinity and tendency scores for all STATs.  By comparative screening of a natural product library we provided initial proof for the possibility to identify STAT1 as well as STAT3-specific inhibitors, introducing the 'STAT-comparative binding affinity value' and 'ligand binding pose variation' as selection criteria.  In silico screening of a multi-million clean leads (CL) compd. library for binding of all STATs, likewise identified potential specific inhibitors for STAT1 and STAT3 after docking validation.  Based on comparative virtual screening and docking validation, we developed a novel STAT inhibitor screening tool that allows identification of specific STAT1 and STAT3 inhibitory compds.  This could increase our understanding of the functional role of these STATs in different diseases and benefit the clin. need for more drugable STAT inhibitors with high specificity, potency and excellent bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-INvAZE2X7Vg90H21EOLACvtfcHk0ljAJxdXiS1DzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ClsrbL&md5=db30348a06c759470c20a5ffe346367e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0116688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0116688%26sid%3Dliteratum%253Aachs%26aulast%3DSzelag%26aufirst%3DM.%26aulast%3DCzerwoniec%26aufirst%3DA.%26aulast%3DWesoly%26aufirst%3DJ.%26aulast%3DBluyssen%26aufirst%3DH.%2BA.%26atitle%3DIdentification%2520of%2520STAT1%2520and%2520STAT3%2520specific%2520inhibitors%2520using%2520comparative%2520virtual%2520screening%2520and%2520docking%2520validation%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0116688%26doi%3D10.1371%2Fjournal.pone.0116688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bohm, H. J.</span><span> </span><span class="NLM_article-title">The computer program LUDI: a new method for the de novo design of enzyme inhibitors</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1007/BF00124387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1007%2FBF00124387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1583540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A280%3ADyaK383mtVarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=61-78&author=H.+J.+Bohm&title=The+computer+program+LUDI%3A+a+new+method+for+the+de+novo+design+of+enzyme+inhibitors&doi=10.1007%2FBF00124387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The computer program LUDI: a new method for the de novo design of enzyme inhibitors</span></div><div class="casAuthors">Bohm H J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-78</span>
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    </div><div class="casAbstract">A new computer program is described, which positions small molecules into clefts of protein structures (e.g. an active site of an enzyme) in such a way that hydrogen bonds can be formed with the enzyme and hydrophobic pockets are filled with hydrophobic groups.  The program works in three steps.  First it calculates interaction sites, which are discrete positions in space suitable to form hydrogen bonds or to fill a hydrophobic pocket.  The interaction sites are derived from distributions of nonbonded contacts generated by a search through the Cambridge Structural Database.  An alternative route to generate the interaction sites is the use of rules.  The second step is the fit of molecular fragments onto the interaction sites.  Currently we use a library of 600 fragments for the fitting.  The final step in the present program is the connection of some or all of the fitted fragments to a single molecule.  This is done by bridge fragments.  Applications are presented for the crystal packing of benzoic acid and the enzymes dihydrofolate reductase and trypsin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaYlhxlen0XYvKgEt20y1XfW6udTcc2eadTq-y-oaqJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383mtVarsw%253D%253D&md5=430014acc628395868a68729410b09c0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2FBF00124387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00124387%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520computer%2520program%2520LUDI%253A%2520a%2520new%2520method%2520for%2520the%2520de%2520novo%2520design%2520of%2520enzyme%2520inhibitors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1992%26volume%3D6%26spage%3D61%26epage%3D78%26doi%3D10.1007%2FBF00124387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Multiple ligand simultaneous docking: orchestrated dancing of ligands in binding sites of protein</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2014</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span><span class="refDoi"> DOI: 10.1002/jcc.21486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fjcc.21486" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=2014-2022&author=H.+Liauthor=C.+Li&title=Multiple+ligand+simultaneous+docking%3A+orchestrated+dancing+of+ligands+in+binding+sites+of+protein&doi=10.1002%2Fjcc.21486"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21486%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DMultiple%2520ligand%2520simultaneous%2520docking%253A%2520orchestrated%2520dancing%2520of%2520ligands%2520in%2520binding%2520sites%2520of%2520protein%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D2014%26epage%3D2022%26doi%3D10.1002%2Fjcc.21486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">Schrödinger Release 2015-2:</p></div><div class="NLM_citation" id="rightTab-cit33"><span>LigPrep, version 3.4; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+3.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">Schrödinger Release 2015-2:</p></div><div class="NLM_citation" id="rightTab-cit34"><span>Canvas, version 2.4; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Canvas%2C+version+2.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCanvas%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Bhasin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etter, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chettiar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span> </span><span class="NLM_article-title">Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6864</span><span class="NLM_x">–</span> <span class="NLM_lpage">6867</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.bmcl.2013.09.098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6864-6867&author=D.+Bhasinauthor=J.+P.+Etterauthor=S.+N.+Chettiarauthor=M.+Mokauthor=P.+K.+Li&title=Antiproliferative+activities+and+SAR+studies+of+substituted+anthraquinones+and+1%2C4-naphthoquinones&doi=10.1016%2Fj.bmcl.2013.09.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.098%26sid%3Dliteratum%253Aachs%26aulast%3DBhasin%26aufirst%3DD.%26aulast%3DEtter%26aufirst%3DJ.%2BP.%26aulast%3DChettiar%26aufirst%3DS.%2BN.%26aulast%3DMok%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DP.%2BK.%26atitle%3DAntiproliferative%2520activities%2520and%2520SAR%2520studies%2520of%2520substituted%2520anthraquinones%2520and%25201%252C4-naphthoquinones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6864%26epage%3D6867%26doi%3D10.1016%2Fj.bmcl.2013.09.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">Schrödinger Release 2015-2:</p></div><div class="NLM_citation" id="rightTab-cit36a"><span>Protein Preparation Wizard;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Protein+Preparation+Wizard%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Preparation%2520Wizard" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span>Epik, version 3.2;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Epik%2C+version+3.2%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DEpik" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36c"><span>Impact, version 6.7;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Impact%2C+version+6.7%3B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DImpact" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36"><span>Prime, version 4.0; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+4.0%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2785</span><span class="NLM_x">–</span> <span class="NLM_lpage">2791</span><span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=Autodock4+and+AutoDockTools4%3A+automated+docking+with+selective+receptor+flexiblity&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljWI2GJ-lXGiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutodock4%2520and%2520AutoDockTools4%253A%2520automated%2520docking%2520with%2520selective%2520receptor%2520flexiblity%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span> </span><span class="NLM_article-title">Regioselective one-pot C-N coupling of substituted naphthoquinones: selective intramolecular ring fusion of sulfonamides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1016/j.tet.2013.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.tet.2013.11.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=459-464&author=W.+Yuauthor=C.+Li&title=Regioselective+one-pot+C-N+coupling+of+substituted+naphthoquinones%3A+selective+intramolecular+ring+fusion+of+sulfonamides&doi=10.1016%2Fj.tet.2013.11.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2013.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2013.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DRegioselective%2520one-pot%2520C-N%2520coupling%2520of%2520substituted%2520naphthoquinones%253A%2520selective%2520intramolecular%2520ring%2520fusion%2520of%2520sulfonamides%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26spage%3D459%26epage%3D464%26doi%3D10.1016%2Fj.tet.2013.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/j.ab.2008.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.ab.2008.01.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=249-254&author=J.+Mullerauthor=J.+Schustauthor=T.+Berg&title=A+high-throughput+assay+for+signal+transducer+and+activator+of+transcription+5b+based+on+fluorescence+polarization&doi=10.1016%2Fj.ab.2008.01.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2008.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2008.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DSchust%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DA%2520high-throughput%2520assay%2520for%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25205b%2520based%2520on%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D375%26spage%3D249%26epage%3D254%26doi%3D10.1016%2Fj.ab.2008.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">A cell-permeable STAT3 SH2 domain mimetic inhibits STAT3 activation and induces antitumor cell effects in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">35855</span><span class="NLM_x">–</span> <span class="NLM_lpage">35865</span><span class="refDoi"> DOI: 10.1074/jbc.M110.154088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1074%2Fjbc.M110.154088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=20807764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35855-35865&author=W.+Zhaoauthor=S.+Jaganathanauthor=J.+Turkson&title=A+cell-permeable+STAT3+SH2+domain+mimetic+inhibits+STAT3+activation+and+induces+antitumor+cell+effects+in+vitro&doi=10.1074%2Fjbc.M110.154088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro</span></div><div class="casAuthors">Zhao, Wei; Jaganathan, Soumya; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">35855-35865</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Given the role of constitutively active Signal Transducer and Activator of Transcription (Stat) 3 in human tumors, Stat3 inhibitors would be useful as novel therapeutics and as tools for probing Stat3-mediated tumor processes.  We herein report that a 28-mer peptide, SPI, derived from the Stat3 SH2 domain, replicates Stat3 biochem. properties.  Studies show SPI and Stat3 (or Stat3 SH2 domain) bind with similar affinities to known Stat3-binding phosphotyrosine (pY) peptide motifs, including those of the epidermal growth factor receptor (EGFR) and the high-affinity, IL-6R/gp130-derived pY-peptide, GpYLPQTV-NH2.  Consequently, SPI functions as a potent and selective inhibitor of Stat3 SH2 domain:pTyr interactions and disrupts the binding of Stat3 to the IL-6R/gp130 peptide, GpYLPQTV-NH2.  Fluorescence imaging and immunofluorescence staining/laser-scanning confocal microscopy show SPI is cell membrane-permeable, assocs. with the cytoplasmic tail of EGFR in NIH3T3/hEGFR, and is present in the cytoplasm, but strongly localized at the plasma membrane and in the nucleus in malignant cells harboring persistently active Stat3.  Moreover, SPI specifically blocks constitutive Stat3 phosphorylation, DNA binding activity, and transcriptional function in malignant cells, with little or no effect on the induction of Stat1, Stat5, and Erk1/2MAPK pathways, or on general pTyr profile at the concns. that inhibit Stat3 activity.  Significantly, treatment with SPI of human breast, pancreatic, prostate, and non-small cell lung cancer cells harboring constitutively active Stat3 induced extensive morphol. changes, assocd. with viability loss and apoptosis.  Our study identifies SPI as a novel mol. probe for interrogating Stat3 signaling and that functions as a selective inhibitor of Stat3 activation with antitumor cell effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5xNMqd5Ho5rVg90H21EOLACvtfcHk0ljWI2GJ-lXGiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyntLfL&md5=a1ac33150ab27d501fdb519800a3b406</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.154088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.154088%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DJaganathan%26aufirst%3DS.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DA%2520cell-permeable%2520STAT3%2520SH2%2520domain%2520mimetic%2520inhibits%2520STAT3%2520activation%2520and%2520induces%2520antitumor%2520cell%2520effects%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D35855%26epage%3D35865%26doi%3D10.1074%2Fjbc.M110.154088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Shahani, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharmeen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhai, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1016%2Fj.bmc.2010.12.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1823-1838&author=V.+M.+Shahaniauthor=P.+Yueauthor=S.+Fletcherauthor=S.+Sharmeenauthor=M.+A.+Sukhaiauthor=D.+P.+Luuauthor=X.+Zhangauthor=H.+Sunauthor=W.+Zhaoauthor=A.+D.+Schimmerauthor=J.+Turksonauthor=P.+T.+Gunning&title=Design%2C+synthesis%2C+and+in+vitro+characterization+of+novel+hybrid+peptidomimetic+inhibitors+of+STAT3+protein&doi=10.1016%2Fj.bmc.2010.12.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DShahani%26aufirst%3DV.%2BM.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DSharmeen%26aufirst%3DS.%26aulast%3DSukhai%26aufirst%3DM.%2BA.%26aulast%3DLuu%26aufirst%3DD.%2BP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520characterization%2520of%2520novel%2520hybrid%2520peptidomimetic%2520inhibitors%2520of%2520STAT3%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1823%26epage%3D1838%26doi%3D10.1016%2Fj.bmc.2010.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2011.01932.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1111%2Fj.1349-7006.2011.01932.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=21435102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlShsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2011&pages=1381-1387&author=A.+Liuauthor=Y.+Liuauthor=Z.+Xuauthor=W.+Yuauthor=H.+Wangauthor=C.+Liauthor=J.+Lin&title=Novel+small+molecule%2C+XZH-5%2C+inhibits+constitutive+and+interleukin-6-induced+STAT3+phosphorylation+in+human+rhabdomyosarcoma+cells&doi=10.1111%2Fj.1349-7006.2011.01932.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells</span></div><div class="casAuthors">Liu, Aiguo; Liu, Yan; Xu, Zhenghu; Yu, Wenying; Wang, Hong; Li, Chenglong; Lin, Jiayuh</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1381-1387</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Signal transducers and activators of transcription 3 (STAT3) signaling is constitutively activated in many types of human cancers and cancer cell lines and represents a promising target for cancer therapy.  We previously reported that the STAT3 signaling pathway is constitutively activated in human rhabodomyosarcoma cell lines (RH28, RH30 and RD2).  We also demonstrated that inhibition of the STAT3 pathway led to apoptosis in human rhabdomyosarcoma cells.  In the present study, we investigated the inhibitory effects of a novel small mol., XZH-5, on the STAT3 signaling pathway in human rhabdomyosarcoma cells.  XZH-5 was designed based on STAT3 structure, and our idea was to design peptide mimics to bind to the phosphorylated Tyr705 site and the side pocket.  We found that XZH-5 downregulated STAT3 phosphorylation.  The inhibition of STAT3 by XZH-5 was confirmed by the inhibition of STAT3 DNA binding ability and the downregulation of STAT3 downstream genes, such as Bcl-2, Bcl-xL, Cyclin D1 and Survivin; we also demonstrated that blockade of STAT3 phosphorylation in human rhabdomyosarcoma cells with XZH-5 caused apoptosis and suppressed colony-forming ability and cell migration.  In addn. to reducing constitutive STAT3 phosphorylation, XZH-5 also exhibited the potency to block interleukin-6 (IL-6)-induced STAT3 phosphorylation and nuclear translocation but did not inhibit the stimulation of STAT1 phosphorylation by interferon (IFN)-γ.  Our findings indicate that XZH-5 has the potential for targeting human rhabdomyosarcoma cells expressing constitutive STAT3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaOC1XRYzhHLVg90H21EOLACvtfcHk0lhKQWlRl4IqTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlShsr8%253D&md5=29479872d0d577206c1e99d81df85d76</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2011.01932.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2011.01932.x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DNovel%2520small%2520molecule%252C%2520XZH-5%252C%2520inhibits%2520constitutive%2520and%2520interleukin-6-induced%2520STAT3%2520phosphorylation%2520in%2520human%2520rhabdomyosarcoma%2520cells%26jtitle%3DCancer%2520Sci.%26date%3D2011%26volume%3D102%26spage%3D1381%26epage%3D1387%26doi%3D10.1111%2Fj.1349-7006.2011.01932.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, C.</span><span> </span><span class="NLM_article-title">The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3190</span><span class="NLM_x">–</span> <span class="NLM_lpage">3202</span><span class="refDoi"> DOI: 10.1128/MCB.00159-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=10.1128%2FMCB.00159-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=22665497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2itrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=3190-3202&author=H.+Wangauthor=M.+Jiangauthor=H.+Cuiauthor=M.+Chenauthor=R.+Buttyanauthor=S.+W.+Haywardauthor=T.+Haiauthor=Z.+Wangauthor=C.+Yan&title=The+stress+response+mediator+ATF3+represses+androgen+signaling+by+binding+the+androgen+receptor&doi=10.1128%2FMCB.00159-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor</span></div><div class="casAuthors">Wang, Hongbo; Jiang, Ming; Cui, Hongmei; Chen, Mengqian; Buttyan, Ralph; Hayward, Simon W.; Hai, Tsonwin; Wang, Zhengxin; Yan, Chunhong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3190-3202</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Activating transcription factor 3 (ATF3) is a common mediator of cellular stress response signaling and is often aberrantly expressed in prostate cancer.  The authors report that ATF3 can directly bind the androgen receptor (AR) and consequently repress AR-mediated gene expression.  The ATF3-AR interaction requires the leucine zipper domain of ATF3 that independently binds the DNA-binding and ligand-binding domains of AR, and the interaction prevents AR from binding to cis-acting elements required for expression of androgen-dependent genes while inhibiting the AR N- and C-terminal interaction.  The functional consequences of the loss of ATF3 expression include increased transcription of androgen-dependent genes in prostate cancer cells that correlates with increased ability to grow in low-androgen-contg. medium and increased proliferative activity of the prostate epithelium in ATF3 knockout mice that is assocd. with prostatic hyperplasia.  The authors' results thus demonstrate that ATF3 is a novel repressor of androgen signaling that can inhibit AR functions, allowing prostate cells to restore homeostasis and maintain integrity in the face of a broad spectrum of intrinsic and environmental insults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaTv9uACvuvbVg90H21EOLACvtfcHk0lhKQWlRl4IqTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2itrjK&md5=a6b63480303c69c660803b5022504bec</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1128%2FMCB.00159-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00159-12%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DButtyan%26aufirst%3DR.%26aulast%3DHayward%26aufirst%3DS.%2BW.%26aulast%3DHai%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DC.%26atitle%3DThe%2520stress%2520response%2520mediator%2520ATF3%2520represses%2520androgen%2520signaling%2520by%2520binding%2520the%2520androgen%2520receptor%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2012%26volume%3D32%26spage%3D3190%26epage%3D3202%26doi%3D10.1128%2FMCB.00159-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1','PDB','1BG1'); return false;">PDB: 1BG1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF5','PDB','1BF5'); return false;">PDB: 1BF5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U','PDB','1Y1U'); return false;">PDB: 1Y1U</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF1','PDB','1BF1'); return false;">PDB: 1BF1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01489">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_33241"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01489">10.1021/acs.jmedchem.6b01489</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Design, biological assays, PAINS assay and methods, and method validation of the pharmacokinetic study (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_002.csv">CSV</a>)</p></li><li><p class="inline">Atomic coordinates of the STAT3/<b>9</b>/(FC of <b>9</b>) complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Atomic coordinates of the STAT5/<b>9</b> complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_004.pdb">PDB</a>)</p></li><li><p class="inline">Atomic coordinates of the STAT1/<b>9</b> complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_005.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_001.pdf">jm6b01489_si_001.pdf (1.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_002.csv">jm6b01489_si_002.csv (0.58 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_003.pdb">jm6b01489_si_003.pdb (162.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_004.pdb">jm6b01489_si_004.pdb (702.22 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01489/suppl_file/jm6b01489_si_005.pdb">jm6b01489_si_005.pdb (701.63 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">STAT3β/DNA complex: Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BG1">1BG1</a>. STAT1/DNA complex: Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1BF1">1BF1</a>. STAT5A: Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U">1Y1U</a>. The authors will release the atomic coordinates of the STAT3/<b>9</b>/(FC of <b>9</b>) complex, STAT1/<b>9</b> complex, and STAT5/<b>9</b> complex and the experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01489&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01489%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01489" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66798625ad5932a9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
